<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Catal</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Catal</journal-id>
    <journal-id journal-id-type="publisher-id">cs</journal-id>
    <journal-id journal-id-type="coden">accacs</journal-id>
    <journal-title-group>
      <journal-title>ACS Catalysis</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2155-5435</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10510103</article-id>
    <article-id pub-id-type="doi">10.1021/acscatal.3c02278</article-id>
    <article-categories>
      <subj-group>
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Structure-Based
Design of Small Imine Reductase Panels
for Target Substrates</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <name>
          <surname>Yu</surname>
          <given-names>Yuqi</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8932-8763</contrib-id>
        <name>
          <surname>Rué Casamajo</surname>
          <given-names>Arnau</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1061-7800</contrib-id>
        <name>
          <surname>Finnigan</surname>
          <given-names>William</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4331-2675</contrib-id>
        <name>
          <surname>Schnepel</surname>
          <given-names>Christian</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Barker</surname>
          <given-names>Rhys</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Morrill</surname>
          <given-names>Charlotte</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Heath</surname>
          <given-names>Rachel S.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8061-4242</contrib-id>
        <name>
          <surname>De Maria</surname>
          <given-names>Leonardo</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath9">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8708-0781</contrib-id>
        <name>
          <surname>Turner</surname>
          <given-names>Nicholas J.</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath10">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4182-3500</contrib-id>
        <name>
          <surname>Scrutton</surname>
          <given-names>Nigel S.</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Department
of Chemistry, <institution>The University of Manchester,
Manchester Institute of Biotechnology</institution>, 131 Princess Street, Manchester M1 7DN, <country>U.K.</country></aff>
      <aff id="aff2"><label>‡</label>Augmented
Biologics Discovery &amp; Design, Department of Biologics Engineering, <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Cambridge CB21 6GH, <country>U.K.</country></aff>
      <aff id="aff3"><label>§</label>Medicinal
Chemistry, Research and Early Development, Respiratory and Immunology
(RI), <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Gothenburg 43150, <country>Sweden</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>yuqi.yu@astrazeneca.com</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>nicholas.turner@manchester.ac.uk</email>.</corresp>
      <corresp id="cor3"><label>*</label>Email: <email>nigel.scrutton@manchester.ac.uk</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>05</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <volume>13</volume>
    <issue>18</issue>
    <fpage>12310</fpage>
    <lpage>12321</lpage>
    <history>
      <date date-type="received">
        <day>19</day>
        <month>05</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>08</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0008" id="ab-tgr1"/>
      </p>
      <p>Biocatalysis is important in the discovery, development,
and manufacture
of pharmaceuticals. However, the identification of enzymes for target
transformations of interest requires major screening efforts. Here,
we report a structure-based computational workflow to prioritize protein
sequences by a score based on predicted activities on substrates,
thereby reducing a resource-intensive laboratory-based biocatalyst
screening. We selected imine reductases (IREDs) as a class of biocatalysts
to illustrate the application of the computational workflow termed
IREDFisher. Validation by using published data showed that IREDFisher
can retrieve the best enzymes and increase the hit rate by identifying
the top 20 ranked sequences. The power of IREDFisher is confirmed
by computationally screening 1400 sequences for chosen reductive amination
reactions with different levels of complexity. Highly active IREDs
were identified by only testing 20 samples in vitro. Our speed test
shows that it only takes 90 min to rank 85 sequences from user input
and 30 min for the established IREDFisher database containing 591
IRED sequences. IREDFisher is available as a user-friendly web interface
(<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher enables the rapid discovery of IREDs for applications
in synthesis and directed evolution studies, with minimal time and
resource expenditure. Future use of the workflow with other enzyme
families could be implemented following the modification of the workflow
scoring function.</p>
    </abstract>
    <kwd-group>
      <kwd>biocatalysis</kwd>
      <kwd>enzyme screening</kwd>
      <kwd>imine reductase</kwd>
      <kwd>computational workflow</kwd>
      <kwd>structural modeling</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>AstraZeneca</institution>
            <institution-id institution-id-type="doi">10.13039/100004325</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Biotechnology and Biological Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000268</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Engineering and Physical Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000266</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Enzymatic synthesis has gained growing
attention in recent years
due to the inherent advantages of benign reaction conditions along
with exquisite chemo-, stereo-, and regio-selectivity.<sup><xref ref-type="bibr" rid="ref1">1</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> However, finding the optimal biocatalyst to effect the transformation
of a substrate of interest is often challenging and time consuming.
There are two strategies commonly used in enzyme discovery (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, left panel). One
is to manually select the enzymes that have been reported to be active
toward similar substrate(s) in the literature. However, this approach
restricts the diversity of accessible enzymes and may result in potentially
active enzymes being missed. Consequently, the alternative strategy
of searching for homologous enzymes from databases is increasingly
applied. However, this approach typically generates a very large number
of sequences, the majority of which have not been characterized experimentally.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> Screening all of these sequences is time consuming, requiring the
extensive use of analytical equipment and other methods for high-throughput
screening.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Solutions of enzyme discovery for targeted substrate(s). Left:
two common methods for finding hit enzymes for targeted substrate(s).
Right: a schematic diagram of IREDFisher developed in this work. Input
sequences are filtered by IREDFisher with the aid of structural modeling
and molecular docking, which allows the user to obtain a small panel
consisting of prioritized sequences.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0002" id="gr1" position="float"/>
    </fig>
    <p>Computational tools have shown great power in the
development and
application of biocatalysts including synthetic pathway design,<sup><xref ref-type="bibr" rid="ref8">8</xref>−<xref ref-type="bibr" rid="ref10">10</xref></sup> enzyme engineering,<sup><xref ref-type="bibr" rid="ref11">11</xref>−<xref ref-type="bibr" rid="ref14">14</xref></sup> and de novo design.<sup><xref ref-type="bibr" rid="ref15">15</xref>−<xref ref-type="bibr" rid="ref18">18</xref></sup> However, in silico pipelines that prioritize sequences and thus
reduce the necessary screening throughput in the laboratory are still
underdeveloped. The current structure-based pipelines are either struggling
in dealing with large numbers of sequences and are thus mainly used
for engineering an initially known active enzyme<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> or require a detailed description of the catalytic geometry based
on a known ligand-binding motif.<sup><xref ref-type="bibr" rid="ref21">21</xref>−<xref ref-type="bibr" rid="ref23">23</xref></sup> Sequence-based pipelines<sup><xref ref-type="bibr" rid="ref24">24</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup> can realize high throughput but they generally ignore substrate
variations (a key consideration in establishing biocatalytic panels),
leading to poor activity predictions of enzymes in relation to target
substrates. Standalone methods such as homology modeling and molecular
docking have been established over many years but are generally used
individually rather than in automated combination, which limits throughput
in biocatalyst screening programs. Integration of these approaches
into an automated pipeline for biocatalyst discovery is urgently needed
to rapidly model enzyme–substrate complexes and generate rank
ordering of likely active sequences. Only a few structure-based computational
pipelines<sup><xref ref-type="bibr" rid="ref38">38</xref>−<xref ref-type="bibr" rid="ref41">41</xref></sup> have been published. However, none of these have been automated
to enable easy access to laboratory-based scientists. An “easy-to-use”
in silico web application is required for experimentalists who need
to conduct efficient and rapid screens to identify active enzymes
but are struggling to use more specialized computational tools. Consequently,
an “easy-to-use” in silico web-based application will
streamline experimental screening and thereby reduce the time and
resources required to identify biocatalysts for use.</p>
    <p>Here, we
report the development and experimental validation of
an in silico pipeline, available also via a web interface, termed
IREDFisher (available for use at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher is a structure-based web server that allows computer-aided
enzyme screening with substrate(s) of interest and recommends a small
(20 enzyme) panel of IREDs for rapid biocatalytic exploration by the
user (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). We
selected imine reductases (IREDs) as a model enzyme in view of their
recent emergence as an enzyme class of interest for the synthesis
of chiral amines. Chiral amines are prevalent motifs that feature
in about 40% of pharmaceuticals.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> IREDs catalyze
enantioselective imine reduction and can also perform the reductive
amination of ketones or aldehydes<sup><xref ref-type="bibr" rid="ref44">44</xref>−<xref ref-type="bibr" rid="ref46">46</xref></sup> and are thus of major
interest to the academic and industrial biocatalysis communities.
Since their discovery in 2010,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> a vast
number of IRED sequences have been published together with a wealth
of activity data for different substrates.<sup><xref ref-type="bibr" rid="ref48">48</xref>−<xref ref-type="bibr" rid="ref58">58</xref></sup> Currently, IREDFisher only applies to IREDs as the scoring function
is modified specifically for these enzymes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Flow chart of the four-step
IREDFisher workflow. The input sequences
are preprocessed in step (1) to remove non-IRED-homologs from the
screening list. The three-dimensional structures of the remaining
sequences are modeled in step (2). In step (3), the structures obtained
from step (2) are aligned to a cofactor- and ligand-bound IRED crystal
structure to locate the active site and cofactor binding site for
each modeled structure. NADPH is placed into individual modeled structures
by taking the coordinates from the crystal structure. An intermediate
imine structure formed by amine and ketone substrates is then docked
into the active site of each structure. In step (4), the best pose
for the substrate within the enzyme is selected by the distance between
two key atoms of the cofactor and substrate. In crystal structures
of IREDs, this distance is around 4 Å. In step (5), the number
of acidic residues <italic>N</italic><sub>acidic</sub>, the number
of basic residues <italic>N</italic><sub>basic</sub>, and the presence
of histidine residues <italic>N</italic><sub>his</sub> = 0 or 1 are
calculated for residues within 8 Å of the substrate. Enzymes
are ranked by a modified scoring function IREDFisher score = 4.0 ×
Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> –
9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> (see details described in the <xref rid="sec4" ref-type="other">Methods</xref> section).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0003" id="gr2" position="float"/>
    </fig>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>IREDFisher Workflow</title>
      <p>Having the initial sequences and
a substrate structure as inputs, the IREDFisher workflow commences
with sequence preprocessing, followed by structural modeling. Then,
the provided substrate is docked into the modeled enzyme structures,
while the protein–substrate complexes are scored by considering
predicted binding affinity and catalytic geometry in the final step
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Specifically,
in step (1), each input sequence is aligned to individual sequences
in the protein data bank (PDB). The input sequence that has the highest
sequence identity to known IREDs in the PDB is considered as a putative
IRED and retained for the next step. In step (2), all three-dimensional
structures of the resulting sequences from step (1) are generated
by MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> followed by an optimization
by the default function in MODELLER,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> which
consists of spatial restraints on distance and dihedral angles obtained
from the target structure and CHARMM energy terms enforcing proper
stereochemistry.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> All models are evaluated
based on the Ramachandran plot, and only those that have over 90%
 of the residues in favorable/coreregions are defined as qualified
models and subsequently used for substrate docking. In step (3), the
substrate is docked into the active site of each qualified model.
Various poses of the substrate in the active site of the enzymes are
generated. In step (4), the distance between NADPH C4 and N atom of
the imine substrate is calculated for all poses. The pose with ∼4
Å is selected as the best pose to realize hydride transfer in
a catalytic process (see pose selection in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> and details in the <xref rid="sec4" ref-type="other">Methods</xref> section). In step (5), the number of acidic residues <italic>N</italic><sub>acidic</sub>, basic residues <italic>N</italic><sub>basic</sub>, and histidine residues <italic>N</italic><sub>His</sub> are calculated
and used to modify the Autodock Vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> scoring
function considering they play important roles in the stabilization
of iminium intermediate formation and proton transfer (see details
in the <xref rid="sec4" ref-type="other">Methods</xref>section). The modified scoring
function Refined score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> was
used to finally rank all input sequences. The top 20 IRED sequences
are then selected for in vitro screening.</p>
    </sec>
    <sec id="sec2.2">
      <title>IREDFisher Validation Using Published Screening Data</title>
      <p>The screening data from three established IRED panels were used to
test the IREDFisher workflow: Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> (85 sequences) for substrates <bold>1</bold>–<bold>9</bold>, France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> (45 sequences)
for substrates <bold>10</bold>–<bold>17</bold>, and Montgomery
et al. IRED panel<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> (93 sequences) for <bold>18</bold>–<bold>24</bold> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Each panel and the corresponding tested
substrates were fed into IREDFisher to obtain the recommended 20 sequences.
As control, 20 sequences were randomly selected from each corresponding
panel. Hit rates using a conversion cutoff of 2% (hit rate of ≥
2% conversion) and 50% (hit rate of ≥ 50% conversion) were
calculated and compared between the two methods (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a,b and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S1</ext-link>). The likelihood of retrieving the best hit in the
20 selected sequences using the two methods was also calculated (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S2</ext-link>). In terms of “hit rate of ≥
2% conversion”, IREDFisher is comparable to random selection,
whereas it outperforms the latter in finding hits with conversions
over 50% (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b).
This shows the capability of IREDFisher in finding competent hits
for downstream optimization. Furthermore, IREDFisher retrieved the
best hit to the top 20 sequences with a likelihood of 100%. By contrast,
the likelihood of picking the best hit by random selection is no more
than 50%. In summary, the IREDFisher workflow is not only able to
improve the hit rate but also retrieves the best enzyme(s) from the
whole IRED panel in the top 20 selected sequences. This emphasizes
the effectiveness of IREDFisher in finding IRED hits, reducing screening
efforts by 50–75%.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tests of reductive amination reactions based
on published data.
Reaction products of IRED-catalyzed reactions are shown with moieties
originating from the amine nucleophile colored in blue and those from
the ketone component displayed in black. Compounds <bold>1–9</bold> are from ref (<xref ref-type="bibr" rid="ref56">56</xref>), compounds <bold>10–17</bold> are from ref (<xref ref-type="bibr" rid="ref52">52</xref>), and compounds <bold>18–24</bold> are from ref (<xref ref-type="bibr" rid="ref53">53</xref>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0004" id="gr3" position="float"/>
      </fig>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Comparison of hit rate and best hit retrieval in 20 sequences
selected
by IREDFisher and by random selection. (a) Hit rate using a conversion
cutoff of 2% calculated by the equation: Hit rate of ≥2% conversion
= <inline-formula id="d33e578"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m001.gif"/></inline-formula>. (b) Hit rate using a conversion cutoff
of 50% calculated by the equation: Hit rate of ≥50% conversion
= <inline-formula id="d33e581"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m002.gif"/></inline-formula>. Symbol × indicates that no hits with
conversion over 50% were found in the in vitro screening of the corresponding
panels. (c) Likelihood of retrieving the best hit from the whole panel
in the 20 selected sequences using IREDFisher. The error bars for
the random selection were calculated by the standard error of the
mean (SEM) based on 95% confidence levels.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.3">
      <title>Experimental Validation of Predictions Made by IREDFisher</title>
      <p>Next, we challenged the IREDFisher workflow by aiming to select
potential IRED hits for subsequent validation by experimental screening.
We chose the following reductive amination reactions as our targets,
namely, <bold>18</bold> and <bold>25–28</bold> (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a), which represent increasingly
demanding conversions for imine reductases. Reactions corresponding
to products <bold>18</bold> and <bold>25</bold> are common starting
points for screening IREDs, whereas products <bold>26</bold> and <bold>27</bold> are important building blocks in the pharmaceutical industry
and proved to be challenging targets in a previous IRED study.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Synthesis of <bold>28</bold> is particularly
challenging due to the negative charge of the carboxylate group in
the substrate. To date, no IREDs have been reported to accept 4-formylbenzoic
acid as a substrate. Also, we note that 4-formylbenzoic acid <bold>28</bold> is a building block for drugs such as procarbazine (chemotherapy),
imatinib (chemotherapy), mocetinostat, etinostat, tucidinostat (HDAC
inhibitors), revefenacin (COPD treatment), bavisant (ADHD treatment),
and fedovapagon (nocturia treatment) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S1</ext-link>). Inclusion of <bold>28</bold> was used to explore whether the IREDFisher
workflow could identify biocatalysts for novel reductive amination
reactions.</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Validation of IREDFisher predictions in identifying hits for five
chosen reactions. (a) IREDFisher was run in two rounds: in the first
round, the sequences from external sources, public databases, and
established panels were ranked by IREDFisher to prioritize those to
be used for gene synthesis and enzyme expression. In the second round,
33 new enzymes with good expression in <italic>Escherichia
coli</italic> and 193 in-house sequences were ranked by IREDFisher.
The top 20 enzymes for each reaction were then investigated in the
laboratory. The percentages of new enzymes and in-house enzymes are
65 and 35% for <bold>18</bold>, 50 and 50% for <bold>25</bold>, 45
and 55% for <bold>26</bold>, 50 and 50% for <bold>27</bold>, and 55
and 45% for <bold>28</bold>. Compounds are shown in product forms.
Amine nucleophile components are colored in blue. (b) The conversion
of IREDFisher selected sequences toward products <bold>18</bold> and <bold>25</bold>–<bold>28</bold>. Hit rates for each reaction were
calculated using a conversion cutoff of 2%: Hit rate = <inline-formula id="d33e662"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m003.gif"/></inline-formula>. NS indicates that this sequence is not
in the top 20 selected by IREDFisher and consequently was not tested
in vitro. Sequences labeled pIR are from the in-house panel. Sequences
labeled yIRED are new uncharacterized sequences and highlighted in
bold and italic font.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0006" id="gr5" position="float"/>
      </fig>
      <p>For sequence input, we used 193 well-expressed
enzymes from our
in-house panel along with 33 new sequences found by IREDFisher that
are also expressed well. To find new active enzymes toward selected
targets, we collected uncharacterized IRED homologs from public databases
(NCBI and UniProt) and IREDs from established panels (Robian et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl
et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> and Yao et al.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup>), generating 1239 sequences in total (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a, lower panel). Then, the
first round of the IREDFisher ranking was run for the collected sequences
based on the targeted product to prioritize successful gene synthesis
and protein expression. The top 20 enzyme sequences for targets <bold>18</bold> and <bold>25–30</bold> were selected in silico.
Then, 60 sequences were identified after removing duplicates from
which genes were synthesized and expressed in <italic>E. coli</italic>. This resulted in 33 enzymes (55% of selected enzymes) that expressed
well in <italic>E. coli</italic>, while 27 enzymes (45%
of selected enzymes) failed in cloning and/or expression.</p>
      <p>We
then combined these 33 enzymes with 193 sequences from our in-house
panel and ran a second round of IREDFisher ranking to prioritize these
sequences in activity screening experiments. The top 20 IREDs obtained
by IREDFisher for each targeted reaction were screened in vitro, and
corresponding conversions to products were determined by GC or HPLC
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b). Reaction
optimization was not carried out, as only the relative efficiency
of IREDFisher under standardized conditions was being evaluated. For
target reactions <bold>18</bold> and <bold>25–28</bold>, the
hit rate decreases as the difficulty of the IRED reactions increases,
with 2–11 hits (over 90% conversion) of corresponding substrates
obtained. In a previous study, the hit rate of <bold>26</bold> (26b
in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) and <bold>27</bold> (<bold>23d</bold> in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) by screening a panel of 384 IREDs was low (2.6% for <bold>26</bold> and 5.5% for <bold>27</bold>), whereas the hit rate in this study
employing IREDFisher increased substantially to 60 and 40%, respectively.
Notably, two hits, with conversion ≥ 90%, were found for the
challenging product <bold>28</bold>, demonstrating that IREDFisher
can find enzymes that catalyze reactions of pharmaceutical importance.
Furthermore, by exploiting the resources from public databases, highly
active IREDs that have not been reported previously were identified
and multiple enzymes (e.g., yIRED10, yIRED23, yIRED25) were found
to have broad substrate scope. The benefit of IREDFisher in prioritizing
screening is clear, in this case reducing the experimental screening
required from ≥ 1000 samples without IREDFisher virtual screening
to only 20 samples.</p>
    </sec>
    <sec id="sec2.4">
      <title>IREDFisher Web Interface and Speed Test</title>
      <p>Encouraged
by the validation results using established screening data and our
own experiments, our intention was to develop a user-friendly workflow
that can be widely used by the biocatalysis community. To avoid any
requirement for the use of personal computational/programming skills,
we have built an IREDFisher web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>). We emphasize
that the current methodology only applies to IREDs. For the input
structure, the imine structure formed by the condensation of aldehyde
or ketone and amine is required. This can be obtained by the free
online structure drawing tool Marvin JS (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">https://marvinjs-demo.chemaxon.com/latest/</uri>) from ChemAxon (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the square on the right). The index of the N
atom in the C=N bond is also required as an input, which can
be generated using the Marvin interface. A FASTA-formatted sequence
file is required if users intend to rank their own sequences (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the
square on the left). After the job is submitted, output files such
as three-dimensional structures of IREDs, substrate-bound complex
structures, and scoring files are generated and added to the web page.
By checking the sorted rescoring file, the user can obtain an optimized
small IRED screening panel with 20 recommended sequences by IREDFisher
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b). In addition,
IREDFisher also allows users to rank the sequences from established
panels and public databases (see the <xref rid="sec4" ref-type="other">Methods</xref> section for details). Therefore, IREDFisher can be employed in ranking:
(i) user-defined sequences; (ii) established IRED panels, e.g., Robian
et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> etc.; and (iii)
IRED sequences collected from the public database in this study. The
speed test showed that IREDFisher can perform the calculation of a
user-defined panel with 85 sequences in 90 min. Moreover, it only
takes ca 30 min to complete the ranking of the established IRED panels
and sequences from public databases by using the structures already
deposited in the IREDFisher web server. Consequently, based on simple
data input, nonspecialists in bioinformatics can have access to workflow
outputs using only a few mouse clicks without human interference,
which makes it applicable for small IRED panel design.</p>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Web interface of IREDFisher.
(a) Job submission interface and input
file examples. Left square: FASTA-formatted sequence file. Right square:
generation of substrate structure and N atom index by Marvin JS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">&lt;underline≥https://marvinjs-demo.chemaxon.com/latest/&lt;/underline≥</ext-link>). (b) Output files. The file for sequence ranking (1a_imine_sort_rescore.csv
in the example) is shown.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0007" id="gr6" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p>The computational four-step workflow IREDFisher
that aims to streamline
the screening of enzyme panels was produced by integrating sequence
analysis, structure modeling, and molecular docking. Although large
numbers of protein structures have been released recently by AlphaFold,<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> the structures obtained are not always applicable
for the use of molecular docking. For many enzymes, the substrate-binding
site is formed by monomers/dimers, but only monomeric structures were
deposited in the database. For example, most of the new sequences
used in this study were only modeled as monomer in the AlphaFold database.
We have shown that the active site is similar between the dimer models
generated by homology modeling and AlphaFold (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S2</ext-link>), while the former approach saves considerable computation
time (3 min by homology modeling versus 30 min by AlphaFold per structure).
This is also suggested by a previous publication.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> Therefore, the template-based homology modeling is beneficial
for the rapid building of structures in the IREDFisher workflow, allowing
users to rank large numbers of sequences.</p>
    <p>The workflow was applied
by using a model enzyme IRED and subsequently
validated using previously published screening data. IREDFisher demonstrated
the power of retrieving the best hit found simply by screening a small
panel of 20 sequences using the IREDFisher workflow. Experimental
validation in which IREDFisher selects 20 enzymes from a pool of ∼1400
sequences for 5 reactions, and with different levels of product complexity,
further establishes the effectiveness of IREDFisher. IREDFisher ranks
enzymes based on enzyme–substrate-binding interactions and
does not consider features such as the charge distribution on the
protein surface, which might, for example, be important for successful
protein expression in <italic>E. coli</italic>. As such,
poorly expressed proteins could rank better than proteins that are
expressed well in <italic>E. coli</italic>. The workflow
was run initially to identify sequences for gene synthesis and protein
expression analysis. We then performed a second screening experiment
to rank new IRED biocatalysts only with those sequences that expressed
well in <italic>E. coli</italic>. The prediction of
enantioselectivity by IREDFisher is not investigated in this study
because this is challenging. That said, IREDFisher narrows the search
to a small panel of IREDs such that screening those biocatalysts for
enantioselectivity is no longer an onerous task.</p>
    <p>It is noteworthy
that most biocatalytic processes for drug production
need to go through extensive reaction optimization and mutagenesis
approaches such as directed evolution to obtain a biocatalyst that
fulfills the desired process requirements. Directed evolution relies
on the screening of thousands of enzyme variants and usually involves
several rounds of library generation and screening, resulting in large
numbers of variants that require high-throughput screening (HTS) methods
for their evaluation. As such, screening remains the major bottleneck
in biocatalysis applications, and this places major burdens on the
resources and time required to generate a suitable biocatalyst. By
taking advantage of the IREDFisher computational workflow, we have
shown that it is possible to identify suitable biocatalysts for simple
and challenging substrates. If needed, these could be evolved further
to fulfill process needs with reduced screening efforts. IREDFisher
is therefore valuable, either as a standalone computational workflow
to aid the rapid identification of biocatalysts or as a “front-end’
workflow to accelerate directed evolution programs by selecting the
prototype, catalytically competent enzyme scaffolds for a target reaction.
However, we clarify that IREDFisher takes wild-type sequences as input,
which limits its ability to “design” enzymes with non-natural
functions to catalyze extremely challenging reactions.</p>
    <p>IREDFisher
is designed as a “fast prescreen method”
to rank input sequences. As such, it has limitations. Protein dynamics
and energy barrier calculations are not incorporated because this
would be too time consuming for a fast prescreening tool for use by
experimentalists. The IREDFisher scoring function works as a tool
to rank input sequences instead of accurately predicting the conversion/activity
of enzymes. We trained the scoring instead to deliver a maximum hit
rate of the top 20 sequences because 20 screening experiments can
be carried out in one batch with overnight incubation for rapid enzyme
screening. That said, the IREDFisher workflow has the power to find
highly active hits in the 20 recommended sequences. This indicates
that a trade-off between speed and accuracy has been achieved to some
extent. Currently, it is applicable to IREDs as the scoring function
is designed specifically for this enzyme family. We have also tested
IREDFisher on haloalkane dehydrogenases and compared our results with
a previous study.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Only one enzyme identified by
this previous study was ranked in the top 20 sequences from IREDFisher.
Clearly, generic substrate inputs and associated scoring functions
will need to be explored to expand the utility of our workflow to
different enzyme reactions. Specifically, reactive atoms in the substrate
and catalytic residues in the enzyme should be provided by the user
to help select the best binding pose after docking. Also, deep learning
methods are promising approaches to train a model, e.g., by taking
features from predicted binding modes such as distances and angles
between key atoms, atom types, and charge distributions in the active
site. This challenge, together with integration into RetroBiocat,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> will be implemented to enable the process from
the biocatalytic pathway design all the way through to the generation
of small screening panels to allow for direct hit identification.</p>
    <p>In summary, the development and use of IREDFisher have reduced
the size of screening panels to only 20 enzymes, with significant
savings in resource and time required to perform the experimental
screening. For challenging substrates, where conversions with the
wild-type enzyme may be low, the hits obtained could then be used
as a parent sequence for subsequent directed evolution approaches.
The workflow provides a user-friendly free web interface (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>), requiring no experience in computational chemistry or programming,
which users can implement with only a few “mouse clicks”.
The expansion of the web tool to other enzyme classes is envisaged
with more accurate scoring functions, taking advantage of machine
learning and other approaches. This will assist in the identification
of enzymes for transformations of interest from a plethora of continuously
growing sequence data and, therefore, contribute to the increasing
application of biocatalytic methods in the synthesis.</p>
  </sec>
  <sec id="sec4">
    <title>Methods</title>
    <sec id="sec4.1">
      <title>IREDFisher Four-Step Panel Optimization Workflow</title>
      <sec id="sec4.1.1">
        <title>Sequence Preprocessing</title>
        <p>A FASTA-formatted sequence file
given by the user was loaded into the workflow. Each individual sequence
was generated by splitting the whole sequences. For sequence, we searched
homologous proteins in the Protein Data Bank using MODELLER.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> The one with the highest sequence identity was
considered as the template protein of the query sequence. For imine
reductases, only sequences with characterized IREDs (PDB codes: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3ZGY">3ZGY</ext-link>,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3D">4D3D</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3S">4D3S</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQY">4OQY</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQZ">4OQZ</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5A9T">5A9T</ext-link>,<sup><xref ref-type="bibr" rid="ref67">67</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OJL">5OJL</ext-link>,<sup><xref ref-type="bibr" rid="ref69">69</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6EOD">6EOD</ext-link>,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIT">6JIT</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIZ">6JIZ</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6GRL">6GRL</ext-link>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5G6R">5G6R</ext-link>) as the template
proteins were retained for the next step.</p>
      </sec>
      <sec id="sec4.1.2">
        <title>Structure Modeling</title>
        <p>IREDs form homodimers with the active
site located at the interface between the monomers, thus making it
more challenging to build a model in an automated way.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> The general sequence alignment between the template
protein and query sequence was calculated only for one chain. To overcome
this issue, the single-chain sequence alignment between each query
sequence and the template protein was repeated once more by an in-house
script to generate a double-chain sequence alignment file. To automate
the modeling of the IRED dimeric form, a template protein needs to
be specified. The imine reductase from <italic>Streptosporangium
roseum</italic> (PDB code: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>(<xref ref-type="bibr" rid="ref68">68</xref>)) is selected
as the dimer template protein given its high resolution and the clear
substrate and cofactor NADPH binding site. Then, models are generated
and optimized using MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> based on
the modified double-chain sequence alignment. All models are evaluated
based on the Ramachandran plot, and only those that have over  90% of
the residues in the favorable/core region are defined as qualified
models and subsequently are used for substrate docking.</p>
      </sec>
      <sec id="sec4.1.3">
        <title>Molecular Docking</title>
        <p>To locate the active site easily,
all three-dimensional structures obtained from the last step are aligned
to the template structure 5OCM by the PyMol python library. The cofactor
NADPH is directly placed into the cofactor binding site of each modeled
structure using the reference NADPH from the crystal structure prior
to substrate docking. The center of mass of the bound ligand 9RH in
5OCM is used as the center of the docking box. The docking box size
is calculated by using script eBoxSize.pl,<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> considering the gyration radius of the substrate, which improves
the docking accuracy.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> Then, all aligned
structures with the bound NADPH are prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> To input the structure of the imine form of
the substrate formed by the condensation of amine and ketone, the
three-dimensional coordinates are generated by Babel<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> and then prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> Multiple poses are generated by Autodock vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> with exhaustiveness value 10.</p>
        <p>Scoring
and ranking. When the IRED reaction occurs, NADPH transfers a hydride
from atom C4 to the imine substrate.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> To obtain the most reliable pose, the distance between
the C4 atom in NADPH and N in imine, the substrate is used as a criterion
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Docking
poses with the C4···N distance shorter than 3.5 Å
are removed to avoid clashes. Poses with the C4···N
distance longer than 6.0 Å are also removed because it is beyond
the distance range for hydride transfer. The remaining poses having
the closest C4···N distance are selected as the best
model. To improve the scoring function, we take the catalytic mechanism,
proton transfer, and hydride transfer<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> into consideration. It has been reported that acidic residues, basic
residues, and a conserved histidine residue in the active site play
important roles in the stabilization of the key intermediate in the
IRED-catalyzed reaction.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> Accordingly,
we included three terms in the scoring function: the number of acidic
residues <italic>N</italic><sub>acidic</sub>, the number of basic
residues <italic>N</italic><sub>basic</sub>, and the presence of histidine
residues to represent the effect enzymes have on reactions. The final
scoring function after the optimization of hyperparameters is refined
score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub>. In this equation, <italic>N</italic><sub>acidic</sub>/<italic>N</italic><sub>basic</sub> is
the total number of acidic/basic residues in the active site and <italic>N</italic><sub>His</sub> is the presence (<italic>N</italic><sub>His</sub> = 1) or absence of histidine (<italic>N</italic><sub>his</sub> = 0) residue in the active site. The weights for each component
of the scoring function were tuned by running with a range of −10
to 10 using compounds <bold>18</bold>–<bold>24</bold> screened
by Montgomery et al. IRED panel,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> and
the best weight was decided by the highest percentage of hits with
conversion over 50% in the top 20 list. The scoring function was tested
by Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> for substrates <bold>1</bold>–<bold>9</bold> and France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> for substrates <bold>10</bold>–<bold>17</bold>. Only residues within 8 angstroms of the ligand are taken
into account when we count the number of key residues.</p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <title>IREDFisher Structure Databases</title>
      <p>To help users design
an IRED screening panel from scratch by the IREDFisher workflow, we
collected published IRED panels: GSK panel in 2017,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> MIB panel in 2018,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> MIB panel
in 2020,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> MIB metagenomic panel in 2021,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Roche panel in 2016,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> and Peiyuan Yao panel<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> in 2018. After
sequence preprocessing step, a total of 451 published sequences were
collected including the characterized IRED sequences.</p>
      <p>To make
use of the public database, we conducted homology search in UniProt<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and NCBI reference protein<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> databases using the characterized IREDs as seed sequences.
Homologous sequences with sequence identity over 30%, coverage over
80%, and <italic>E</italic>-value under 10 compared to the corresponding
seed sequence were downloaded. 1028 sequences were collected after
removing duplicates, followed by a clustering with threshold 0.7 by
cd-hit.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> After sequence preprocessing,
a total of 591 sequences were collected from the public database.</p>
      <p>All of the above sequences were modeled and prepared for docking
by the IREDFisher workflow. With the well-prepared structure database,
IREDFisher runs much faster.</p>
    </sec>
  </sec>
  <sec id="sec5">
    <title>Experimental Details for In Vitro Screening</title>
    <sec id="sec5.1">
      <title>General (Chemicals and Enzymes)</title>
      <p>All chemicals and solvents
were purchased from commercial sources such as Acros Organics (Geel,
Belgium), Fluorochem (Hadfield, Derbyshire, UK), Alfa Aesar (Karlsruhe,
Germany), and Sigma-Aldrich (Poole, Dorset, UK). Chemicals were used
without additional purification. GC gases were obtained from BOC gases
(Guildford, UK), and HPLC solvents were obtained from Honeywell (Seelze,
Germany).</p>
      <p>GC-MS analysis was performed using an Agilent 7890B
Series GC with a 5977B MS-EI detector in positive mode at a constant
He flow. HPLC analysis was performed using an Agilent 1200 Series
with a UV detector Agilent 1200 Series. LC-MS analysis was performed
using an Agilent 1260 Infinity II with an Agilent 6130 Quadrupole
detector in positive mode using ESI as the ionization source.</p>
      <p>Conversions were determined by achiral HPLC and GC-MS and calculated
with respect to the carbonyl compound based on the convention used
for reductive amination and by LC-MS with the calibration curve. Products
were identified by LC-MS and by comparing retention time with standards.</p>
    </sec>
  </sec>
  <sec id="sec6">
    <title>Enzyme Production and Expression</title>
    <p>All IREDs used in
this study were obtained and expressed using
the same conditions as outlined in <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/s41557-020-00606-w">https://doi.org/10.1038/s41557-020-00606-w</uri><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Section S3</ext-link>.</p>
  </sec>
  <sec id="sec7">
    <title>Screening</title>
    <sec id="sec7.1">
      <title>Enzyme Screening for Target Product <bold>18</bold></title>
      <p>Analytical scale reductive amination biotransformations were carried
on 500 μL scale, adjusted to pH 8.0, containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of cyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 20 h. After 24 h, 500 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 500 μL of dichloromethane
(DCM). The organic phase was dried over anhydrous magnesium sulfate
(MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
    </sec>
  </sec>
  <sec id="sec8">
    <title>Enzyme Screening for Target Product <bold>25</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40 mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of benzaldehyde, and 5% and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. Following 24 h, the reaction
was quenched by the addition of 1 volume of methanol. The mixture
was centrifuged for 5 min at 13300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
  <sec id="sec9">
    <title>Enzyme Screening for Target Product <bold>26</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20
mM of <sc>d</sc>-glucose, 5 mM of 2-chlorocyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 250 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 250 μL of dichloromethane
(DCM) to extract the substrate and possible byproducts. The organic
phase was dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>). The other 250 μL was extracted with 250 μL of dichloromethane
(DCM) to extract the product. The two organic phases were combined,
dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>), and analyzed
by GC-MS.</p>
  </sec>
  <sec id="sec10">
    <title>Enzyme Screening for Target Product <bold>27</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μl scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40
mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of cycloheptanone, and
10 equivalents of propargylamine (1 M propargylamine stock pH 8.0
adjusted), with the reaction volume made up to 500 μL in 100
mM tris buffer. The reaction mixture was incubated at 37 °C with
shaking at 900 rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 500
μL was recovered from the reaction mixture and quenched with
20 μL of 10 M sodium hydroxide and extracted with 500 μL
of dichloromethane (DCM). The organic phase was dried over anhydrous
magnesium sulfate (MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
  </sec>
  <sec id="sec11">
    <title>Enzyme Screening for Target Product <bold>28</bold></title>
    <p>Previous test reactions were carried on at pH 8 as IREDs usually
exhibit higher activities on slightly basic pH. However, reaction
test 3 was done at pH 6 since the acid is partially deprotonated and
the aim was to use pH values closer to formylbenzoic acid pKa to make
it less negatively charged. Analytical scale reductive amination biotransformations
were carried out on a 500 μL scale adjusted to pH 6.0 containing
4 mg/mL of lyophilized powder of the supernatant of lysate IRED, 0.5
mg/mL of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix),
20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of 4-formylbenzoic
acid, and 20 equivalents of cyclopropylamine (1 M cyclopropylamine
stock pH 6.0 adjusted), with the reaction volume made up to 500 μL
min of 100 mM 2-(<italic>N</italic>-morpholino) ethanesulfonic acid
(MES) buffer. The reaction mixture was incubated at 37 °C with
shaking at 200 rpm (incubator with orbital shaker) for 24 h and quenched
by the addition of 1 volume of methanol. The mixture was centrifuged
for 5 min at 13 300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-2">
    <title>Data Availability Statement</title>
    <p>All data are
within the article and the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Information</ext-link> and are also available from the corresponding author upon reasonable
request. IREDFisher is a free web server: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>. The source code was provided on GitHub (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/yuyuqi-design/iredfisher_src">https://github.com/yuyuqi-design/iredfisher_src</uri>) and can be freely downloaded.</p>
  </notes>
  <notes id="notes-4" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting
Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acscatal.3c02278?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscatal.3c02278</ext-link>.<list id="silist" list-type="simple"><list-item><p>Additional in silico screening details; experimental
details; and materials and methods, including HPLC and LC/MS chromatograms
for the reactions conducted in this study and the sequences of all
new putative imine reductases (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_si_001.pdf">
        <caption>
          <p>cs3c02278_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-3">
    <title>Author Contributions</title>
    <p>N.S.S., N.J.T.,
and L.D.M. supervised the project. N.S.S., N.J.T., Y.Y., and L.D.M.
devised the concept. Y.Y., W.F., and R.B. performed the construction
of the workflow, web server, and database. Y.Y. performed the in silico
validation of the workflow. A.R.C., Y.Y., C.S., and R.S.H. performed
the experiment. C.M. performed the organic synthesis. Y.Y., A.R.C.,
N.S.S., N.J.J., and L.D.M. wrote the manuscript and generated the
figures.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d14e1070-autogenerated">
    <p>The authors declare the
following competing financial interest(s): NSS is co-founder, executive
director and share holder of C3 Biotechnologies Ltd which is active
in engineering biology for synthetic fuels production.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors thank Research
IT and the use of the Computational
Shared Facility at The University of Manchester. This study was funded
by the EPSRC, BBSRC, and AstraZeneca plc for funding under the Prosperity
Partnership EP/S005226/1.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Clouthier</surname><given-names>C. M.</given-names></name>; <name><surname>Pelletier</surname><given-names>J. N.</given-names></name><article-title>Expanding the organic toolbox: a guide to integrating
biocatalysis in synthesis</article-title>. <source>Chem. Soc. Rev.</source><year>2012</year>, <volume>41</volume>, <fpage>1585</fpage>–<lpage>1605</lpage>. <pub-id pub-id-type="doi">10.1039/c2cs15286j</pub-id>.<pub-id pub-id-type="pmid">22234546</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Sheldon</surname><given-names>R. A.</given-names></name>; <name><surname>Woodley</surname><given-names>J. M.</given-names></name><article-title>Role of Biocatalysis in Sustainable Chemistry</article-title>. <source>Chem. Rev.</source><year>2018</year>, <volume>118</volume>, <fpage>801</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00203</pub-id>.<pub-id pub-id-type="pmid">28876904</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Panke</surname><given-names>S.</given-names></name>; <name><surname>Held</surname><given-names>M.</given-names></name>; <name><surname>Wubbolts</surname><given-names>M.</given-names></name><article-title>Trends and
innovations in industrial
biocatalysis for the production of fine chemicals</article-title>. <source>Curr. Opin. Biotechnol.</source><year>2004</year>, <volume>15</volume>, <fpage>272</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2004.06.011</pub-id>.<pub-id pub-id-type="pmid">15357999</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Kohls</surname><given-names>H.</given-names></name>; <name><surname>Steffen-Munsberg</surname><given-names>F.</given-names></name>; <name><surname>Hohne</surname><given-names>M.</given-names></name><article-title>Recent achievements in developing
the biocatalytic toolbox for chiral amine synthesis</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2014</year>, <volume>19</volume>, <fpage>180</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2014.02.021</pub-id>.<pub-id pub-id-type="pmid">24721252</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Wu</surname><given-names>S.</given-names></name>; <name><surname>Snajdrova</surname><given-names>R.</given-names></name>; <name><surname>Moore</surname><given-names>J. C.</given-names></name>; <name><surname>Baldenius</surname><given-names>K.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name><article-title>Biocatalysis:
Enzymatic Synthesis for Industrial Applications</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2021</year>, <volume>60</volume>, <fpage>88</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202006648</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><article-title>UniProt: the universal
protein knowledgebase in 2021</article-title>. <source>Nucleic Acids
Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D480</fpage>–<lpage>D489</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1100</pub-id>.<pub-id pub-id-type="pmid">33237286</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Sayers</surname><given-names>E. W.</given-names></name>; <name><surname>Beck</surname><given-names>J.</given-names></name>; <name><surname>Bolton</surname><given-names>E. E.</given-names></name>; <name><surname>Bourexis</surname><given-names>D.</given-names></name>; <name><surname>Brister</surname><given-names>J. R.</given-names></name>; <name><surname>Canese</surname><given-names>K.</given-names></name>; <name><surname>Comeau</surname><given-names>D. C.</given-names></name>; <name><surname>Funk</surname><given-names>K.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Klimke</surname><given-names>W.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Landrum</surname><given-names>M.</given-names></name>; <name><surname>Lathrop</surname><given-names>S.</given-names></name>; <name><surname>Lu</surname><given-names>Z.</given-names></name>; <name><surname>Madden</surname><given-names>T. L.</given-names></name>; <name><surname>O’Leary</surname><given-names>N.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Rangwala</surname><given-names>S. H.</given-names></name>; <name><surname>Schneider</surname><given-names>V. A.</given-names></name>; <name><surname>Skripchenko</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Ye</surname><given-names>J.</given-names></name>; <name><surname>Trawick</surname><given-names>B. W.</given-names></name>; <name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Sherry</surname><given-names>S. T.</given-names></name><article-title>Database resources
of the National Center for Biotechnology Information</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D10</fpage>–<lpage>D17</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa892</pub-id>.<pub-id pub-id-type="pmid">33095870</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Finnigan</surname><given-names>W.</given-names></name>; <name><surname>Hepworth</surname><given-names>L. J.</given-names></name>; <name><surname>Flitsch</surname><given-names>S. L.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>RetroBioCat as a
computer-aided synthesis planning tool for biocatalytic reactions
and cascades</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>98</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-020-00556-z</pub-id>.<pub-id pub-id-type="pmid">33604511</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Coley</surname><given-names>C. W.</given-names></name>; <name><surname>Rogers</surname><given-names>L.</given-names></name>; <name><surname>Green</surname><given-names>W. H.</given-names></name>; <name><surname>Jensen</surname><given-names>K. F.</given-names></name><article-title>Computer-Assisted
Retrosynthesis Based on Molecular Similarity</article-title>. <source>ACS Cent. Sci.</source><year>2017</year>, <volume>3</volume>, <fpage>1237</fpage>–<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00355</pub-id>.<pub-id pub-id-type="pmid">29296663</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Szymkuć</surname><given-names>S.</given-names></name>; <name><surname>Gajewska</surname><given-names>E. P.</given-names></name>; <name><surname>Klucznik</surname><given-names>T.</given-names></name>; <name><surname>Molga</surname><given-names>K.</given-names></name>; <name><surname>Dittwald</surname><given-names>P.</given-names></name>; <name><surname>Startek</surname><given-names>M.</given-names></name>; <name><surname>Bajczyk</surname><given-names>M.</given-names></name>; <name><surname>Grzybowski</surname><given-names>B. A.</given-names></name><article-title>Computer-Assisted
Synthetic Planning: The End of the Beginning</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2016</year>, <volume>55</volume>, <fpage>5904</fpage>–<lpage>5937</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201506101</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Cui</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Tian</surname><given-names>W.</given-names></name>; <name><surname>Bu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Cui</surname><given-names>X.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Wu</surname><given-names>B.</given-names></name><article-title>Development of a versatile
and efficient C–N lyase platform for asymmetric hydroamination
via computational enzyme redesign</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>364</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00604-2</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Bell</surname><given-names>S. G.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>F.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name>; <name><surname>Wong</surname><given-names>L. L.</given-names></name><article-title>Engineering
substrate recognition in catalysis by cytochrome P450cam</article-title>. <source>Biochem. Soc. Trans.</source><year>2003</year>, <volume>31</volume>, <fpage>558</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1042/bst0310558</pub-id>.<pub-id pub-id-type="pmid">12773156</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Dunn</surname><given-names>B. J.</given-names></name>; <name><surname>Khosla</surname><given-names>C.</given-names></name><article-title>Engineering the acyltransferase
substrate specificity
of assembly line polyketide synthases</article-title>. <source>J. R.
Soc., Interface</source><year>2013</year>, <volume>10</volume>, <elocation-id>20130297</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2013.0297</pub-id>.<pub-id pub-id-type="pmid">23720536</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Ali</surname><given-names>M.</given-names></name>; <name><surname>Ishqi</surname><given-names>H. M.</given-names></name>; <name><surname>Husain</surname><given-names>Q.</given-names></name><article-title>Enzyme engineering: Reshaping the
biocatalytic functions</article-title>. <source>Biotechnol. Bioeng.</source><year>2020</year>, <volume>117</volume>, <fpage>1877</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27329</pub-id>.<pub-id pub-id-type="pmid">32159220</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Quijano-Rubio</surname><given-names>A.</given-names></name>; <name><surname>Yeh</surname><given-names>H. W.</given-names></name>; <name><surname>Park</surname><given-names>J.</given-names></name>; <name><surname>Lee</surname><given-names>H.</given-names></name>; <name><surname>Langan</surname><given-names>R. A.</given-names></name>; <name><surname>Boyken</surname><given-names>S. E.</given-names></name>; <name><surname>Lajoie</surname><given-names>M. J.</given-names></name>; <name><surname>Cao</surname><given-names>L.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Miranda</surname><given-names>M. C.</given-names></name>; <name><surname>Wi</surname><given-names>J.</given-names></name>; <name><surname>Hong</surname><given-names>H. J.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Oh</surname><given-names>B-H.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of modular and tunable
protein biosensors</article-title>. <source>Nature</source><year>2021</year>, <volume>591</volume>, <fpage>482</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03258-z</pub-id>.<pub-id pub-id-type="pmid">33503651</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>White</surname><given-names>P.</given-names></name>; <name><surname>Liang</surname><given-names>B.</given-names></name>; <name><surname>Horne</surname><given-names>J. E.</given-names></name>; <name><surname>Bera</surname><given-names>A. K.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Gerben</surname><given-names>S.</given-names></name>; <name><surname>Marx</surname><given-names>S.</given-names></name>; <name><surname>Kang</surname><given-names>A.</given-names></name>; <name><surname>Stiving</surname><given-names>A. Q.</given-names></name>; <name><surname>Harvey</surname><given-names>S. R.</given-names></name>; <name><surname>Marx</surname><given-names>D. C.</given-names></name>; <name><surname>Khan</surname><given-names>G. N.</given-names></name>; <name><surname>Fleming</surname><given-names>K. G.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Brockwell</surname><given-names>D. J.</given-names></name>; <name><surname>Tamm</surname><given-names>L. K.</given-names></name>; <name><surname>Radford</surname><given-names>S. E.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of transmembrane
beta barrels</article-title>. <source>Science</source><year>2021</year>, <volume>371</volume>, <elocation-id>eabc8182</elocation-id><pub-id pub-id-type="doi">10.1126/science.abc8182</pub-id>.<pub-id pub-id-type="pmid">33602829</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Klima</surname><given-names>J. C.</given-names></name>; <name><surname>Doyle</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>J. D.</given-names></name>; <name><surname>Rappleye</surname><given-names>M.</given-names></name>; <name><surname>Gagnon</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>M. Y.</given-names></name>; <name><surname>Barros</surname><given-names>E. P.</given-names></name>; <name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>Dou</surname><given-names>J.</given-names></name>; <name><surname>Bremner</surname><given-names>S.</given-names></name>; <name><surname>Quon</surname><given-names>J. S.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Carter</surname><given-names>L.</given-names></name>; <name><surname>Mack</surname><given-names>D. L.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Vaughan</surname><given-names>J. C.</given-names></name>; <name><surname>Berndt</surname><given-names>A.</given-names></name>; <name><surname>Stoddard</surname><given-names>B. L.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Incorporation of sensing modalities
into de novo designed fluorescence-activating proteins</article-title>. <source>Nat. Commun.</source><year>2021</year>, <volume>12</volume>, <fpage>856</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-18911-w</pub-id>.<pub-id pub-id-type="pmid">33558528</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Sahtoe</surname><given-names>D. D.</given-names></name>; <name><surname>Coscia</surname><given-names>A.</given-names></name>; <name><surname>Mustafaoglu</surname><given-names>N.</given-names></name>; <name><surname>Miller</surname><given-names>L. M.</given-names></name>; <name><surname>Olal</surname><given-names>D.</given-names></name>; <name><surname>Vulovic</surname><given-names>I.</given-names></name>; <name><surname>Yu</surname><given-names>T. Y.</given-names></name>; <name><surname>Goreshnik</surname><given-names>I.</given-names></name>; <name><surname>Lin</surname><given-names>Y. R.</given-names></name>; <name><surname>Clark</surname><given-names>L.</given-names></name>; <name><surname>Busch</surname><given-names>F.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Ingber</surname><given-names>D. E.</given-names></name>; <name><surname>Abraham</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Transferrin
receptor targeting by de novo sheet extension</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2021569118</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Vavra</surname><given-names>O.</given-names></name>; <name><surname>Kokkonen</surname><given-names>P.</given-names></name>; <name><surname>Filipovic</surname><given-names>J.</given-names></name>; <name><surname>Pinto</surname><given-names>G.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name><article-title>Caver Web 1.0: identification of
tunnels and channels
in proteins and analysis of ligand transport</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>W414</fpage>–<lpage>W422</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz378</pub-id>.<pub-id pub-id-type="pmid">31114897</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Sumbalova</surname><given-names>L.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>HotSpot Wizard
3.0: web server for automated design of mutations and smart libraries
based on sequence input information</article-title>. <source>Nucleic
Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W356</fpage>–<lpage>W362</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky417</pub-id>.<pub-id pub-id-type="pmid">29796670</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Angles</surname><given-names>R.</given-names></name>; <name><surname>Arenas-Salinas</surname><given-names>M.</given-names></name>; <name><surname>Garcia</surname><given-names>R.</given-names></name>; <name><surname>Reyes-Suarez</surname><given-names>J. A.</given-names></name>; <name><surname>Pohl</surname><given-names>E.</given-names></name><article-title>GSP4PDB: a web tool
to visualize, search and explore protein-ligand
structural patterns</article-title>. <source>BMC Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s12859-020-3352-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Viet
Hung</surname><given-names>L.</given-names></name>; <name><surname>Caprari</surname><given-names>S.</given-names></name>; <name><surname>Bizai</surname><given-names>M.</given-names></name>; <name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA: LIgand
Binding site Recognition Application</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>4020</fpage>–<lpage>4022</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv489</pub-id>.<pub-id pub-id-type="pmid">26315904</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Viet Hung</surname><given-names>L.</given-names></name>; <name><surname>Tortosa</surname><given-names>V.</given-names></name>; <name><surname>Brandi</surname><given-names>V.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA-WA:
a web application for ligand binding site detection and protein function
recognition</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>878</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx715</pub-id>.<pub-id pub-id-type="pmid">29126218</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Lilley</surname><given-names>D. M.</given-names></name>; <name><surname>Clegg</surname><given-names>R. M.</given-names></name>; <name><surname>Diekmann</surname><given-names>S.</given-names></name>; <name><surname>Seeman</surname><given-names>N. C.</given-names></name>; <name><surname>von Kitzing</surname><given-names>E.</given-names></name>; <name><surname>Hagerman</surname><given-names>P.</given-names></name><article-title>Nomenclature Committee of the International
Union of
Biochemistry and Molecular Biology (NC-IUBMB). A nomenclature of junctions
and branchpoints in nucleic acids. Recommendations 1994</article-title>. <source>Eur. J. Biochem.</source><year>1995</year>, <volume>230</volume>, <fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20526.x</pub-id>.<pub-id pub-id-type="pmid">7601087</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Dalkiran</surname><given-names>A.</given-names></name>; <name><surname>Rifaioglu</surname><given-names>A. S.</given-names></name>; <name><surname>Martin</surname><given-names>M. J.</given-names></name>; <name><surname>Cetin-Atalay</surname><given-names>R.</given-names></name>; <name><surname>Atalay</surname><given-names>V.</given-names></name>; <name><surname>Dogan</surname><given-names>T.</given-names></name><article-title>ECPred: a
tool for the prediction
of the enzymatic functions of protein sequences based on the EC nomenclature</article-title>. <source>BMC Bioinf.</source><year>2018</year>, <volume>19</volume>, <fpage>334</fpage><pub-id pub-id-type="doi">10.1186/s12859-018-2368-y</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Shen</surname><given-names>H. B.</given-names></name>; <name><surname>Chou</surname><given-names>K. C.</given-names></name><article-title>EzyPred: a top-down
approach for predicting enzyme
functional classes and subclasses</article-title>. <source>Biochem.
Biophys. Res. Commun.</source><year>2007</year>, <volume>364</volume>, <fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.098</pub-id>.<pub-id pub-id-type="pmid">17931599</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Umarov</surname><given-names>R.</given-names></name>; <name><surname>Xie</surname><given-names>B.</given-names></name>; <name><surname>Fan</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name><article-title>DEEPre: sequence-based
enzyme EC number prediction
by deep learning</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>760</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx680</pub-id>.<pub-id pub-id-type="pmid">29069344</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Memon</surname><given-names>S. A.</given-names></name>; <name><surname>Khan</surname><given-names>K. A.</given-names></name>; <name><surname>Naveed</surname><given-names>H.</given-names></name><article-title>HECNet: a hierarchical
approach to
enzyme function classification using a Siamese Triplet Network</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>4583</fpage>–<lpage>4589</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa536</pub-id>.<pub-id pub-id-type="pmid">32449765</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Zhang</surname><given-names>T.</given-names></name>; <name><surname>Tian</surname><given-names>Y.</given-names></name>; <name><surname>Yuan</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>F.</given-names></name>; <name><surname>Ren</surname><given-names>A.</given-names></name>; <name><surname>Hu</surname><given-names>Q. N.</given-names></name><article-title>Bio2Rxn: sequence-based enzymatic reaction predictions by a consensus
strategy</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>3600</fpage>–<lpage>3601</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa135</pub-id>.<pub-id pub-id-type="pmid">32108855</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E. L. L.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Paladin</surname><given-names>L.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L. J.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name><article-title>Pfam: The protein families
database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D412</fpage>–<lpage>D419</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Blum</surname><given-names>M.</given-names></name>; <name><surname>Chang</surname><given-names>H. Y.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Grego</surname><given-names>T.</given-names></name>; <name><surname>Kandasaamy</surname><given-names>S.</given-names></name>; <name><surname>Mitchell</surname><given-names>A.</given-names></name>; <name><surname>Nuka</surname><given-names>G.</given-names></name>; <name><surname>Paysan-Lafosse</surname><given-names>T.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Bridge</surname><given-names>A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Haft</surname><given-names>D. H.</given-names></name>; <name><surname>Letunic</surname><given-names>I.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Mi</surname><given-names>H.</given-names></name>; <name><surname>Natale</surname><given-names>D.</given-names></name>; <name><surname>Necci</surname><given-names>M.</given-names></name>; <name><surname>Orengo</surname><given-names>C. A.</given-names></name>; <name><surname>Pandurangen</surname><given-names>A. P.</given-names></name>; <name><surname>Rivoire</surname><given-names>C.</given-names></name>; <name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Sillitoe</surname><given-names>I.</given-names></name>; <name><surname>Thanki</surname><given-names>N.</given-names></name>; <name><surname>Thomas</surname><given-names>P. D.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name><article-title>The InterPro protein families and domains database:
20 years on</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D344</fpage>–<lpage>D354</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa977</pub-id>.<pub-id pub-id-type="pmid">33156333</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Borko</surname><given-names>S.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>EnzymeMiner:
automated mining of soluble enzymes with diverse structures, catalytic
properties and stabilities</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W104</fpage>–<lpage>W109</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa372</pub-id>.<pub-id pub-id-type="pmid">32392342</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Nikolskaya</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Yeh</surname><given-names>L. S.</given-names></name>; <name><surname>Natale</surname><given-names>D. A.</given-names></name>; <name><surname>Vinayaka</surname><given-names>C. R.</given-names></name>; <name><surname>Hu</surname><given-names>Z. Z.</given-names></name>; <name><surname>Mazumder</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Kourtesis</surname><given-names>P.</given-names></name>; <name><surname>Ledley</surname><given-names>R. S.</given-names></name>; <name><surname>Suzek</surname><given-names>B. E.</given-names></name>; <name><surname>Arminski</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Cardenas</surname><given-names>J. L.</given-names></name>; <name><surname>Chung</surname><given-names>S.</given-names></name>; <name><surname>Castro-Alvear</surname><given-names>J.</given-names></name>; <name><surname>Dinkov</surname><given-names>G.</given-names></name>; <name><surname>Barker</surname><given-names>W. C.</given-names></name><article-title>PIRSF:
family classification
system at the Protein Information Resource</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>, <volume>32</volume>, <fpage>D112</fpage>–<lpage>D114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh097</pub-id>.<pub-id pub-id-type="pmid">14681371</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Qian</surname><given-names>Z.</given-names></name>; <name><surname>Cai</surname><given-names>Y. D.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name><article-title>ECS: an automatic enzyme
classifier based on functional domain composition</article-title>. <source>Comput. Biol. Chem.</source><year>2007</year>, <volume>31</volume>, <fpage>226</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2007.03.008</pub-id>.<pub-id pub-id-type="pmid">17500036</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Alborzi</surname><given-names>S. Z.</given-names></name>; <name><surname>Devignes</surname><given-names>M. D.</given-names></name>; <name><surname>Ritchie</surname><given-names>D. W.</given-names></name><article-title>ECDomainMiner:
discovering hidden
associations between enzyme commission numbers and Pfam domains</article-title>. <source>BMC Bioinf.</source><year>2017</year>, <volume>18</volume>, <fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s12859-017-1519-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Cerutti</surname><given-names>L.</given-names></name>; <name><surname>de Castro</surname><given-names>E.</given-names></name>; <name><surname>Langendijk-Genevaux</surname><given-names>P. S.</given-names></name>; <name><surname>Bulliard</surname><given-names>V.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Hulo</surname><given-names>N.</given-names></name><article-title>PROSITE, a protein
domain database for functional characterization and annotation</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>, <volume>38</volume>, <fpage>D161</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp885</pub-id>.<pub-id pub-id-type="pmid">19858104</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>de
Rond</surname><given-names>T.</given-names></name>; <name><surname>Asay</surname><given-names>J. E.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name><article-title>Co-occurrence of enzyme domains guides
the discovery of an oxazolone synthetase</article-title>. <source>Nat.
Chem. Biol.</source><year>2021</year>, <volume>17</volume>, <fpage>794</fpage>–<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-021-00808-4</pub-id>.<pub-id pub-id-type="pmid">34099916</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Mak</surname><given-names>W. S.</given-names></name>; <name><surname>Tran</surname><given-names>S.</given-names></name>; <name><surname>Marcheschi</surname><given-names>R.</given-names></name>; <name><surname>Bertolani</surname><given-names>S.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name>; <name><surname>Liao</surname><given-names>J. C.</given-names></name>; <name><surname>Siegel</surname><given-names>J. B.</given-names></name><article-title>Integrative
genomic mining for enzyme function to enable engineering of a non-natural
biosynthetic pathway</article-title>. <source>Nat. Commun.</source><year>2015</year>, <volume>6</volume>, <elocation-id>10005</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10005</pub-id>.<pub-id pub-id-type="pmid">26598135</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Vasina</surname><given-names>M.</given-names></name>; <name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Kovar</surname><given-names>D.</given-names></name>; <name><surname>Faldynova</surname><given-names>H.</given-names></name>; <name><surname>Kunka</surname><given-names>A.</given-names></name>; <name><surname>Buryska</surname><given-names>T.</given-names></name>; <name><surname>Badenhorst</surname><given-names>C. P. S.</given-names></name>; <name><surname>Mazurenko</surname><given-names>S.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Stavrakis</surname><given-names>S.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name>; <name><surname>deMello</surname><given-names>A.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name><article-title>Advanced database mining of efficient haloalkane dehalogenases
by sequence and structure bioinformatics and microfluidics</article-title>. <source>Chem. Catal.</source><year>2022</year>, <volume>2</volume>, <fpage>2704</fpage>–<lpage>2725</lpage>. <pub-id pub-id-type="doi">10.1016/j.checat.2022.09.011</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Sebestova</surname><given-names>E.</given-names></name>; <name><surname>Babkova</surname><given-names>P.</given-names></name>; <name><surname>Bidmanova</surname><given-names>S.</given-names></name>; <name><surname>Daniel</surname><given-names>L.</given-names></name>; <name><surname>Dvorak</surname><given-names>P.</given-names></name>; <name><surname>Stepankova</surname><given-names>V.</given-names></name>; <name><surname>Chaloupkova</surname><given-names>R.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>Exploration
of Enzyme Diversity by Integrating Bioinformatics with Expression
Analysis and Biochemical Characterization</article-title>. <source>ACS
Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>2402</fpage>–<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.7b03523</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Lobb</surname><given-names>B.</given-names></name>; <name><surname>Doxey</surname><given-names>A. C.</given-names></name><article-title>Novel function discovery
through sequence and structural
data mining</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2016</year>, <volume>38</volume>, <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2016.05.017</pub-id>.<pub-id pub-id-type="pmid">27289211</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Ghislieri</surname><given-names>D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Approaches
to the Synthesis of Enantiomerically
Pure Chiral Amines</article-title>. <source>Top. Catal.</source><year>2014</year>, <volume>57</volume>, <fpage>284</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s11244-013-0184-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Du</surname><given-names>S.</given-names></name>; <name><surname>Gao</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Chang</surname><given-names>M.</given-names></name><article-title>Secondary amines as coupling partners
in direct catalytic asymmetric
reductive amination</article-title>. <source>Chem. Sci.</source><year>2019</year>, <volume>10</volume>, <fpage>4509</fpage>–<lpage>4514</lpage>. <pub-id pub-id-type="doi">10.1039/C9SC00323A</pub-id>.<pub-id pub-id-type="pmid">31057780</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>A mechanism for reductive
amination catalyzed by fungal reductive aminases</article-title>. <source>ACS Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>11534</fpage>–<lpage>11541</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.8b03491</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Devine</surname><given-names>P. N.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Thompson</surname><given-names>M. P.</given-names></name>; <name><surname>Truppo</surname><given-names>M. D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Extending the application
of biocatalysis to meet the
challenges of drug development</article-title>. <source>Nat. Rev. Chem.</source><year>2018</year>, <volume>2</volume>, <fpage>409</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/s41570-018-0055-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>A reductive aminase
from Aspergillus
oryzae</article-title>. <source>Nat. Chem.</source><year>2017</year>, <volume>9</volume>, <fpage>961</fpage>–<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2782</pub-id>.<pub-id pub-id-type="pmid">28937665</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Mitsukura</surname><given-names>K.</given-names></name>; <name><surname>Suzuki</surname><given-names>M.</given-names></name>; <name><surname>Tada</surname><given-names>K.</given-names></name>; <name><surname>Yoshida</surname><given-names>T.</given-names></name>; <name><surname>Nagasawa</surname><given-names>T.</given-names></name><article-title>Asymmetric
synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell
catalyst of enantioselective imine reductase</article-title>. <source>Org. Biomol. Chem.</source><year>2010</year>, <volume>8</volume>, <fpage>4533</fpage>–<lpage>4535</lpage>. <pub-id pub-id-type="doi">10.1039/C0OB00353K</pub-id>.<pub-id pub-id-type="pmid">20820664</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Finnigan</surname><given-names>J. D.</given-names></name>; <name><surname>Thorpe</surname><given-names>T. W.</given-names></name>; <name><surname>Palmer</surname><given-names>R. B.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Duncan</surname><given-names>R. A. M.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Graham</surname><given-names>K. M.</given-names></name>; <name><surname>Cook</surname><given-names>D. J.</given-names></name>; <name><surname>Charnock</surname><given-names>S. J.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Screening
and characterization of a diverse panel of metagenomic imine reductases
for biocatalytic reductive amination</article-title>. <source>Nat. Chem.</source><year>2021</year>, <volume>13</volume>, <fpage>140</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-020-00606-w</pub-id>.<pub-id pub-id-type="pmid">33380742</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Luan</surname><given-names>Z.-J.</given-names></name>; <name><surname>Zheng</surname><given-names>G.-W.</given-names></name>; <name><surname>Xu</surname><given-names>J.-H.</given-names></name><article-title>Efficient Synthesis
of Chiral Indolines using an Imine Reductase from Paenibacillus lactis</article-title>. <source>Adv. Synth. Catal.</source><year>2015</year>, <volume>357</volume>, <fpage>1692</fpage>–<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201500160</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name><article-title>One-step asymmetric synthesis of
(R)- and (S)-rasagiline by reductive amination applying imine reductases</article-title>. <source>Green Chem.</source><year>2017</year>, <volume>19</volume>, <fpage>385</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1039/C6GC03023H</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>S.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Zhu</surname><given-names>D.</given-names></name><article-title>Imine Reductase-Catalyzed
Enantioselective Reduction of Bulky α,β-Unsaturated Imines
en Route to a Pharmaceutically Important Morphinan Skeleton</article-title>. <source>Adv. Synth. Catal.</source><year>2019</year>, <volume>361</volume>, <fpage>556</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201801326</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Weise</surname><given-names>N. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Identification
of Novel Bacterial Members of the Imine Reductase Enzyme Family that
Perform Reductive Amination</article-title>. <source>ChemCatChem</source><year>2018</year>, <volume>10</volume>, <fpage>510</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701408</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Pushpanath</surname><given-names>A.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Klemstein</surname><given-names>U.</given-names></name>; <name><surname>Galman</surname><given-names>J. L.</given-names></name>; <name><surname>Woodlock</surname><given-names>D.</given-names></name>; <name><surname>Bisagni</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>C. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Dominguez</surname><given-names>B.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Characterization of imine reductases in reductive amination
for the exploration of structure-activity relationships</article-title>. <source>Sci. Adv.</source><year>2020</year>, <volume>6</volume>, <elocation-id>eaay9320</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay9320</pub-id>.<pub-id pub-id-type="pmid">32494734</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Berrera</surname><given-names>M.</given-names></name>; <name><surname>Sandon</surname><given-names>N.</given-names></name>; <name><surname>Fishlock</surname><given-names>D.</given-names></name>; <name><surname>Ebeling</surname><given-names>M.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Hanlon</surname><given-names>S.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Expanding
the Imine Reductase Toolbox by Exploring the Bacterial Protein-Sequence
Space</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1749</fpage>–<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500218</pub-id>.<pub-id pub-id-type="pmid">26044455</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Ross</surname><given-names>A.</given-names></name>; <name><surname>Müller</surname><given-names>H.</given-names></name>; <name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Hanlon</surname><given-names>S. P.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Asymmetric Reductive
Amination of Ketones Catalyzed by Imine Reductases</article-title>. <source>ChemCatChem</source><year>2016</year>, <volume>8</volume>, <fpage>2023</fpage>–<lpage>2026</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201600384</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Roiban</surname><given-names>G.-D.</given-names></name>; <name><surname>Kern</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Hyslop</surname><given-names>J.</given-names></name>; <name><surname>Tey</surname><given-names>P. L.</given-names></name>; <name><surname>Levine</surname><given-names>M. S.</given-names></name>; <name><surname>Jordan</surname><given-names>L. S.</given-names></name>; <name><surname>Brown</surname><given-names>K. K.</given-names></name>; <name><surname>Hadi</surname><given-names>T.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name><article-title>Efficient
Biocatalytic Reductive
Aminations by Extending the Imine Reductase Toolbox</article-title>. <source>ChemCatChem</source><year>2017</year>, <volume>9</volume>, <fpage>4475</fpage>–<lpage>4479</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701379</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Schober</surname><given-names>M.</given-names></name>; <name><surname>MacDermaid</surname><given-names>C.</given-names></name>; <name><surname>Ollis</surname><given-names>A. A.</given-names></name>; <name><surname>Chang</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>D.</given-names></name>; <name><surname>Hosford</surname><given-names>J.</given-names></name>; <name><surname>Latham</surname><given-names>J.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name>; <name><surname>Fuerst</surname><given-names>D.</given-names></name>; <name><surname>Sanganee</surname><given-names>M. J.</given-names></name>; <name><surname>Roiban</surname><given-names>G.-D.</given-names></name><article-title>Chiral synthesis
of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine
reductase</article-title>. <source>Nat. Catal.</source><year>2019</year>, <volume>2</volume>, <fpage>909</fpage>–<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0341-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Karmilowicz</surname><given-names>M. J.</given-names></name>; <name><surname>Burke</surname><given-names>D.</given-names></name>; <name><surname>Burns</surname><given-names>M. P.</given-names></name>; <name><surname>Clark</surname><given-names>L. A.</given-names></name>; <name><surname>Connor</surname><given-names>C. G.</given-names></name>; <name><surname>Cordi</surname><given-names>E.</given-names></name>; <name><surname>Do</surname><given-names>N. M.</given-names></name>; <name><surname>Doyle</surname><given-names>K. M.</given-names></name>; <name><surname>Hoagland</surname><given-names>S.</given-names></name>; <name><surname>Lewis</surname><given-names>C. A.</given-names></name>; <name><surname>Mangan</surname><given-names>D.</given-names></name>; <name><surname>Martinez</surname><given-names>C. A.</given-names></name>; <name><surname>McInturff</surname><given-names>E. L.</given-names></name>; <name><surname>Meldrum</surname><given-names>K.</given-names></name>; <name><surname>Pearson</surname><given-names>R.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Rane</surname><given-names>A.</given-names></name>; <name><surname>Weaver</surname><given-names>J.</given-names></name><article-title>Biocatalytic reductive
amination
from discovery to commercial manufacturing applied to abrocitinib
JAK1 inhibitor</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>775</fpage>–<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00671-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Webb</surname><given-names>B.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name><article-title>Comparative Protein Structure Modeling
Using MODELLER</article-title>. <source>Curr. Protoc. Bioinf.</source><year>2016</year>, <volume>54</volume>, <fpage>5</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/cpbi.3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Sánchez</surname><given-names>R.</given-names></name>; <name><surname>Šali</surname><given-names>A.</given-names></name><article-title>Comparative protein structure modeling as an optimization
problem</article-title>. <source>J. Mol. Struct.: THEOCHEM</source><year>1997</year>, <volume>398-399</volume>, <fpage>489</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-1280(96)04971-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Trott</surname><given-names>O.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock Vina: improving
the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source>J. Comput. Chem.</source><year>2010</year>, <volume>31</volume>, <fpage>455</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>.<pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></name>; <name><surname>Adler</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Green</surname><given-names>T.</given-names></name>; <name><surname>Zielinski</surname><given-names>M.</given-names></name>; <name><surname>Zidek</surname><given-names>A.</given-names></name>; <name><surname>Bridgland</surname><given-names>A.</given-names></name>; <name><surname>Cowie</surname><given-names>A.</given-names></name>; <name><surname>Meyer</surname><given-names>C.</given-names></name>; <name><surname>Laydon</surname><given-names>A.</given-names></name>; <name><surname>Velankar</surname><given-names>S.</given-names></name>; <name><surname>Kleywegt</surname><given-names>G. J.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Evans</surname><given-names>R.</given-names></name>; <name><surname>Pritzel</surname><given-names>A.</given-names></name>; <name><surname>Figurnov</surname><given-names>M.</given-names></name>; <name><surname>Ronneberger</surname><given-names>O.</given-names></name>; <name><surname>Bates</surname><given-names>R.</given-names></name>; <name><surname>Kohl</surname><given-names>S. A. A.</given-names></name>; <name><surname>Potapenko</surname><given-names>A.</given-names></name>; <name><surname>Ballard</surname><given-names>A. J.</given-names></name>; <name><surname>Romera-Paredes</surname><given-names>B.</given-names></name>; <name><surname>Nikolov</surname><given-names>S.</given-names></name>; <name><surname>Jain</surname><given-names>R.</given-names></name>; <name><surname>Clancy</surname><given-names>E.</given-names></name>; <name><surname>Reiman</surname><given-names>D.</given-names></name>; <name><surname>Petersen</surname><given-names>S.</given-names></name>; <name><surname>Senior</surname><given-names>A. W.</given-names></name>; <name><surname>Kavukcuoglo</surname><given-names>K.</given-names></name>; <name><surname>Birney</surname><given-names>E.</given-names></name>; <name><surname>Pushmeet</surname><given-names>K.</given-names></name>; <name><surname>Jumper</surname><given-names>J.</given-names></name>; <name><surname>Hassabis</surname><given-names>D.</given-names></name><article-title>Highly accurate
protein structure prediction for the
human proteome</article-title>. <source>Nature</source><year>2021</year>, <volume>596</volume>, <fpage>590</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>.<pub-id pub-id-type="pmid">34293799</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Lee</surname><given-names>C.</given-names></name>; <name><surname>Su</surname><given-names>B. H.</given-names></name>; <name><surname>Tseng</surname><given-names>Y. J.</given-names></name><article-title>Comparative studies of AlphaFold,
RoseTTAFold and Modeller: a case study involving the use of G-protein-coupled
receptors</article-title>. <source>Briefings Bioinf.</source><year>2022</year>, <volume>23</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbac308</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Rodríguez-Mata</surname><given-names>M.</given-names></name>; <name><surname>Frank</surname><given-names>A.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure and activity
of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus,
which catalyses the R-selective reduction of an imine substrate</article-title>. <source>ChemBioChem</source><year>2013</year>, <volume>14</volume>, <fpage>1372</fpage>–<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201300321</pub-id>.<pub-id pub-id-type="pmid">23813853</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure, Activity
and Stereoselectivity of NADPH-Dependent Oxidoreductases Catalysing
the S-Selective Reduction of the Imine Substrate 2-Methylpyrroline</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1052</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201402625</pub-id>.<pub-id pub-id-type="pmid">25809902</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Huber</surname><given-names>T.</given-names></name>; <name><surname>Schneider</surname><given-names>L.</given-names></name>; <name><surname>Präg</surname><given-names>A.</given-names></name>; <name><surname>Gerhardt</surname><given-names>S.</given-names></name>; <name><surname>Einsle</surname><given-names>O.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name><article-title>Direct Reductive
Amination of Ketones: Structure and
Activity ofS-Selective Imine Reductases fromStreptomyces</article-title>. <source>ChemCatChem</source><year>2014</year>, <volume>6</volume>, <fpage>2248</fpage>–<lpage>2252</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201402218</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Toca-Gonzalez</surname><given-names>L.</given-names></name>; <name><surname>Marchington</surname><given-names>R.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Stereoselectivity and Structural
Characterization of an Imine Reductase (IRED) from Amycolatopsis orientalis</article-title>. <source>ACS Catal.</source><year>2016</year>, <volume>6</volume>, <fpage>3880</fpage>–<lpage>3889</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.6b00782</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Lenz</surname><given-names>M.</given-names></name>; <name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name><article-title>New imine-reducing
enzymes from beta-hydroxyacid dehydrogenases
by single amino acid substitutions</article-title>. <source>Protein
Eng., Des. Sel.</source><year>2018</year>, <volume>31</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/protein/gzy006</pub-id>.<pub-id pub-id-type="pmid">29733377</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Adams</surname><given-names>R. W.</given-names></name>; <name><surname>Slabu</surname><given-names>I.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Wallace</surname><given-names>T. W.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Routes to Enantiomerically
Enriched Dibenz[c,e]azepines</article-title>. <source>Angew. Chem.,
Int. Ed.</source><year>2017</year>, <volume>56</volume>, <fpage>15589</fpage>–<lpage>15593</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201708453</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Imine reductases
(IREDs)</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2017</year>, <volume>37</volume>, <fpage>19</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2016.11.022</pub-id>.<pub-id pub-id-type="pmid">28038349</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Feinstein</surname><given-names>W. P.</given-names></name>; <name><surname>Brylinski</surname><given-names>M.</given-names></name><article-title>Calculating an optimal box size for
ligand docking
and virtual screening against experimental and predicted binding pockets</article-title>. <source>J. Cheminf.</source><year>2015</year>, <volume>7</volume>, <elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-015-0067-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Morris</surname><given-names>G. M.</given-names></name>; <name><surname>Huey</surname><given-names>R.</given-names></name>; <name><surname>Lindstrom</surname><given-names>W.</given-names></name>; <name><surname>Sanner</surname><given-names>M. F.</given-names></name>; <name><surname>Belew</surname><given-names>R. K.</given-names></name>; <name><surname>Goodsell</surname><given-names>D. S.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock4
and AutoDockTools4: Automated
docking with selective receptor flexibility</article-title>. <source>J. Comput. Chem.</source><year>2009</year>, <volume>30</volume>, <fpage>2785</fpage>–<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>.<pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>O’Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name><article-title>Open Babel:
An open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Stockinger</surname><given-names>P.</given-names></name>; <name><surname>Roth</surname><given-names>S.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Systematic Evaluation
of Imine-Reducing Enzymes: Common Principles in Imine Reductases,
beta-Hydroxy Acid Dehydrogenases, and Short-Chain Dehydrogenases/
Reductases</article-title>. <source>ChemBioChem</source><year>2020</year>, <volume>21</volume>, <fpage>2689</fpage>–<lpage>2695</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.202000213</pub-id>.<pub-id pub-id-type="pmid">32311225</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Scheller</surname><given-names>P. N.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name>; <name><surname>Hauer</surname><given-names>B.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Identification
of imine reductase-specific sequence motifs</article-title>. <source>Proteins</source><year>2016</year>, <volume>84</volume>, <fpage>600</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/prot.25008</pub-id>.<pub-id pub-id-type="pmid">26857686</pub-id></mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Tatusova</surname><given-names>T.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>NCBI reference
sequences (RefSeq):
a curated non-redundant sequence database of genomes, transcripts
and proteins</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>, <volume>35</volume>, <fpage>D61</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl842</pub-id>.<pub-id pub-id-type="pmid">17130148</pub-id></mixed-citation>
    </ref>
    <ref id="ref77">
      <mixed-citation publication-type="journal" id="cit77"><name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Godzik</surname><given-names>A.</given-names></name><article-title>Cd-hit: a fast program for clustering and comparing
large sets of protein or nucleotide sequences</article-title>. <source>Bioinformatics</source><year>2006</year>, <volume>22</volume>, <fpage>1658</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id>.<pub-id pub-id-type="pmid">16731699</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Catal</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Catal</journal-id>
    <journal-id journal-id-type="publisher-id">cs</journal-id>
    <journal-id journal-id-type="coden">accacs</journal-id>
    <journal-title-group>
      <journal-title>ACS Catalysis</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2155-5435</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10510103</article-id>
    <article-id pub-id-type="doi">10.1021/acscatal.3c02278</article-id>
    <article-categories>
      <subj-group>
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Structure-Based
Design of Small Imine Reductase Panels
for Target Substrates</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <name>
          <surname>Yu</surname>
          <given-names>Yuqi</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8932-8763</contrib-id>
        <name>
          <surname>Rué Casamajo</surname>
          <given-names>Arnau</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1061-7800</contrib-id>
        <name>
          <surname>Finnigan</surname>
          <given-names>William</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4331-2675</contrib-id>
        <name>
          <surname>Schnepel</surname>
          <given-names>Christian</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Barker</surname>
          <given-names>Rhys</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Morrill</surname>
          <given-names>Charlotte</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Heath</surname>
          <given-names>Rachel S.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8061-4242</contrib-id>
        <name>
          <surname>De Maria</surname>
          <given-names>Leonardo</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath9">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8708-0781</contrib-id>
        <name>
          <surname>Turner</surname>
          <given-names>Nicholas J.</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath10">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4182-3500</contrib-id>
        <name>
          <surname>Scrutton</surname>
          <given-names>Nigel S.</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Department
of Chemistry, <institution>The University of Manchester,
Manchester Institute of Biotechnology</institution>, 131 Princess Street, Manchester M1 7DN, <country>U.K.</country></aff>
      <aff id="aff2"><label>‡</label>Augmented
Biologics Discovery &amp; Design, Department of Biologics Engineering, <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Cambridge CB21 6GH, <country>U.K.</country></aff>
      <aff id="aff3"><label>§</label>Medicinal
Chemistry, Research and Early Development, Respiratory and Immunology
(RI), <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Gothenburg 43150, <country>Sweden</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>yuqi.yu@astrazeneca.com</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>nicholas.turner@manchester.ac.uk</email>.</corresp>
      <corresp id="cor3"><label>*</label>Email: <email>nigel.scrutton@manchester.ac.uk</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>05</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <volume>13</volume>
    <issue>18</issue>
    <fpage>12310</fpage>
    <lpage>12321</lpage>
    <history>
      <date date-type="received">
        <day>19</day>
        <month>05</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>08</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0008" id="ab-tgr1"/>
      </p>
      <p>Biocatalysis is important in the discovery, development,
and manufacture
of pharmaceuticals. However, the identification of enzymes for target
transformations of interest requires major screening efforts. Here,
we report a structure-based computational workflow to prioritize protein
sequences by a score based on predicted activities on substrates,
thereby reducing a resource-intensive laboratory-based biocatalyst
screening. We selected imine reductases (IREDs) as a class of biocatalysts
to illustrate the application of the computational workflow termed
IREDFisher. Validation by using published data showed that IREDFisher
can retrieve the best enzymes and increase the hit rate by identifying
the top 20 ranked sequences. The power of IREDFisher is confirmed
by computationally screening 1400 sequences for chosen reductive amination
reactions with different levels of complexity. Highly active IREDs
were identified by only testing 20 samples in vitro. Our speed test
shows that it only takes 90 min to rank 85 sequences from user input
and 30 min for the established IREDFisher database containing 591
IRED sequences. IREDFisher is available as a user-friendly web interface
(<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher enables the rapid discovery of IREDs for applications
in synthesis and directed evolution studies, with minimal time and
resource expenditure. Future use of the workflow with other enzyme
families could be implemented following the modification of the workflow
scoring function.</p>
    </abstract>
    <kwd-group>
      <kwd>biocatalysis</kwd>
      <kwd>enzyme screening</kwd>
      <kwd>imine reductase</kwd>
      <kwd>computational workflow</kwd>
      <kwd>structural modeling</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>AstraZeneca</institution>
            <institution-id institution-id-type="doi">10.13039/100004325</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Biotechnology and Biological Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000268</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Engineering and Physical Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000266</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Enzymatic synthesis has gained growing
attention in recent years
due to the inherent advantages of benign reaction conditions along
with exquisite chemo-, stereo-, and regio-selectivity.<sup><xref ref-type="bibr" rid="ref1">1</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> However, finding the optimal biocatalyst to effect the transformation
of a substrate of interest is often challenging and time consuming.
There are two strategies commonly used in enzyme discovery (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, left panel). One
is to manually select the enzymes that have been reported to be active
toward similar substrate(s) in the literature. However, this approach
restricts the diversity of accessible enzymes and may result in potentially
active enzymes being missed. Consequently, the alternative strategy
of searching for homologous enzymes from databases is increasingly
applied. However, this approach typically generates a very large number
of sequences, the majority of which have not been characterized experimentally.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> Screening all of these sequences is time consuming, requiring the
extensive use of analytical equipment and other methods for high-throughput
screening.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Solutions of enzyme discovery for targeted substrate(s). Left:
two common methods for finding hit enzymes for targeted substrate(s).
Right: a schematic diagram of IREDFisher developed in this work. Input
sequences are filtered by IREDFisher with the aid of structural modeling
and molecular docking, which allows the user to obtain a small panel
consisting of prioritized sequences.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0002" id="gr1" position="float"/>
    </fig>
    <p>Computational tools have shown great power in the
development and
application of biocatalysts including synthetic pathway design,<sup><xref ref-type="bibr" rid="ref8">8</xref>−<xref ref-type="bibr" rid="ref10">10</xref></sup> enzyme engineering,<sup><xref ref-type="bibr" rid="ref11">11</xref>−<xref ref-type="bibr" rid="ref14">14</xref></sup> and de novo design.<sup><xref ref-type="bibr" rid="ref15">15</xref>−<xref ref-type="bibr" rid="ref18">18</xref></sup> However, in silico pipelines that prioritize sequences and thus
reduce the necessary screening throughput in the laboratory are still
underdeveloped. The current structure-based pipelines are either struggling
in dealing with large numbers of sequences and are thus mainly used
for engineering an initially known active enzyme<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> or require a detailed description of the catalytic geometry based
on a known ligand-binding motif.<sup><xref ref-type="bibr" rid="ref21">21</xref>−<xref ref-type="bibr" rid="ref23">23</xref></sup> Sequence-based pipelines<sup><xref ref-type="bibr" rid="ref24">24</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup> can realize high throughput but they generally ignore substrate
variations (a key consideration in establishing biocatalytic panels),
leading to poor activity predictions of enzymes in relation to target
substrates. Standalone methods such as homology modeling and molecular
docking have been established over many years but are generally used
individually rather than in automated combination, which limits throughput
in biocatalyst screening programs. Integration of these approaches
into an automated pipeline for biocatalyst discovery is urgently needed
to rapidly model enzyme–substrate complexes and generate rank
ordering of likely active sequences. Only a few structure-based computational
pipelines<sup><xref ref-type="bibr" rid="ref38">38</xref>−<xref ref-type="bibr" rid="ref41">41</xref></sup> have been published. However, none of these have been automated
to enable easy access to laboratory-based scientists. An “easy-to-use”
in silico web application is required for experimentalists who need
to conduct efficient and rapid screens to identify active enzymes
but are struggling to use more specialized computational tools. Consequently,
an “easy-to-use” in silico web-based application will
streamline experimental screening and thereby reduce the time and
resources required to identify biocatalysts for use.</p>
    <p>Here, we
report the development and experimental validation of
an in silico pipeline, available also via a web interface, termed
IREDFisher (available for use at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher is a structure-based web server that allows computer-aided
enzyme screening with substrate(s) of interest and recommends a small
(20 enzyme) panel of IREDs for rapid biocatalytic exploration by the
user (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). We
selected imine reductases (IREDs) as a model enzyme in view of their
recent emergence as an enzyme class of interest for the synthesis
of chiral amines. Chiral amines are prevalent motifs that feature
in about 40% of pharmaceuticals.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> IREDs catalyze
enantioselective imine reduction and can also perform the reductive
amination of ketones or aldehydes<sup><xref ref-type="bibr" rid="ref44">44</xref>−<xref ref-type="bibr" rid="ref46">46</xref></sup> and are thus of major
interest to the academic and industrial biocatalysis communities.
Since their discovery in 2010,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> a vast
number of IRED sequences have been published together with a wealth
of activity data for different substrates.<sup><xref ref-type="bibr" rid="ref48">48</xref>−<xref ref-type="bibr" rid="ref58">58</xref></sup> Currently, IREDFisher only applies to IREDs as the scoring function
is modified specifically for these enzymes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Flow chart of the four-step
IREDFisher workflow. The input sequences
are preprocessed in step (1) to remove non-IRED-homologs from the
screening list. The three-dimensional structures of the remaining
sequences are modeled in step (2). In step (3), the structures obtained
from step (2) are aligned to a cofactor- and ligand-bound IRED crystal
structure to locate the active site and cofactor binding site for
each modeled structure. NADPH is placed into individual modeled structures
by taking the coordinates from the crystal structure. An intermediate
imine structure formed by amine and ketone substrates is then docked
into the active site of each structure. In step (4), the best pose
for the substrate within the enzyme is selected by the distance between
two key atoms of the cofactor and substrate. In crystal structures
of IREDs, this distance is around 4 Å. In step (5), the number
of acidic residues <italic>N</italic><sub>acidic</sub>, the number
of basic residues <italic>N</italic><sub>basic</sub>, and the presence
of histidine residues <italic>N</italic><sub>his</sub> = 0 or 1 are
calculated for residues within 8 Å of the substrate. Enzymes
are ranked by a modified scoring function IREDFisher score = 4.0 ×
Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> –
9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> (see details described in the <xref rid="sec4" ref-type="other">Methods</xref> section).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0003" id="gr2" position="float"/>
    </fig>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>IREDFisher Workflow</title>
      <p>Having the initial sequences and
a substrate structure as inputs, the IREDFisher workflow commences
with sequence preprocessing, followed by structural modeling. Then,
the provided substrate is docked into the modeled enzyme structures,
while the protein–substrate complexes are scored by considering
predicted binding affinity and catalytic geometry in the final step
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Specifically,
in step (1), each input sequence is aligned to individual sequences
in the protein data bank (PDB). The input sequence that has the highest
sequence identity to known IREDs in the PDB is considered as a putative
IRED and retained for the next step. In step (2), all three-dimensional
structures of the resulting sequences from step (1) are generated
by MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> followed by an optimization
by the default function in MODELLER,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> which
consists of spatial restraints on distance and dihedral angles obtained
from the target structure and CHARMM energy terms enforcing proper
stereochemistry.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> All models are evaluated
based on the Ramachandran plot, and only those that have over 90%
 of the residues in favorable/coreregions are defined as qualified
models and subsequently used for substrate docking. In step (3), the
substrate is docked into the active site of each qualified model.
Various poses of the substrate in the active site of the enzymes are
generated. In step (4), the distance between NADPH C4 and N atom of
the imine substrate is calculated for all poses. The pose with ∼4
Å is selected as the best pose to realize hydride transfer in
a catalytic process (see pose selection in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> and details in the <xref rid="sec4" ref-type="other">Methods</xref> section). In step (5), the number of acidic residues <italic>N</italic><sub>acidic</sub>, basic residues <italic>N</italic><sub>basic</sub>, and histidine residues <italic>N</italic><sub>His</sub> are calculated
and used to modify the Autodock Vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> scoring
function considering they play important roles in the stabilization
of iminium intermediate formation and proton transfer (see details
in the <xref rid="sec4" ref-type="other">Methods</xref>section). The modified scoring
function Refined score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> was
used to finally rank all input sequences. The top 20 IRED sequences
are then selected for in vitro screening.</p>
    </sec>
    <sec id="sec2.2">
      <title>IREDFisher Validation Using Published Screening Data</title>
      <p>The screening data from three established IRED panels were used to
test the IREDFisher workflow: Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> (85 sequences) for substrates <bold>1</bold>–<bold>9</bold>, France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> (45 sequences)
for substrates <bold>10</bold>–<bold>17</bold>, and Montgomery
et al. IRED panel<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> (93 sequences) for <bold>18</bold>–<bold>24</bold> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Each panel and the corresponding tested
substrates were fed into IREDFisher to obtain the recommended 20 sequences.
As control, 20 sequences were randomly selected from each corresponding
panel. Hit rates using a conversion cutoff of 2% (hit rate of ≥
2% conversion) and 50% (hit rate of ≥ 50% conversion) were
calculated and compared between the two methods (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a,b and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S1</ext-link>). The likelihood of retrieving the best hit in the
20 selected sequences using the two methods was also calculated (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S2</ext-link>). In terms of “hit rate of ≥
2% conversion”, IREDFisher is comparable to random selection,
whereas it outperforms the latter in finding hits with conversions
over 50% (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b).
This shows the capability of IREDFisher in finding competent hits
for downstream optimization. Furthermore, IREDFisher retrieved the
best hit to the top 20 sequences with a likelihood of 100%. By contrast,
the likelihood of picking the best hit by random selection is no more
than 50%. In summary, the IREDFisher workflow is not only able to
improve the hit rate but also retrieves the best enzyme(s) from the
whole IRED panel in the top 20 selected sequences. This emphasizes
the effectiveness of IREDFisher in finding IRED hits, reducing screening
efforts by 50–75%.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tests of reductive amination reactions based
on published data.
Reaction products of IRED-catalyzed reactions are shown with moieties
originating from the amine nucleophile colored in blue and those from
the ketone component displayed in black. Compounds <bold>1–9</bold> are from ref (<xref ref-type="bibr" rid="ref56">56</xref>), compounds <bold>10–17</bold> are from ref (<xref ref-type="bibr" rid="ref52">52</xref>), and compounds <bold>18–24</bold> are from ref (<xref ref-type="bibr" rid="ref53">53</xref>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0004" id="gr3" position="float"/>
      </fig>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Comparison of hit rate and best hit retrieval in 20 sequences
selected
by IREDFisher and by random selection. (a) Hit rate using a conversion
cutoff of 2% calculated by the equation: Hit rate of ≥2% conversion
= <inline-formula id="d33e578"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m001.gif"/></inline-formula>. (b) Hit rate using a conversion cutoff
of 50% calculated by the equation: Hit rate of ≥50% conversion
= <inline-formula id="d33e581"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m002.gif"/></inline-formula>. Symbol × indicates that no hits with
conversion over 50% were found in the in vitro screening of the corresponding
panels. (c) Likelihood of retrieving the best hit from the whole panel
in the 20 selected sequences using IREDFisher. The error bars for
the random selection were calculated by the standard error of the
mean (SEM) based on 95% confidence levels.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.3">
      <title>Experimental Validation of Predictions Made by IREDFisher</title>
      <p>Next, we challenged the IREDFisher workflow by aiming to select
potential IRED hits for subsequent validation by experimental screening.
We chose the following reductive amination reactions as our targets,
namely, <bold>18</bold> and <bold>25–28</bold> (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a), which represent increasingly
demanding conversions for imine reductases. Reactions corresponding
to products <bold>18</bold> and <bold>25</bold> are common starting
points for screening IREDs, whereas products <bold>26</bold> and <bold>27</bold> are important building blocks in the pharmaceutical industry
and proved to be challenging targets in a previous IRED study.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Synthesis of <bold>28</bold> is particularly
challenging due to the negative charge of the carboxylate group in
the substrate. To date, no IREDs have been reported to accept 4-formylbenzoic
acid as a substrate. Also, we note that 4-formylbenzoic acid <bold>28</bold> is a building block for drugs such as procarbazine (chemotherapy),
imatinib (chemotherapy), mocetinostat, etinostat, tucidinostat (HDAC
inhibitors), revefenacin (COPD treatment), bavisant (ADHD treatment),
and fedovapagon (nocturia treatment) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S1</ext-link>). Inclusion of <bold>28</bold> was used to explore whether the IREDFisher
workflow could identify biocatalysts for novel reductive amination
reactions.</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Validation of IREDFisher predictions in identifying hits for five
chosen reactions. (a) IREDFisher was run in two rounds: in the first
round, the sequences from external sources, public databases, and
established panels were ranked by IREDFisher to prioritize those to
be used for gene synthesis and enzyme expression. In the second round,
33 new enzymes with good expression in <italic>Escherichia
coli</italic> and 193 in-house sequences were ranked by IREDFisher.
The top 20 enzymes for each reaction were then investigated in the
laboratory. The percentages of new enzymes and in-house enzymes are
65 and 35% for <bold>18</bold>, 50 and 50% for <bold>25</bold>, 45
and 55% for <bold>26</bold>, 50 and 50% for <bold>27</bold>, and 55
and 45% for <bold>28</bold>. Compounds are shown in product forms.
Amine nucleophile components are colored in blue. (b) The conversion
of IREDFisher selected sequences toward products <bold>18</bold> and <bold>25</bold>–<bold>28</bold>. Hit rates for each reaction were
calculated using a conversion cutoff of 2%: Hit rate = <inline-formula id="d33e662"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m003.gif"/></inline-formula>. NS indicates that this sequence is not
in the top 20 selected by IREDFisher and consequently was not tested
in vitro. Sequences labeled pIR are from the in-house panel. Sequences
labeled yIRED are new uncharacterized sequences and highlighted in
bold and italic font.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0006" id="gr5" position="float"/>
      </fig>
      <p>For sequence input, we used 193 well-expressed
enzymes from our
in-house panel along with 33 new sequences found by IREDFisher that
are also expressed well. To find new active enzymes toward selected
targets, we collected uncharacterized IRED homologs from public databases
(NCBI and UniProt) and IREDs from established panels (Robian et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl
et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> and Yao et al.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup>), generating 1239 sequences in total (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a, lower panel). Then, the
first round of the IREDFisher ranking was run for the collected sequences
based on the targeted product to prioritize successful gene synthesis
and protein expression. The top 20 enzyme sequences for targets <bold>18</bold> and <bold>25–30</bold> were selected in silico.
Then, 60 sequences were identified after removing duplicates from
which genes were synthesized and expressed in <italic>E. coli</italic>. This resulted in 33 enzymes (55% of selected enzymes) that expressed
well in <italic>E. coli</italic>, while 27 enzymes (45%
of selected enzymes) failed in cloning and/or expression.</p>
      <p>We
then combined these 33 enzymes with 193 sequences from our in-house
panel and ran a second round of IREDFisher ranking to prioritize these
sequences in activity screening experiments. The top 20 IREDs obtained
by IREDFisher for each targeted reaction were screened in vitro, and
corresponding conversions to products were determined by GC or HPLC
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b). Reaction
optimization was not carried out, as only the relative efficiency
of IREDFisher under standardized conditions was being evaluated. For
target reactions <bold>18</bold> and <bold>25–28</bold>, the
hit rate decreases as the difficulty of the IRED reactions increases,
with 2–11 hits (over 90% conversion) of corresponding substrates
obtained. In a previous study, the hit rate of <bold>26</bold> (26b
in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) and <bold>27</bold> (<bold>23d</bold> in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) by screening a panel of 384 IREDs was low (2.6% for <bold>26</bold> and 5.5% for <bold>27</bold>), whereas the hit rate in this study
employing IREDFisher increased substantially to 60 and 40%, respectively.
Notably, two hits, with conversion ≥ 90%, were found for the
challenging product <bold>28</bold>, demonstrating that IREDFisher
can find enzymes that catalyze reactions of pharmaceutical importance.
Furthermore, by exploiting the resources from public databases, highly
active IREDs that have not been reported previously were identified
and multiple enzymes (e.g., yIRED10, yIRED23, yIRED25) were found
to have broad substrate scope. The benefit of IREDFisher in prioritizing
screening is clear, in this case reducing the experimental screening
required from ≥ 1000 samples without IREDFisher virtual screening
to only 20 samples.</p>
    </sec>
    <sec id="sec2.4">
      <title>IREDFisher Web Interface and Speed Test</title>
      <p>Encouraged
by the validation results using established screening data and our
own experiments, our intention was to develop a user-friendly workflow
that can be widely used by the biocatalysis community. To avoid any
requirement for the use of personal computational/programming skills,
we have built an IREDFisher web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>). We emphasize
that the current methodology only applies to IREDs. For the input
structure, the imine structure formed by the condensation of aldehyde
or ketone and amine is required. This can be obtained by the free
online structure drawing tool Marvin JS (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">https://marvinjs-demo.chemaxon.com/latest/</uri>) from ChemAxon (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the square on the right). The index of the N
atom in the C=N bond is also required as an input, which can
be generated using the Marvin interface. A FASTA-formatted sequence
file is required if users intend to rank their own sequences (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the
square on the left). After the job is submitted, output files such
as three-dimensional structures of IREDs, substrate-bound complex
structures, and scoring files are generated and added to the web page.
By checking the sorted rescoring file, the user can obtain an optimized
small IRED screening panel with 20 recommended sequences by IREDFisher
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b). In addition,
IREDFisher also allows users to rank the sequences from established
panels and public databases (see the <xref rid="sec4" ref-type="other">Methods</xref> section for details). Therefore, IREDFisher can be employed in ranking:
(i) user-defined sequences; (ii) established IRED panels, e.g., Robian
et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> etc.; and (iii)
IRED sequences collected from the public database in this study. The
speed test showed that IREDFisher can perform the calculation of a
user-defined panel with 85 sequences in 90 min. Moreover, it only
takes ca 30 min to complete the ranking of the established IRED panels
and sequences from public databases by using the structures already
deposited in the IREDFisher web server. Consequently, based on simple
data input, nonspecialists in bioinformatics can have access to workflow
outputs using only a few mouse clicks without human interference,
which makes it applicable for small IRED panel design.</p>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Web interface of IREDFisher.
(a) Job submission interface and input
file examples. Left square: FASTA-formatted sequence file. Right square:
generation of substrate structure and N atom index by Marvin JS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">&lt;underline≥https://marvinjs-demo.chemaxon.com/latest/&lt;/underline≥</ext-link>). (b) Output files. The file for sequence ranking (1a_imine_sort_rescore.csv
in the example) is shown.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0007" id="gr6" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p>The computational four-step workflow IREDFisher
that aims to streamline
the screening of enzyme panels was produced by integrating sequence
analysis, structure modeling, and molecular docking. Although large
numbers of protein structures have been released recently by AlphaFold,<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> the structures obtained are not always applicable
for the use of molecular docking. For many enzymes, the substrate-binding
site is formed by monomers/dimers, but only monomeric structures were
deposited in the database. For example, most of the new sequences
used in this study were only modeled as monomer in the AlphaFold database.
We have shown that the active site is similar between the dimer models
generated by homology modeling and AlphaFold (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S2</ext-link>), while the former approach saves considerable computation
time (3 min by homology modeling versus 30 min by AlphaFold per structure).
This is also suggested by a previous publication.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> Therefore, the template-based homology modeling is beneficial
for the rapid building of structures in the IREDFisher workflow, allowing
users to rank large numbers of sequences.</p>
    <p>The workflow was applied
by using a model enzyme IRED and subsequently
validated using previously published screening data. IREDFisher demonstrated
the power of retrieving the best hit found simply by screening a small
panel of 20 sequences using the IREDFisher workflow. Experimental
validation in which IREDFisher selects 20 enzymes from a pool of ∼1400
sequences for 5 reactions, and with different levels of product complexity,
further establishes the effectiveness of IREDFisher. IREDFisher ranks
enzymes based on enzyme–substrate-binding interactions and
does not consider features such as the charge distribution on the
protein surface, which might, for example, be important for successful
protein expression in <italic>E. coli</italic>. As such,
poorly expressed proteins could rank better than proteins that are
expressed well in <italic>E. coli</italic>. The workflow
was run initially to identify sequences for gene synthesis and protein
expression analysis. We then performed a second screening experiment
to rank new IRED biocatalysts only with those sequences that expressed
well in <italic>E. coli</italic>. The prediction of
enantioselectivity by IREDFisher is not investigated in this study
because this is challenging. That said, IREDFisher narrows the search
to a small panel of IREDs such that screening those biocatalysts for
enantioselectivity is no longer an onerous task.</p>
    <p>It is noteworthy
that most biocatalytic processes for drug production
need to go through extensive reaction optimization and mutagenesis
approaches such as directed evolution to obtain a biocatalyst that
fulfills the desired process requirements. Directed evolution relies
on the screening of thousands of enzyme variants and usually involves
several rounds of library generation and screening, resulting in large
numbers of variants that require high-throughput screening (HTS) methods
for their evaluation. As such, screening remains the major bottleneck
in biocatalysis applications, and this places major burdens on the
resources and time required to generate a suitable biocatalyst. By
taking advantage of the IREDFisher computational workflow, we have
shown that it is possible to identify suitable biocatalysts for simple
and challenging substrates. If needed, these could be evolved further
to fulfill process needs with reduced screening efforts. IREDFisher
is therefore valuable, either as a standalone computational workflow
to aid the rapid identification of biocatalysts or as a “front-end’
workflow to accelerate directed evolution programs by selecting the
prototype, catalytically competent enzyme scaffolds for a target reaction.
However, we clarify that IREDFisher takes wild-type sequences as input,
which limits its ability to “design” enzymes with non-natural
functions to catalyze extremely challenging reactions.</p>
    <p>IREDFisher
is designed as a “fast prescreen method”
to rank input sequences. As such, it has limitations. Protein dynamics
and energy barrier calculations are not incorporated because this
would be too time consuming for a fast prescreening tool for use by
experimentalists. The IREDFisher scoring function works as a tool
to rank input sequences instead of accurately predicting the conversion/activity
of enzymes. We trained the scoring instead to deliver a maximum hit
rate of the top 20 sequences because 20 screening experiments can
be carried out in one batch with overnight incubation for rapid enzyme
screening. That said, the IREDFisher workflow has the power to find
highly active hits in the 20 recommended sequences. This indicates
that a trade-off between speed and accuracy has been achieved to some
extent. Currently, it is applicable to IREDs as the scoring function
is designed specifically for this enzyme family. We have also tested
IREDFisher on haloalkane dehydrogenases and compared our results with
a previous study.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Only one enzyme identified by
this previous study was ranked in the top 20 sequences from IREDFisher.
Clearly, generic substrate inputs and associated scoring functions
will need to be explored to expand the utility of our workflow to
different enzyme reactions. Specifically, reactive atoms in the substrate
and catalytic residues in the enzyme should be provided by the user
to help select the best binding pose after docking. Also, deep learning
methods are promising approaches to train a model, e.g., by taking
features from predicted binding modes such as distances and angles
between key atoms, atom types, and charge distributions in the active
site. This challenge, together with integration into RetroBiocat,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> will be implemented to enable the process from
the biocatalytic pathway design all the way through to the generation
of small screening panels to allow for direct hit identification.</p>
    <p>In summary, the development and use of IREDFisher have reduced
the size of screening panels to only 20 enzymes, with significant
savings in resource and time required to perform the experimental
screening. For challenging substrates, where conversions with the
wild-type enzyme may be low, the hits obtained could then be used
as a parent sequence for subsequent directed evolution approaches.
The workflow provides a user-friendly free web interface (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>), requiring no experience in computational chemistry or programming,
which users can implement with only a few “mouse clicks”.
The expansion of the web tool to other enzyme classes is envisaged
with more accurate scoring functions, taking advantage of machine
learning and other approaches. This will assist in the identification
of enzymes for transformations of interest from a plethora of continuously
growing sequence data and, therefore, contribute to the increasing
application of biocatalytic methods in the synthesis.</p>
  </sec>
  <sec id="sec4">
    <title>Methods</title>
    <sec id="sec4.1">
      <title>IREDFisher Four-Step Panel Optimization Workflow</title>
      <sec id="sec4.1.1">
        <title>Sequence Preprocessing</title>
        <p>A FASTA-formatted sequence file
given by the user was loaded into the workflow. Each individual sequence
was generated by splitting the whole sequences. For sequence, we searched
homologous proteins in the Protein Data Bank using MODELLER.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> The one with the highest sequence identity was
considered as the template protein of the query sequence. For imine
reductases, only sequences with characterized IREDs (PDB codes: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3ZGY">3ZGY</ext-link>,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3D">4D3D</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3S">4D3S</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQY">4OQY</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQZ">4OQZ</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5A9T">5A9T</ext-link>,<sup><xref ref-type="bibr" rid="ref67">67</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OJL">5OJL</ext-link>,<sup><xref ref-type="bibr" rid="ref69">69</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6EOD">6EOD</ext-link>,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIT">6JIT</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIZ">6JIZ</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6GRL">6GRL</ext-link>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5G6R">5G6R</ext-link>) as the template
proteins were retained for the next step.</p>
      </sec>
      <sec id="sec4.1.2">
        <title>Structure Modeling</title>
        <p>IREDs form homodimers with the active
site located at the interface between the monomers, thus making it
more challenging to build a model in an automated way.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> The general sequence alignment between the template
protein and query sequence was calculated only for one chain. To overcome
this issue, the single-chain sequence alignment between each query
sequence and the template protein was repeated once more by an in-house
script to generate a double-chain sequence alignment file. To automate
the modeling of the IRED dimeric form, a template protein needs to
be specified. The imine reductase from <italic>Streptosporangium
roseum</italic> (PDB code: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>(<xref ref-type="bibr" rid="ref68">68</xref>)) is selected
as the dimer template protein given its high resolution and the clear
substrate and cofactor NADPH binding site. Then, models are generated
and optimized using MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> based on
the modified double-chain sequence alignment. All models are evaluated
based on the Ramachandran plot, and only those that have over  90% of
the residues in the favorable/core region are defined as qualified
models and subsequently are used for substrate docking.</p>
      </sec>
      <sec id="sec4.1.3">
        <title>Molecular Docking</title>
        <p>To locate the active site easily,
all three-dimensional structures obtained from the last step are aligned
to the template structure 5OCM by the PyMol python library. The cofactor
NADPH is directly placed into the cofactor binding site of each modeled
structure using the reference NADPH from the crystal structure prior
to substrate docking. The center of mass of the bound ligand 9RH in
5OCM is used as the center of the docking box. The docking box size
is calculated by using script eBoxSize.pl,<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> considering the gyration radius of the substrate, which improves
the docking accuracy.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> Then, all aligned
structures with the bound NADPH are prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> To input the structure of the imine form of
the substrate formed by the condensation of amine and ketone, the
three-dimensional coordinates are generated by Babel<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> and then prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> Multiple poses are generated by Autodock vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> with exhaustiveness value 10.</p>
        <p>Scoring
and ranking. When the IRED reaction occurs, NADPH transfers a hydride
from atom C4 to the imine substrate.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> To obtain the most reliable pose, the distance between
the C4 atom in NADPH and N in imine, the substrate is used as a criterion
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Docking
poses with the C4···N distance shorter than 3.5 Å
are removed to avoid clashes. Poses with the C4···N
distance longer than 6.0 Å are also removed because it is beyond
the distance range for hydride transfer. The remaining poses having
the closest C4···N distance are selected as the best
model. To improve the scoring function, we take the catalytic mechanism,
proton transfer, and hydride transfer<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> into consideration. It has been reported that acidic residues, basic
residues, and a conserved histidine residue in the active site play
important roles in the stabilization of the key intermediate in the
IRED-catalyzed reaction.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> Accordingly,
we included three terms in the scoring function: the number of acidic
residues <italic>N</italic><sub>acidic</sub>, the number of basic
residues <italic>N</italic><sub>basic</sub>, and the presence of histidine
residues to represent the effect enzymes have on reactions. The final
scoring function after the optimization of hyperparameters is refined
score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub>. In this equation, <italic>N</italic><sub>acidic</sub>/<italic>N</italic><sub>basic</sub> is
the total number of acidic/basic residues in the active site and <italic>N</italic><sub>His</sub> is the presence (<italic>N</italic><sub>His</sub> = 1) or absence of histidine (<italic>N</italic><sub>his</sub> = 0) residue in the active site. The weights for each component
of the scoring function were tuned by running with a range of −10
to 10 using compounds <bold>18</bold>–<bold>24</bold> screened
by Montgomery et al. IRED panel,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> and
the best weight was decided by the highest percentage of hits with
conversion over 50% in the top 20 list. The scoring function was tested
by Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> for substrates <bold>1</bold>–<bold>9</bold> and France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> for substrates <bold>10</bold>–<bold>17</bold>. Only residues within 8 angstroms of the ligand are taken
into account when we count the number of key residues.</p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <title>IREDFisher Structure Databases</title>
      <p>To help users design
an IRED screening panel from scratch by the IREDFisher workflow, we
collected published IRED panels: GSK panel in 2017,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> MIB panel in 2018,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> MIB panel
in 2020,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> MIB metagenomic panel in 2021,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Roche panel in 2016,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> and Peiyuan Yao panel<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> in 2018. After
sequence preprocessing step, a total of 451 published sequences were
collected including the characterized IRED sequences.</p>
      <p>To make
use of the public database, we conducted homology search in UniProt<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and NCBI reference protein<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> databases using the characterized IREDs as seed sequences.
Homologous sequences with sequence identity over 30%, coverage over
80%, and <italic>E</italic>-value under 10 compared to the corresponding
seed sequence were downloaded. 1028 sequences were collected after
removing duplicates, followed by a clustering with threshold 0.7 by
cd-hit.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> After sequence preprocessing,
a total of 591 sequences were collected from the public database.</p>
      <p>All of the above sequences were modeled and prepared for docking
by the IREDFisher workflow. With the well-prepared structure database,
IREDFisher runs much faster.</p>
    </sec>
  </sec>
  <sec id="sec5">
    <title>Experimental Details for In Vitro Screening</title>
    <sec id="sec5.1">
      <title>General (Chemicals and Enzymes)</title>
      <p>All chemicals and solvents
were purchased from commercial sources such as Acros Organics (Geel,
Belgium), Fluorochem (Hadfield, Derbyshire, UK), Alfa Aesar (Karlsruhe,
Germany), and Sigma-Aldrich (Poole, Dorset, UK). Chemicals were used
without additional purification. GC gases were obtained from BOC gases
(Guildford, UK), and HPLC solvents were obtained from Honeywell (Seelze,
Germany).</p>
      <p>GC-MS analysis was performed using an Agilent 7890B
Series GC with a 5977B MS-EI detector in positive mode at a constant
He flow. HPLC analysis was performed using an Agilent 1200 Series
with a UV detector Agilent 1200 Series. LC-MS analysis was performed
using an Agilent 1260 Infinity II with an Agilent 6130 Quadrupole
detector in positive mode using ESI as the ionization source.</p>
      <p>Conversions were determined by achiral HPLC and GC-MS and calculated
with respect to the carbonyl compound based on the convention used
for reductive amination and by LC-MS with the calibration curve. Products
were identified by LC-MS and by comparing retention time with standards.</p>
    </sec>
  </sec>
  <sec id="sec6">
    <title>Enzyme Production and Expression</title>
    <p>All IREDs used in
this study were obtained and expressed using
the same conditions as outlined in <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/s41557-020-00606-w">https://doi.org/10.1038/s41557-020-00606-w</uri><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Section S3</ext-link>.</p>
  </sec>
  <sec id="sec7">
    <title>Screening</title>
    <sec id="sec7.1">
      <title>Enzyme Screening for Target Product <bold>18</bold></title>
      <p>Analytical scale reductive amination biotransformations were carried
on 500 μL scale, adjusted to pH 8.0, containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of cyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 20 h. After 24 h, 500 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 500 μL of dichloromethane
(DCM). The organic phase was dried over anhydrous magnesium sulfate
(MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
    </sec>
  </sec>
  <sec id="sec8">
    <title>Enzyme Screening for Target Product <bold>25</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40 mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of benzaldehyde, and 5% and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. Following 24 h, the reaction
was quenched by the addition of 1 volume of methanol. The mixture
was centrifuged for 5 min at 13300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
  <sec id="sec9">
    <title>Enzyme Screening for Target Product <bold>26</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20
mM of <sc>d</sc>-glucose, 5 mM of 2-chlorocyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 250 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 250 μL of dichloromethane
(DCM) to extract the substrate and possible byproducts. The organic
phase was dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>). The other 250 μL was extracted with 250 μL of dichloromethane
(DCM) to extract the product. The two organic phases were combined,
dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>), and analyzed
by GC-MS.</p>
  </sec>
  <sec id="sec10">
    <title>Enzyme Screening for Target Product <bold>27</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μl scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40
mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of cycloheptanone, and
10 equivalents of propargylamine (1 M propargylamine stock pH 8.0
adjusted), with the reaction volume made up to 500 μL in 100
mM tris buffer. The reaction mixture was incubated at 37 °C with
shaking at 900 rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 500
μL was recovered from the reaction mixture and quenched with
20 μL of 10 M sodium hydroxide and extracted with 500 μL
of dichloromethane (DCM). The organic phase was dried over anhydrous
magnesium sulfate (MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
  </sec>
  <sec id="sec11">
    <title>Enzyme Screening for Target Product <bold>28</bold></title>
    <p>Previous test reactions were carried on at pH 8 as IREDs usually
exhibit higher activities on slightly basic pH. However, reaction
test 3 was done at pH 6 since the acid is partially deprotonated and
the aim was to use pH values closer to formylbenzoic acid pKa to make
it less negatively charged. Analytical scale reductive amination biotransformations
were carried out on a 500 μL scale adjusted to pH 6.0 containing
4 mg/mL of lyophilized powder of the supernatant of lysate IRED, 0.5
mg/mL of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix),
20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of 4-formylbenzoic
acid, and 20 equivalents of cyclopropylamine (1 M cyclopropylamine
stock pH 6.0 adjusted), with the reaction volume made up to 500 μL
min of 100 mM 2-(<italic>N</italic>-morpholino) ethanesulfonic acid
(MES) buffer. The reaction mixture was incubated at 37 °C with
shaking at 200 rpm (incubator with orbital shaker) for 24 h and quenched
by the addition of 1 volume of methanol. The mixture was centrifuged
for 5 min at 13 300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-2">
    <title>Data Availability Statement</title>
    <p>All data are
within the article and the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Information</ext-link> and are also available from the corresponding author upon reasonable
request. IREDFisher is a free web server: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>. The source code was provided on GitHub (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/yuyuqi-design/iredfisher_src">https://github.com/yuyuqi-design/iredfisher_src</uri>) and can be freely downloaded.</p>
  </notes>
  <notes id="notes-4" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting
Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acscatal.3c02278?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscatal.3c02278</ext-link>.<list id="silist" list-type="simple"><list-item><p>Additional in silico screening details; experimental
details; and materials and methods, including HPLC and LC/MS chromatograms
for the reactions conducted in this study and the sequences of all
new putative imine reductases (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_si_001.pdf">
        <caption>
          <p>cs3c02278_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-3">
    <title>Author Contributions</title>
    <p>N.S.S., N.J.T.,
and L.D.M. supervised the project. N.S.S., N.J.T., Y.Y., and L.D.M.
devised the concept. Y.Y., W.F., and R.B. performed the construction
of the workflow, web server, and database. Y.Y. performed the in silico
validation of the workflow. A.R.C., Y.Y., C.S., and R.S.H. performed
the experiment. C.M. performed the organic synthesis. Y.Y., A.R.C.,
N.S.S., N.J.J., and L.D.M. wrote the manuscript and generated the
figures.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d14e1070-autogenerated">
    <p>The authors declare the
following competing financial interest(s): NSS is co-founder, executive
director and share holder of C3 Biotechnologies Ltd which is active
in engineering biology for synthetic fuels production.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors thank Research
IT and the use of the Computational
Shared Facility at The University of Manchester. This study was funded
by the EPSRC, BBSRC, and AstraZeneca plc for funding under the Prosperity
Partnership EP/S005226/1.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Clouthier</surname><given-names>C. M.</given-names></name>; <name><surname>Pelletier</surname><given-names>J. N.</given-names></name><article-title>Expanding the organic toolbox: a guide to integrating
biocatalysis in synthesis</article-title>. <source>Chem. Soc. Rev.</source><year>2012</year>, <volume>41</volume>, <fpage>1585</fpage>–<lpage>1605</lpage>. <pub-id pub-id-type="doi">10.1039/c2cs15286j</pub-id>.<pub-id pub-id-type="pmid">22234546</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Sheldon</surname><given-names>R. A.</given-names></name>; <name><surname>Woodley</surname><given-names>J. M.</given-names></name><article-title>Role of Biocatalysis in Sustainable Chemistry</article-title>. <source>Chem. Rev.</source><year>2018</year>, <volume>118</volume>, <fpage>801</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00203</pub-id>.<pub-id pub-id-type="pmid">28876904</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Panke</surname><given-names>S.</given-names></name>; <name><surname>Held</surname><given-names>M.</given-names></name>; <name><surname>Wubbolts</surname><given-names>M.</given-names></name><article-title>Trends and
innovations in industrial
biocatalysis for the production of fine chemicals</article-title>. <source>Curr. Opin. Biotechnol.</source><year>2004</year>, <volume>15</volume>, <fpage>272</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2004.06.011</pub-id>.<pub-id pub-id-type="pmid">15357999</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Kohls</surname><given-names>H.</given-names></name>; <name><surname>Steffen-Munsberg</surname><given-names>F.</given-names></name>; <name><surname>Hohne</surname><given-names>M.</given-names></name><article-title>Recent achievements in developing
the biocatalytic toolbox for chiral amine synthesis</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2014</year>, <volume>19</volume>, <fpage>180</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2014.02.021</pub-id>.<pub-id pub-id-type="pmid">24721252</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Wu</surname><given-names>S.</given-names></name>; <name><surname>Snajdrova</surname><given-names>R.</given-names></name>; <name><surname>Moore</surname><given-names>J. C.</given-names></name>; <name><surname>Baldenius</surname><given-names>K.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name><article-title>Biocatalysis:
Enzymatic Synthesis for Industrial Applications</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2021</year>, <volume>60</volume>, <fpage>88</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202006648</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><article-title>UniProt: the universal
protein knowledgebase in 2021</article-title>. <source>Nucleic Acids
Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D480</fpage>–<lpage>D489</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1100</pub-id>.<pub-id pub-id-type="pmid">33237286</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Sayers</surname><given-names>E. W.</given-names></name>; <name><surname>Beck</surname><given-names>J.</given-names></name>; <name><surname>Bolton</surname><given-names>E. E.</given-names></name>; <name><surname>Bourexis</surname><given-names>D.</given-names></name>; <name><surname>Brister</surname><given-names>J. R.</given-names></name>; <name><surname>Canese</surname><given-names>K.</given-names></name>; <name><surname>Comeau</surname><given-names>D. C.</given-names></name>; <name><surname>Funk</surname><given-names>K.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Klimke</surname><given-names>W.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Landrum</surname><given-names>M.</given-names></name>; <name><surname>Lathrop</surname><given-names>S.</given-names></name>; <name><surname>Lu</surname><given-names>Z.</given-names></name>; <name><surname>Madden</surname><given-names>T. L.</given-names></name>; <name><surname>O’Leary</surname><given-names>N.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Rangwala</surname><given-names>S. H.</given-names></name>; <name><surname>Schneider</surname><given-names>V. A.</given-names></name>; <name><surname>Skripchenko</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Ye</surname><given-names>J.</given-names></name>; <name><surname>Trawick</surname><given-names>B. W.</given-names></name>; <name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Sherry</surname><given-names>S. T.</given-names></name><article-title>Database resources
of the National Center for Biotechnology Information</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D10</fpage>–<lpage>D17</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa892</pub-id>.<pub-id pub-id-type="pmid">33095870</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Finnigan</surname><given-names>W.</given-names></name>; <name><surname>Hepworth</surname><given-names>L. J.</given-names></name>; <name><surname>Flitsch</surname><given-names>S. L.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>RetroBioCat as a
computer-aided synthesis planning tool for biocatalytic reactions
and cascades</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>98</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-020-00556-z</pub-id>.<pub-id pub-id-type="pmid">33604511</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Coley</surname><given-names>C. W.</given-names></name>; <name><surname>Rogers</surname><given-names>L.</given-names></name>; <name><surname>Green</surname><given-names>W. H.</given-names></name>; <name><surname>Jensen</surname><given-names>K. F.</given-names></name><article-title>Computer-Assisted
Retrosynthesis Based on Molecular Similarity</article-title>. <source>ACS Cent. Sci.</source><year>2017</year>, <volume>3</volume>, <fpage>1237</fpage>–<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00355</pub-id>.<pub-id pub-id-type="pmid">29296663</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Szymkuć</surname><given-names>S.</given-names></name>; <name><surname>Gajewska</surname><given-names>E. P.</given-names></name>; <name><surname>Klucznik</surname><given-names>T.</given-names></name>; <name><surname>Molga</surname><given-names>K.</given-names></name>; <name><surname>Dittwald</surname><given-names>P.</given-names></name>; <name><surname>Startek</surname><given-names>M.</given-names></name>; <name><surname>Bajczyk</surname><given-names>M.</given-names></name>; <name><surname>Grzybowski</surname><given-names>B. A.</given-names></name><article-title>Computer-Assisted
Synthetic Planning: The End of the Beginning</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2016</year>, <volume>55</volume>, <fpage>5904</fpage>–<lpage>5937</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201506101</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Cui</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Tian</surname><given-names>W.</given-names></name>; <name><surname>Bu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Cui</surname><given-names>X.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Wu</surname><given-names>B.</given-names></name><article-title>Development of a versatile
and efficient C–N lyase platform for asymmetric hydroamination
via computational enzyme redesign</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>364</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00604-2</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Bell</surname><given-names>S. G.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>F.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name>; <name><surname>Wong</surname><given-names>L. L.</given-names></name><article-title>Engineering
substrate recognition in catalysis by cytochrome P450cam</article-title>. <source>Biochem. Soc. Trans.</source><year>2003</year>, <volume>31</volume>, <fpage>558</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1042/bst0310558</pub-id>.<pub-id pub-id-type="pmid">12773156</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Dunn</surname><given-names>B. J.</given-names></name>; <name><surname>Khosla</surname><given-names>C.</given-names></name><article-title>Engineering the acyltransferase
substrate specificity
of assembly line polyketide synthases</article-title>. <source>J. R.
Soc., Interface</source><year>2013</year>, <volume>10</volume>, <elocation-id>20130297</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2013.0297</pub-id>.<pub-id pub-id-type="pmid">23720536</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Ali</surname><given-names>M.</given-names></name>; <name><surname>Ishqi</surname><given-names>H. M.</given-names></name>; <name><surname>Husain</surname><given-names>Q.</given-names></name><article-title>Enzyme engineering: Reshaping the
biocatalytic functions</article-title>. <source>Biotechnol. Bioeng.</source><year>2020</year>, <volume>117</volume>, <fpage>1877</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27329</pub-id>.<pub-id pub-id-type="pmid">32159220</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Quijano-Rubio</surname><given-names>A.</given-names></name>; <name><surname>Yeh</surname><given-names>H. W.</given-names></name>; <name><surname>Park</surname><given-names>J.</given-names></name>; <name><surname>Lee</surname><given-names>H.</given-names></name>; <name><surname>Langan</surname><given-names>R. A.</given-names></name>; <name><surname>Boyken</surname><given-names>S. E.</given-names></name>; <name><surname>Lajoie</surname><given-names>M. J.</given-names></name>; <name><surname>Cao</surname><given-names>L.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Miranda</surname><given-names>M. C.</given-names></name>; <name><surname>Wi</surname><given-names>J.</given-names></name>; <name><surname>Hong</surname><given-names>H. J.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Oh</surname><given-names>B-H.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of modular and tunable
protein biosensors</article-title>. <source>Nature</source><year>2021</year>, <volume>591</volume>, <fpage>482</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03258-z</pub-id>.<pub-id pub-id-type="pmid">33503651</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>White</surname><given-names>P.</given-names></name>; <name><surname>Liang</surname><given-names>B.</given-names></name>; <name><surname>Horne</surname><given-names>J. E.</given-names></name>; <name><surname>Bera</surname><given-names>A. K.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Gerben</surname><given-names>S.</given-names></name>; <name><surname>Marx</surname><given-names>S.</given-names></name>; <name><surname>Kang</surname><given-names>A.</given-names></name>; <name><surname>Stiving</surname><given-names>A. Q.</given-names></name>; <name><surname>Harvey</surname><given-names>S. R.</given-names></name>; <name><surname>Marx</surname><given-names>D. C.</given-names></name>; <name><surname>Khan</surname><given-names>G. N.</given-names></name>; <name><surname>Fleming</surname><given-names>K. G.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Brockwell</surname><given-names>D. J.</given-names></name>; <name><surname>Tamm</surname><given-names>L. K.</given-names></name>; <name><surname>Radford</surname><given-names>S. E.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of transmembrane
beta barrels</article-title>. <source>Science</source><year>2021</year>, <volume>371</volume>, <elocation-id>eabc8182</elocation-id><pub-id pub-id-type="doi">10.1126/science.abc8182</pub-id>.<pub-id pub-id-type="pmid">33602829</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Klima</surname><given-names>J. C.</given-names></name>; <name><surname>Doyle</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>J. D.</given-names></name>; <name><surname>Rappleye</surname><given-names>M.</given-names></name>; <name><surname>Gagnon</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>M. Y.</given-names></name>; <name><surname>Barros</surname><given-names>E. P.</given-names></name>; <name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>Dou</surname><given-names>J.</given-names></name>; <name><surname>Bremner</surname><given-names>S.</given-names></name>; <name><surname>Quon</surname><given-names>J. S.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Carter</surname><given-names>L.</given-names></name>; <name><surname>Mack</surname><given-names>D. L.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Vaughan</surname><given-names>J. C.</given-names></name>; <name><surname>Berndt</surname><given-names>A.</given-names></name>; <name><surname>Stoddard</surname><given-names>B. L.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Incorporation of sensing modalities
into de novo designed fluorescence-activating proteins</article-title>. <source>Nat. Commun.</source><year>2021</year>, <volume>12</volume>, <fpage>856</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-18911-w</pub-id>.<pub-id pub-id-type="pmid">33558528</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Sahtoe</surname><given-names>D. D.</given-names></name>; <name><surname>Coscia</surname><given-names>A.</given-names></name>; <name><surname>Mustafaoglu</surname><given-names>N.</given-names></name>; <name><surname>Miller</surname><given-names>L. M.</given-names></name>; <name><surname>Olal</surname><given-names>D.</given-names></name>; <name><surname>Vulovic</surname><given-names>I.</given-names></name>; <name><surname>Yu</surname><given-names>T. Y.</given-names></name>; <name><surname>Goreshnik</surname><given-names>I.</given-names></name>; <name><surname>Lin</surname><given-names>Y. R.</given-names></name>; <name><surname>Clark</surname><given-names>L.</given-names></name>; <name><surname>Busch</surname><given-names>F.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Ingber</surname><given-names>D. E.</given-names></name>; <name><surname>Abraham</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Transferrin
receptor targeting by de novo sheet extension</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2021569118</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Vavra</surname><given-names>O.</given-names></name>; <name><surname>Kokkonen</surname><given-names>P.</given-names></name>; <name><surname>Filipovic</surname><given-names>J.</given-names></name>; <name><surname>Pinto</surname><given-names>G.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name><article-title>Caver Web 1.0: identification of
tunnels and channels
in proteins and analysis of ligand transport</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>W414</fpage>–<lpage>W422</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz378</pub-id>.<pub-id pub-id-type="pmid">31114897</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Sumbalova</surname><given-names>L.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>HotSpot Wizard
3.0: web server for automated design of mutations and smart libraries
based on sequence input information</article-title>. <source>Nucleic
Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W356</fpage>–<lpage>W362</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky417</pub-id>.<pub-id pub-id-type="pmid">29796670</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Angles</surname><given-names>R.</given-names></name>; <name><surname>Arenas-Salinas</surname><given-names>M.</given-names></name>; <name><surname>Garcia</surname><given-names>R.</given-names></name>; <name><surname>Reyes-Suarez</surname><given-names>J. A.</given-names></name>; <name><surname>Pohl</surname><given-names>E.</given-names></name><article-title>GSP4PDB: a web tool
to visualize, search and explore protein-ligand
structural patterns</article-title>. <source>BMC Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s12859-020-3352-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Viet
Hung</surname><given-names>L.</given-names></name>; <name><surname>Caprari</surname><given-names>S.</given-names></name>; <name><surname>Bizai</surname><given-names>M.</given-names></name>; <name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA: LIgand
Binding site Recognition Application</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>4020</fpage>–<lpage>4022</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv489</pub-id>.<pub-id pub-id-type="pmid">26315904</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Viet Hung</surname><given-names>L.</given-names></name>; <name><surname>Tortosa</surname><given-names>V.</given-names></name>; <name><surname>Brandi</surname><given-names>V.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA-WA:
a web application for ligand binding site detection and protein function
recognition</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>878</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx715</pub-id>.<pub-id pub-id-type="pmid">29126218</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Lilley</surname><given-names>D. M.</given-names></name>; <name><surname>Clegg</surname><given-names>R. M.</given-names></name>; <name><surname>Diekmann</surname><given-names>S.</given-names></name>; <name><surname>Seeman</surname><given-names>N. C.</given-names></name>; <name><surname>von Kitzing</surname><given-names>E.</given-names></name>; <name><surname>Hagerman</surname><given-names>P.</given-names></name><article-title>Nomenclature Committee of the International
Union of
Biochemistry and Molecular Biology (NC-IUBMB). A nomenclature of junctions
and branchpoints in nucleic acids. Recommendations 1994</article-title>. <source>Eur. J. Biochem.</source><year>1995</year>, <volume>230</volume>, <fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20526.x</pub-id>.<pub-id pub-id-type="pmid">7601087</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Dalkiran</surname><given-names>A.</given-names></name>; <name><surname>Rifaioglu</surname><given-names>A. S.</given-names></name>; <name><surname>Martin</surname><given-names>M. J.</given-names></name>; <name><surname>Cetin-Atalay</surname><given-names>R.</given-names></name>; <name><surname>Atalay</surname><given-names>V.</given-names></name>; <name><surname>Dogan</surname><given-names>T.</given-names></name><article-title>ECPred: a
tool for the prediction
of the enzymatic functions of protein sequences based on the EC nomenclature</article-title>. <source>BMC Bioinf.</source><year>2018</year>, <volume>19</volume>, <fpage>334</fpage><pub-id pub-id-type="doi">10.1186/s12859-018-2368-y</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Shen</surname><given-names>H. B.</given-names></name>; <name><surname>Chou</surname><given-names>K. C.</given-names></name><article-title>EzyPred: a top-down
approach for predicting enzyme
functional classes and subclasses</article-title>. <source>Biochem.
Biophys. Res. Commun.</source><year>2007</year>, <volume>364</volume>, <fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.098</pub-id>.<pub-id pub-id-type="pmid">17931599</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Umarov</surname><given-names>R.</given-names></name>; <name><surname>Xie</surname><given-names>B.</given-names></name>; <name><surname>Fan</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name><article-title>DEEPre: sequence-based
enzyme EC number prediction
by deep learning</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>760</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx680</pub-id>.<pub-id pub-id-type="pmid">29069344</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Memon</surname><given-names>S. A.</given-names></name>; <name><surname>Khan</surname><given-names>K. A.</given-names></name>; <name><surname>Naveed</surname><given-names>H.</given-names></name><article-title>HECNet: a hierarchical
approach to
enzyme function classification using a Siamese Triplet Network</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>4583</fpage>–<lpage>4589</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa536</pub-id>.<pub-id pub-id-type="pmid">32449765</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Zhang</surname><given-names>T.</given-names></name>; <name><surname>Tian</surname><given-names>Y.</given-names></name>; <name><surname>Yuan</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>F.</given-names></name>; <name><surname>Ren</surname><given-names>A.</given-names></name>; <name><surname>Hu</surname><given-names>Q. N.</given-names></name><article-title>Bio2Rxn: sequence-based enzymatic reaction predictions by a consensus
strategy</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>3600</fpage>–<lpage>3601</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa135</pub-id>.<pub-id pub-id-type="pmid">32108855</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E. L. L.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Paladin</surname><given-names>L.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L. J.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name><article-title>Pfam: The protein families
database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D412</fpage>–<lpage>D419</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Blum</surname><given-names>M.</given-names></name>; <name><surname>Chang</surname><given-names>H. Y.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Grego</surname><given-names>T.</given-names></name>; <name><surname>Kandasaamy</surname><given-names>S.</given-names></name>; <name><surname>Mitchell</surname><given-names>A.</given-names></name>; <name><surname>Nuka</surname><given-names>G.</given-names></name>; <name><surname>Paysan-Lafosse</surname><given-names>T.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Bridge</surname><given-names>A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Haft</surname><given-names>D. H.</given-names></name>; <name><surname>Letunic</surname><given-names>I.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Mi</surname><given-names>H.</given-names></name>; <name><surname>Natale</surname><given-names>D.</given-names></name>; <name><surname>Necci</surname><given-names>M.</given-names></name>; <name><surname>Orengo</surname><given-names>C. A.</given-names></name>; <name><surname>Pandurangen</surname><given-names>A. P.</given-names></name>; <name><surname>Rivoire</surname><given-names>C.</given-names></name>; <name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Sillitoe</surname><given-names>I.</given-names></name>; <name><surname>Thanki</surname><given-names>N.</given-names></name>; <name><surname>Thomas</surname><given-names>P. D.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name><article-title>The InterPro protein families and domains database:
20 years on</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D344</fpage>–<lpage>D354</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa977</pub-id>.<pub-id pub-id-type="pmid">33156333</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Borko</surname><given-names>S.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>EnzymeMiner:
automated mining of soluble enzymes with diverse structures, catalytic
properties and stabilities</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W104</fpage>–<lpage>W109</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa372</pub-id>.<pub-id pub-id-type="pmid">32392342</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Nikolskaya</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Yeh</surname><given-names>L. S.</given-names></name>; <name><surname>Natale</surname><given-names>D. A.</given-names></name>; <name><surname>Vinayaka</surname><given-names>C. R.</given-names></name>; <name><surname>Hu</surname><given-names>Z. Z.</given-names></name>; <name><surname>Mazumder</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Kourtesis</surname><given-names>P.</given-names></name>; <name><surname>Ledley</surname><given-names>R. S.</given-names></name>; <name><surname>Suzek</surname><given-names>B. E.</given-names></name>; <name><surname>Arminski</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Cardenas</surname><given-names>J. L.</given-names></name>; <name><surname>Chung</surname><given-names>S.</given-names></name>; <name><surname>Castro-Alvear</surname><given-names>J.</given-names></name>; <name><surname>Dinkov</surname><given-names>G.</given-names></name>; <name><surname>Barker</surname><given-names>W. C.</given-names></name><article-title>PIRSF:
family classification
system at the Protein Information Resource</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>, <volume>32</volume>, <fpage>D112</fpage>–<lpage>D114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh097</pub-id>.<pub-id pub-id-type="pmid">14681371</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Qian</surname><given-names>Z.</given-names></name>; <name><surname>Cai</surname><given-names>Y. D.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name><article-title>ECS: an automatic enzyme
classifier based on functional domain composition</article-title>. <source>Comput. Biol. Chem.</source><year>2007</year>, <volume>31</volume>, <fpage>226</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2007.03.008</pub-id>.<pub-id pub-id-type="pmid">17500036</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Alborzi</surname><given-names>S. Z.</given-names></name>; <name><surname>Devignes</surname><given-names>M. D.</given-names></name>; <name><surname>Ritchie</surname><given-names>D. W.</given-names></name><article-title>ECDomainMiner:
discovering hidden
associations between enzyme commission numbers and Pfam domains</article-title>. <source>BMC Bioinf.</source><year>2017</year>, <volume>18</volume>, <fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s12859-017-1519-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Cerutti</surname><given-names>L.</given-names></name>; <name><surname>de Castro</surname><given-names>E.</given-names></name>; <name><surname>Langendijk-Genevaux</surname><given-names>P. S.</given-names></name>; <name><surname>Bulliard</surname><given-names>V.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Hulo</surname><given-names>N.</given-names></name><article-title>PROSITE, a protein
domain database for functional characterization and annotation</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>, <volume>38</volume>, <fpage>D161</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp885</pub-id>.<pub-id pub-id-type="pmid">19858104</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>de
Rond</surname><given-names>T.</given-names></name>; <name><surname>Asay</surname><given-names>J. E.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name><article-title>Co-occurrence of enzyme domains guides
the discovery of an oxazolone synthetase</article-title>. <source>Nat.
Chem. Biol.</source><year>2021</year>, <volume>17</volume>, <fpage>794</fpage>–<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-021-00808-4</pub-id>.<pub-id pub-id-type="pmid">34099916</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Mak</surname><given-names>W. S.</given-names></name>; <name><surname>Tran</surname><given-names>S.</given-names></name>; <name><surname>Marcheschi</surname><given-names>R.</given-names></name>; <name><surname>Bertolani</surname><given-names>S.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name>; <name><surname>Liao</surname><given-names>J. C.</given-names></name>; <name><surname>Siegel</surname><given-names>J. B.</given-names></name><article-title>Integrative
genomic mining for enzyme function to enable engineering of a non-natural
biosynthetic pathway</article-title>. <source>Nat. Commun.</source><year>2015</year>, <volume>6</volume>, <elocation-id>10005</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10005</pub-id>.<pub-id pub-id-type="pmid">26598135</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Vasina</surname><given-names>M.</given-names></name>; <name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Kovar</surname><given-names>D.</given-names></name>; <name><surname>Faldynova</surname><given-names>H.</given-names></name>; <name><surname>Kunka</surname><given-names>A.</given-names></name>; <name><surname>Buryska</surname><given-names>T.</given-names></name>; <name><surname>Badenhorst</surname><given-names>C. P. S.</given-names></name>; <name><surname>Mazurenko</surname><given-names>S.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Stavrakis</surname><given-names>S.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name>; <name><surname>deMello</surname><given-names>A.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name><article-title>Advanced database mining of efficient haloalkane dehalogenases
by sequence and structure bioinformatics and microfluidics</article-title>. <source>Chem. Catal.</source><year>2022</year>, <volume>2</volume>, <fpage>2704</fpage>–<lpage>2725</lpage>. <pub-id pub-id-type="doi">10.1016/j.checat.2022.09.011</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Sebestova</surname><given-names>E.</given-names></name>; <name><surname>Babkova</surname><given-names>P.</given-names></name>; <name><surname>Bidmanova</surname><given-names>S.</given-names></name>; <name><surname>Daniel</surname><given-names>L.</given-names></name>; <name><surname>Dvorak</surname><given-names>P.</given-names></name>; <name><surname>Stepankova</surname><given-names>V.</given-names></name>; <name><surname>Chaloupkova</surname><given-names>R.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>Exploration
of Enzyme Diversity by Integrating Bioinformatics with Expression
Analysis and Biochemical Characterization</article-title>. <source>ACS
Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>2402</fpage>–<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.7b03523</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Lobb</surname><given-names>B.</given-names></name>; <name><surname>Doxey</surname><given-names>A. C.</given-names></name><article-title>Novel function discovery
through sequence and structural
data mining</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2016</year>, <volume>38</volume>, <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2016.05.017</pub-id>.<pub-id pub-id-type="pmid">27289211</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Ghislieri</surname><given-names>D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Approaches
to the Synthesis of Enantiomerically
Pure Chiral Amines</article-title>. <source>Top. Catal.</source><year>2014</year>, <volume>57</volume>, <fpage>284</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s11244-013-0184-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Du</surname><given-names>S.</given-names></name>; <name><surname>Gao</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Chang</surname><given-names>M.</given-names></name><article-title>Secondary amines as coupling partners
in direct catalytic asymmetric
reductive amination</article-title>. <source>Chem. Sci.</source><year>2019</year>, <volume>10</volume>, <fpage>4509</fpage>–<lpage>4514</lpage>. <pub-id pub-id-type="doi">10.1039/C9SC00323A</pub-id>.<pub-id pub-id-type="pmid">31057780</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>A mechanism for reductive
amination catalyzed by fungal reductive aminases</article-title>. <source>ACS Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>11534</fpage>–<lpage>11541</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.8b03491</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Devine</surname><given-names>P. N.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Thompson</surname><given-names>M. P.</given-names></name>; <name><surname>Truppo</surname><given-names>M. D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Extending the application
of biocatalysis to meet the
challenges of drug development</article-title>. <source>Nat. Rev. Chem.</source><year>2018</year>, <volume>2</volume>, <fpage>409</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/s41570-018-0055-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>A reductive aminase
from Aspergillus
oryzae</article-title>. <source>Nat. Chem.</source><year>2017</year>, <volume>9</volume>, <fpage>961</fpage>–<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2782</pub-id>.<pub-id pub-id-type="pmid">28937665</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Mitsukura</surname><given-names>K.</given-names></name>; <name><surname>Suzuki</surname><given-names>M.</given-names></name>; <name><surname>Tada</surname><given-names>K.</given-names></name>; <name><surname>Yoshida</surname><given-names>T.</given-names></name>; <name><surname>Nagasawa</surname><given-names>T.</given-names></name><article-title>Asymmetric
synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell
catalyst of enantioselective imine reductase</article-title>. <source>Org. Biomol. Chem.</source><year>2010</year>, <volume>8</volume>, <fpage>4533</fpage>–<lpage>4535</lpage>. <pub-id pub-id-type="doi">10.1039/C0OB00353K</pub-id>.<pub-id pub-id-type="pmid">20820664</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Finnigan</surname><given-names>J. D.</given-names></name>; <name><surname>Thorpe</surname><given-names>T. W.</given-names></name>; <name><surname>Palmer</surname><given-names>R. B.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Duncan</surname><given-names>R. A. M.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Graham</surname><given-names>K. M.</given-names></name>; <name><surname>Cook</surname><given-names>D. J.</given-names></name>; <name><surname>Charnock</surname><given-names>S. J.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Screening
and characterization of a diverse panel of metagenomic imine reductases
for biocatalytic reductive amination</article-title>. <source>Nat. Chem.</source><year>2021</year>, <volume>13</volume>, <fpage>140</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-020-00606-w</pub-id>.<pub-id pub-id-type="pmid">33380742</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Luan</surname><given-names>Z.-J.</given-names></name>; <name><surname>Zheng</surname><given-names>G.-W.</given-names></name>; <name><surname>Xu</surname><given-names>J.-H.</given-names></name><article-title>Efficient Synthesis
of Chiral Indolines using an Imine Reductase from Paenibacillus lactis</article-title>. <source>Adv. Synth. Catal.</source><year>2015</year>, <volume>357</volume>, <fpage>1692</fpage>–<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201500160</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name><article-title>One-step asymmetric synthesis of
(R)- and (S)-rasagiline by reductive amination applying imine reductases</article-title>. <source>Green Chem.</source><year>2017</year>, <volume>19</volume>, <fpage>385</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1039/C6GC03023H</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>S.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Zhu</surname><given-names>D.</given-names></name><article-title>Imine Reductase-Catalyzed
Enantioselective Reduction of Bulky α,β-Unsaturated Imines
en Route to a Pharmaceutically Important Morphinan Skeleton</article-title>. <source>Adv. Synth. Catal.</source><year>2019</year>, <volume>361</volume>, <fpage>556</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201801326</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Weise</surname><given-names>N. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Identification
of Novel Bacterial Members of the Imine Reductase Enzyme Family that
Perform Reductive Amination</article-title>. <source>ChemCatChem</source><year>2018</year>, <volume>10</volume>, <fpage>510</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701408</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Pushpanath</surname><given-names>A.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Klemstein</surname><given-names>U.</given-names></name>; <name><surname>Galman</surname><given-names>J. L.</given-names></name>; <name><surname>Woodlock</surname><given-names>D.</given-names></name>; <name><surname>Bisagni</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>C. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Dominguez</surname><given-names>B.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Characterization of imine reductases in reductive amination
for the exploration of structure-activity relationships</article-title>. <source>Sci. Adv.</source><year>2020</year>, <volume>6</volume>, <elocation-id>eaay9320</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay9320</pub-id>.<pub-id pub-id-type="pmid">32494734</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Berrera</surname><given-names>M.</given-names></name>; <name><surname>Sandon</surname><given-names>N.</given-names></name>; <name><surname>Fishlock</surname><given-names>D.</given-names></name>; <name><surname>Ebeling</surname><given-names>M.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Hanlon</surname><given-names>S.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Expanding
the Imine Reductase Toolbox by Exploring the Bacterial Protein-Sequence
Space</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1749</fpage>–<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500218</pub-id>.<pub-id pub-id-type="pmid">26044455</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Ross</surname><given-names>A.</given-names></name>; <name><surname>Müller</surname><given-names>H.</given-names></name>; <name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Hanlon</surname><given-names>S. P.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Asymmetric Reductive
Amination of Ketones Catalyzed by Imine Reductases</article-title>. <source>ChemCatChem</source><year>2016</year>, <volume>8</volume>, <fpage>2023</fpage>–<lpage>2026</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201600384</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Roiban</surname><given-names>G.-D.</given-names></name>; <name><surname>Kern</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Hyslop</surname><given-names>J.</given-names></name>; <name><surname>Tey</surname><given-names>P. L.</given-names></name>; <name><surname>Levine</surname><given-names>M. S.</given-names></name>; <name><surname>Jordan</surname><given-names>L. S.</given-names></name>; <name><surname>Brown</surname><given-names>K. K.</given-names></name>; <name><surname>Hadi</surname><given-names>T.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name><article-title>Efficient
Biocatalytic Reductive
Aminations by Extending the Imine Reductase Toolbox</article-title>. <source>ChemCatChem</source><year>2017</year>, <volume>9</volume>, <fpage>4475</fpage>–<lpage>4479</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701379</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Schober</surname><given-names>M.</given-names></name>; <name><surname>MacDermaid</surname><given-names>C.</given-names></name>; <name><surname>Ollis</surname><given-names>A. A.</given-names></name>; <name><surname>Chang</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>D.</given-names></name>; <name><surname>Hosford</surname><given-names>J.</given-names></name>; <name><surname>Latham</surname><given-names>J.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name>; <name><surname>Fuerst</surname><given-names>D.</given-names></name>; <name><surname>Sanganee</surname><given-names>M. J.</given-names></name>; <name><surname>Roiban</surname><given-names>G.-D.</given-names></name><article-title>Chiral synthesis
of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine
reductase</article-title>. <source>Nat. Catal.</source><year>2019</year>, <volume>2</volume>, <fpage>909</fpage>–<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0341-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Karmilowicz</surname><given-names>M. J.</given-names></name>; <name><surname>Burke</surname><given-names>D.</given-names></name>; <name><surname>Burns</surname><given-names>M. P.</given-names></name>; <name><surname>Clark</surname><given-names>L. A.</given-names></name>; <name><surname>Connor</surname><given-names>C. G.</given-names></name>; <name><surname>Cordi</surname><given-names>E.</given-names></name>; <name><surname>Do</surname><given-names>N. M.</given-names></name>; <name><surname>Doyle</surname><given-names>K. M.</given-names></name>; <name><surname>Hoagland</surname><given-names>S.</given-names></name>; <name><surname>Lewis</surname><given-names>C. A.</given-names></name>; <name><surname>Mangan</surname><given-names>D.</given-names></name>; <name><surname>Martinez</surname><given-names>C. A.</given-names></name>; <name><surname>McInturff</surname><given-names>E. L.</given-names></name>; <name><surname>Meldrum</surname><given-names>K.</given-names></name>; <name><surname>Pearson</surname><given-names>R.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Rane</surname><given-names>A.</given-names></name>; <name><surname>Weaver</surname><given-names>J.</given-names></name><article-title>Biocatalytic reductive
amination
from discovery to commercial manufacturing applied to abrocitinib
JAK1 inhibitor</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>775</fpage>–<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00671-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Webb</surname><given-names>B.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name><article-title>Comparative Protein Structure Modeling
Using MODELLER</article-title>. <source>Curr. Protoc. Bioinf.</source><year>2016</year>, <volume>54</volume>, <fpage>5</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/cpbi.3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Sánchez</surname><given-names>R.</given-names></name>; <name><surname>Šali</surname><given-names>A.</given-names></name><article-title>Comparative protein structure modeling as an optimization
problem</article-title>. <source>J. Mol. Struct.: THEOCHEM</source><year>1997</year>, <volume>398-399</volume>, <fpage>489</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-1280(96)04971-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Trott</surname><given-names>O.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock Vina: improving
the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source>J. Comput. Chem.</source><year>2010</year>, <volume>31</volume>, <fpage>455</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>.<pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></name>; <name><surname>Adler</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Green</surname><given-names>T.</given-names></name>; <name><surname>Zielinski</surname><given-names>M.</given-names></name>; <name><surname>Zidek</surname><given-names>A.</given-names></name>; <name><surname>Bridgland</surname><given-names>A.</given-names></name>; <name><surname>Cowie</surname><given-names>A.</given-names></name>; <name><surname>Meyer</surname><given-names>C.</given-names></name>; <name><surname>Laydon</surname><given-names>A.</given-names></name>; <name><surname>Velankar</surname><given-names>S.</given-names></name>; <name><surname>Kleywegt</surname><given-names>G. J.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Evans</surname><given-names>R.</given-names></name>; <name><surname>Pritzel</surname><given-names>A.</given-names></name>; <name><surname>Figurnov</surname><given-names>M.</given-names></name>; <name><surname>Ronneberger</surname><given-names>O.</given-names></name>; <name><surname>Bates</surname><given-names>R.</given-names></name>; <name><surname>Kohl</surname><given-names>S. A. A.</given-names></name>; <name><surname>Potapenko</surname><given-names>A.</given-names></name>; <name><surname>Ballard</surname><given-names>A. J.</given-names></name>; <name><surname>Romera-Paredes</surname><given-names>B.</given-names></name>; <name><surname>Nikolov</surname><given-names>S.</given-names></name>; <name><surname>Jain</surname><given-names>R.</given-names></name>; <name><surname>Clancy</surname><given-names>E.</given-names></name>; <name><surname>Reiman</surname><given-names>D.</given-names></name>; <name><surname>Petersen</surname><given-names>S.</given-names></name>; <name><surname>Senior</surname><given-names>A. W.</given-names></name>; <name><surname>Kavukcuoglo</surname><given-names>K.</given-names></name>; <name><surname>Birney</surname><given-names>E.</given-names></name>; <name><surname>Pushmeet</surname><given-names>K.</given-names></name>; <name><surname>Jumper</surname><given-names>J.</given-names></name>; <name><surname>Hassabis</surname><given-names>D.</given-names></name><article-title>Highly accurate
protein structure prediction for the
human proteome</article-title>. <source>Nature</source><year>2021</year>, <volume>596</volume>, <fpage>590</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>.<pub-id pub-id-type="pmid">34293799</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Lee</surname><given-names>C.</given-names></name>; <name><surname>Su</surname><given-names>B. H.</given-names></name>; <name><surname>Tseng</surname><given-names>Y. J.</given-names></name><article-title>Comparative studies of AlphaFold,
RoseTTAFold and Modeller: a case study involving the use of G-protein-coupled
receptors</article-title>. <source>Briefings Bioinf.</source><year>2022</year>, <volume>23</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbac308</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Rodríguez-Mata</surname><given-names>M.</given-names></name>; <name><surname>Frank</surname><given-names>A.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure and activity
of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus,
which catalyses the R-selective reduction of an imine substrate</article-title>. <source>ChemBioChem</source><year>2013</year>, <volume>14</volume>, <fpage>1372</fpage>–<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201300321</pub-id>.<pub-id pub-id-type="pmid">23813853</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure, Activity
and Stereoselectivity of NADPH-Dependent Oxidoreductases Catalysing
the S-Selective Reduction of the Imine Substrate 2-Methylpyrroline</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1052</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201402625</pub-id>.<pub-id pub-id-type="pmid">25809902</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Huber</surname><given-names>T.</given-names></name>; <name><surname>Schneider</surname><given-names>L.</given-names></name>; <name><surname>Präg</surname><given-names>A.</given-names></name>; <name><surname>Gerhardt</surname><given-names>S.</given-names></name>; <name><surname>Einsle</surname><given-names>O.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name><article-title>Direct Reductive
Amination of Ketones: Structure and
Activity ofS-Selective Imine Reductases fromStreptomyces</article-title>. <source>ChemCatChem</source><year>2014</year>, <volume>6</volume>, <fpage>2248</fpage>–<lpage>2252</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201402218</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Toca-Gonzalez</surname><given-names>L.</given-names></name>; <name><surname>Marchington</surname><given-names>R.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Stereoselectivity and Structural
Characterization of an Imine Reductase (IRED) from Amycolatopsis orientalis</article-title>. <source>ACS Catal.</source><year>2016</year>, <volume>6</volume>, <fpage>3880</fpage>–<lpage>3889</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.6b00782</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Lenz</surname><given-names>M.</given-names></name>; <name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name><article-title>New imine-reducing
enzymes from beta-hydroxyacid dehydrogenases
by single amino acid substitutions</article-title>. <source>Protein
Eng., Des. Sel.</source><year>2018</year>, <volume>31</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/protein/gzy006</pub-id>.<pub-id pub-id-type="pmid">29733377</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Adams</surname><given-names>R. W.</given-names></name>; <name><surname>Slabu</surname><given-names>I.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Wallace</surname><given-names>T. W.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Routes to Enantiomerically
Enriched Dibenz[c,e]azepines</article-title>. <source>Angew. Chem.,
Int. Ed.</source><year>2017</year>, <volume>56</volume>, <fpage>15589</fpage>–<lpage>15593</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201708453</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Imine reductases
(IREDs)</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2017</year>, <volume>37</volume>, <fpage>19</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2016.11.022</pub-id>.<pub-id pub-id-type="pmid">28038349</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Feinstein</surname><given-names>W. P.</given-names></name>; <name><surname>Brylinski</surname><given-names>M.</given-names></name><article-title>Calculating an optimal box size for
ligand docking
and virtual screening against experimental and predicted binding pockets</article-title>. <source>J. Cheminf.</source><year>2015</year>, <volume>7</volume>, <elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-015-0067-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Morris</surname><given-names>G. M.</given-names></name>; <name><surname>Huey</surname><given-names>R.</given-names></name>; <name><surname>Lindstrom</surname><given-names>W.</given-names></name>; <name><surname>Sanner</surname><given-names>M. F.</given-names></name>; <name><surname>Belew</surname><given-names>R. K.</given-names></name>; <name><surname>Goodsell</surname><given-names>D. S.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock4
and AutoDockTools4: Automated
docking with selective receptor flexibility</article-title>. <source>J. Comput. Chem.</source><year>2009</year>, <volume>30</volume>, <fpage>2785</fpage>–<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>.<pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>O’Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name><article-title>Open Babel:
An open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Stockinger</surname><given-names>P.</given-names></name>; <name><surname>Roth</surname><given-names>S.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Systematic Evaluation
of Imine-Reducing Enzymes: Common Principles in Imine Reductases,
beta-Hydroxy Acid Dehydrogenases, and Short-Chain Dehydrogenases/
Reductases</article-title>. <source>ChemBioChem</source><year>2020</year>, <volume>21</volume>, <fpage>2689</fpage>–<lpage>2695</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.202000213</pub-id>.<pub-id pub-id-type="pmid">32311225</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Scheller</surname><given-names>P. N.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name>; <name><surname>Hauer</surname><given-names>B.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Identification
of imine reductase-specific sequence motifs</article-title>. <source>Proteins</source><year>2016</year>, <volume>84</volume>, <fpage>600</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/prot.25008</pub-id>.<pub-id pub-id-type="pmid">26857686</pub-id></mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Tatusova</surname><given-names>T.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>NCBI reference
sequences (RefSeq):
a curated non-redundant sequence database of genomes, transcripts
and proteins</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>, <volume>35</volume>, <fpage>D61</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl842</pub-id>.<pub-id pub-id-type="pmid">17130148</pub-id></mixed-citation>
    </ref>
    <ref id="ref77">
      <mixed-citation publication-type="journal" id="cit77"><name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Godzik</surname><given-names>A.</given-names></name><article-title>Cd-hit: a fast program for clustering and comparing
large sets of protein or nucleotide sequences</article-title>. <source>Bioinformatics</source><year>2006</year>, <volume>22</volume>, <fpage>1658</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id>.<pub-id pub-id-type="pmid">16731699</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Catal</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Catal</journal-id>
    <journal-id journal-id-type="publisher-id">cs</journal-id>
    <journal-id journal-id-type="coden">accacs</journal-id>
    <journal-title-group>
      <journal-title>ACS Catalysis</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2155-5435</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10510103</article-id>
    <article-id pub-id-type="doi">10.1021/acscatal.3c02278</article-id>
    <article-categories>
      <subj-group>
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Structure-Based
Design of Small Imine Reductase Panels
for Target Substrates</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <name>
          <surname>Yu</surname>
          <given-names>Yuqi</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8932-8763</contrib-id>
        <name>
          <surname>Rué Casamajo</surname>
          <given-names>Arnau</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1061-7800</contrib-id>
        <name>
          <surname>Finnigan</surname>
          <given-names>William</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4331-2675</contrib-id>
        <name>
          <surname>Schnepel</surname>
          <given-names>Christian</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>Barker</surname>
          <given-names>Rhys</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Morrill</surname>
          <given-names>Charlotte</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Heath</surname>
          <given-names>Rachel S.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8061-4242</contrib-id>
        <name>
          <surname>De Maria</surname>
          <given-names>Leonardo</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath9">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8708-0781</contrib-id>
        <name>
          <surname>Turner</surname>
          <given-names>Nicholas J.</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath10">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4182-3500</contrib-id>
        <name>
          <surname>Scrutton</surname>
          <given-names>Nigel S.</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Department
of Chemistry, <institution>The University of Manchester,
Manchester Institute of Biotechnology</institution>, 131 Princess Street, Manchester M1 7DN, <country>U.K.</country></aff>
      <aff id="aff2"><label>‡</label>Augmented
Biologics Discovery &amp; Design, Department of Biologics Engineering, <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Cambridge CB21 6GH, <country>U.K.</country></aff>
      <aff id="aff3"><label>§</label>Medicinal
Chemistry, Research and Early Development, Respiratory and Immunology
(RI), <institution>BioPharmaceuticals R&amp;D, AstraZeneca</institution>, Gothenburg 43150, <country>Sweden</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>yuqi.yu@astrazeneca.com</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>nicholas.turner@manchester.ac.uk</email>.</corresp>
      <corresp id="cor3"><label>*</label>Email: <email>nigel.scrutton@manchester.ac.uk</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>05</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>09</month>
      <year>2023</year>
    </pub-date>
    <volume>13</volume>
    <issue>18</issue>
    <fpage>12310</fpage>
    <lpage>12321</lpage>
    <history>
      <date date-type="received">
        <day>19</day>
        <month>05</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>08</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0008" id="ab-tgr1"/>
      </p>
      <p>Biocatalysis is important in the discovery, development,
and manufacture
of pharmaceuticals. However, the identification of enzymes for target
transformations of interest requires major screening efforts. Here,
we report a structure-based computational workflow to prioritize protein
sequences by a score based on predicted activities on substrates,
thereby reducing a resource-intensive laboratory-based biocatalyst
screening. We selected imine reductases (IREDs) as a class of biocatalysts
to illustrate the application of the computational workflow termed
IREDFisher. Validation by using published data showed that IREDFisher
can retrieve the best enzymes and increase the hit rate by identifying
the top 20 ranked sequences. The power of IREDFisher is confirmed
by computationally screening 1400 sequences for chosen reductive amination
reactions with different levels of complexity. Highly active IREDs
were identified by only testing 20 samples in vitro. Our speed test
shows that it only takes 90 min to rank 85 sequences from user input
and 30 min for the established IREDFisher database containing 591
IRED sequences. IREDFisher is available as a user-friendly web interface
(<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher enables the rapid discovery of IREDs for applications
in synthesis and directed evolution studies, with minimal time and
resource expenditure. Future use of the workflow with other enzyme
families could be implemented following the modification of the workflow
scoring function.</p>
    </abstract>
    <kwd-group>
      <kwd>biocatalysis</kwd>
      <kwd>enzyme screening</kwd>
      <kwd>imine reductase</kwd>
      <kwd>computational workflow</kwd>
      <kwd>structural modeling</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>AstraZeneca</institution>
            <institution-id institution-id-type="doi">10.13039/100004325</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Biotechnology and Biological Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000268</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Engineering and Physical Sciences Research Council</institution>
            <institution-id institution-id-type="doi">10.13039/501100000266</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EP/S005226/1</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>cs3c02278</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Enzymatic synthesis has gained growing
attention in recent years
due to the inherent advantages of benign reaction conditions along
with exquisite chemo-, stereo-, and regio-selectivity.<sup><xref ref-type="bibr" rid="ref1">1</xref>−<xref ref-type="bibr" rid="ref5">5</xref></sup> However, finding the optimal biocatalyst to effect the transformation
of a substrate of interest is often challenging and time consuming.
There are two strategies commonly used in enzyme discovery (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, left panel). One
is to manually select the enzymes that have been reported to be active
toward similar substrate(s) in the literature. However, this approach
restricts the diversity of accessible enzymes and may result in potentially
active enzymes being missed. Consequently, the alternative strategy
of searching for homologous enzymes from databases is increasingly
applied. However, this approach typically generates a very large number
of sequences, the majority of which have not been characterized experimentally.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> Screening all of these sequences is time consuming, requiring the
extensive use of analytical equipment and other methods for high-throughput
screening.</p>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Solutions of enzyme discovery for targeted substrate(s). Left:
two common methods for finding hit enzymes for targeted substrate(s).
Right: a schematic diagram of IREDFisher developed in this work. Input
sequences are filtered by IREDFisher with the aid of structural modeling
and molecular docking, which allows the user to obtain a small panel
consisting of prioritized sequences.</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0002" id="gr1" position="float"/>
    </fig>
    <p>Computational tools have shown great power in the
development and
application of biocatalysts including synthetic pathway design,<sup><xref ref-type="bibr" rid="ref8">8</xref>−<xref ref-type="bibr" rid="ref10">10</xref></sup> enzyme engineering,<sup><xref ref-type="bibr" rid="ref11">11</xref>−<xref ref-type="bibr" rid="ref14">14</xref></sup> and de novo design.<sup><xref ref-type="bibr" rid="ref15">15</xref>−<xref ref-type="bibr" rid="ref18">18</xref></sup> However, in silico pipelines that prioritize sequences and thus
reduce the necessary screening throughput in the laboratory are still
underdeveloped. The current structure-based pipelines are either struggling
in dealing with large numbers of sequences and are thus mainly used
for engineering an initially known active enzyme<sup><xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> or require a detailed description of the catalytic geometry based
on a known ligand-binding motif.<sup><xref ref-type="bibr" rid="ref21">21</xref>−<xref ref-type="bibr" rid="ref23">23</xref></sup> Sequence-based pipelines<sup><xref ref-type="bibr" rid="ref24">24</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup> can realize high throughput but they generally ignore substrate
variations (a key consideration in establishing biocatalytic panels),
leading to poor activity predictions of enzymes in relation to target
substrates. Standalone methods such as homology modeling and molecular
docking have been established over many years but are generally used
individually rather than in automated combination, which limits throughput
in biocatalyst screening programs. Integration of these approaches
into an automated pipeline for biocatalyst discovery is urgently needed
to rapidly model enzyme–substrate complexes and generate rank
ordering of likely active sequences. Only a few structure-based computational
pipelines<sup><xref ref-type="bibr" rid="ref38">38</xref>−<xref ref-type="bibr" rid="ref41">41</xref></sup> have been published. However, none of these have been automated
to enable easy access to laboratory-based scientists. An “easy-to-use”
in silico web application is required for experimentalists who need
to conduct efficient and rapid screens to identify active enzymes
but are struggling to use more specialized computational tools. Consequently,
an “easy-to-use” in silico web-based application will
streamline experimental screening and thereby reduce the time and
resources required to identify biocatalysts for use.</p>
    <p>Here, we
report the development and experimental validation of
an in silico pipeline, available also via a web interface, termed
IREDFisher (available for use at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>). IREDFisher is a structure-based web server that allows computer-aided
enzyme screening with substrate(s) of interest and recommends a small
(20 enzyme) panel of IREDs for rapid biocatalytic exploration by the
user (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). We
selected imine reductases (IREDs) as a model enzyme in view of their
recent emergence as an enzyme class of interest for the synthesis
of chiral amines. Chiral amines are prevalent motifs that feature
in about 40% of pharmaceuticals.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> IREDs catalyze
enantioselective imine reduction and can also perform the reductive
amination of ketones or aldehydes<sup><xref ref-type="bibr" rid="ref44">44</xref>−<xref ref-type="bibr" rid="ref46">46</xref></sup> and are thus of major
interest to the academic and industrial biocatalysis communities.
Since their discovery in 2010,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> a vast
number of IRED sequences have been published together with a wealth
of activity data for different substrates.<sup><xref ref-type="bibr" rid="ref48">48</xref>−<xref ref-type="bibr" rid="ref58">58</xref></sup> Currently, IREDFisher only applies to IREDs as the scoring function
is modified specifically for these enzymes.</p>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Flow chart of the four-step
IREDFisher workflow. The input sequences
are preprocessed in step (1) to remove non-IRED-homologs from the
screening list. The three-dimensional structures of the remaining
sequences are modeled in step (2). In step (3), the structures obtained
from step (2) are aligned to a cofactor- and ligand-bound IRED crystal
structure to locate the active site and cofactor binding site for
each modeled structure. NADPH is placed into individual modeled structures
by taking the coordinates from the crystal structure. An intermediate
imine structure formed by amine and ketone substrates is then docked
into the active site of each structure. In step (4), the best pose
for the substrate within the enzyme is selected by the distance between
two key atoms of the cofactor and substrate. In crystal structures
of IREDs, this distance is around 4 Å. In step (5), the number
of acidic residues <italic>N</italic><sub>acidic</sub>, the number
of basic residues <italic>N</italic><sub>basic</sub>, and the presence
of histidine residues <italic>N</italic><sub>his</sub> = 0 or 1 are
calculated for residues within 8 Å of the substrate. Enzymes
are ranked by a modified scoring function IREDFisher score = 4.0 ×
Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> –
9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> (see details described in the <xref rid="sec4" ref-type="other">Methods</xref> section).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0003" id="gr2" position="float"/>
    </fig>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>IREDFisher Workflow</title>
      <p>Having the initial sequences and
a substrate structure as inputs, the IREDFisher workflow commences
with sequence preprocessing, followed by structural modeling. Then,
the provided substrate is docked into the modeled enzyme structures,
while the protein–substrate complexes are scored by considering
predicted binding affinity and catalytic geometry in the final step
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Specifically,
in step (1), each input sequence is aligned to individual sequences
in the protein data bank (PDB). The input sequence that has the highest
sequence identity to known IREDs in the PDB is considered as a putative
IRED and retained for the next step. In step (2), all three-dimensional
structures of the resulting sequences from step (1) are generated
by MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> followed by an optimization
by the default function in MODELLER,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> which
consists of spatial restraints on distance and dihedral angles obtained
from the target structure and CHARMM energy terms enforcing proper
stereochemistry.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> All models are evaluated
based on the Ramachandran plot, and only those that have over 90%
 of the residues in favorable/coreregions are defined as qualified
models and subsequently used for substrate docking. In step (3), the
substrate is docked into the active site of each qualified model.
Various poses of the substrate in the active site of the enzymes are
generated. In step (4), the distance between NADPH C4 and N atom of
the imine substrate is calculated for all poses. The pose with ∼4
Å is selected as the best pose to realize hydride transfer in
a catalytic process (see pose selection in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> and details in the <xref rid="sec4" ref-type="other">Methods</xref> section). In step (5), the number of acidic residues <italic>N</italic><sub>acidic</sub>, basic residues <italic>N</italic><sub>basic</sub>, and histidine residues <italic>N</italic><sub>His</sub> are calculated
and used to modify the Autodock Vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> scoring
function considering they play important roles in the stabilization
of iminium intermediate formation and proton transfer (see details
in the <xref rid="sec4" ref-type="other">Methods</xref>section). The modified scoring
function Refined score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub> was
used to finally rank all input sequences. The top 20 IRED sequences
are then selected for in vitro screening.</p>
    </sec>
    <sec id="sec2.2">
      <title>IREDFisher Validation Using Published Screening Data</title>
      <p>The screening data from three established IRED panels were used to
test the IREDFisher workflow: Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> (85 sequences) for substrates <bold>1</bold>–<bold>9</bold>, France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> (45 sequences)
for substrates <bold>10</bold>–<bold>17</bold>, and Montgomery
et al. IRED panel<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> (93 sequences) for <bold>18</bold>–<bold>24</bold> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Each panel and the corresponding tested
substrates were fed into IREDFisher to obtain the recommended 20 sequences.
As control, 20 sequences were randomly selected from each corresponding
panel. Hit rates using a conversion cutoff of 2% (hit rate of ≥
2% conversion) and 50% (hit rate of ≥ 50% conversion) were
calculated and compared between the two methods (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a,b and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S1</ext-link>). The likelihood of retrieving the best hit in the
20 selected sequences using the two methods was also calculated (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Table S2</ext-link>). In terms of “hit rate of ≥
2% conversion”, IREDFisher is comparable to random selection,
whereas it outperforms the latter in finding hits with conversions
over 50% (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b).
This shows the capability of IREDFisher in finding competent hits
for downstream optimization. Furthermore, IREDFisher retrieved the
best hit to the top 20 sequences with a likelihood of 100%. By contrast,
the likelihood of picking the best hit by random selection is no more
than 50%. In summary, the IREDFisher workflow is not only able to
improve the hit rate but also retrieves the best enzyme(s) from the
whole IRED panel in the top 20 selected sequences. This emphasizes
the effectiveness of IREDFisher in finding IRED hits, reducing screening
efforts by 50–75%.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tests of reductive amination reactions based
on published data.
Reaction products of IRED-catalyzed reactions are shown with moieties
originating from the amine nucleophile colored in blue and those from
the ketone component displayed in black. Compounds <bold>1–9</bold> are from ref (<xref ref-type="bibr" rid="ref56">56</xref>), compounds <bold>10–17</bold> are from ref (<xref ref-type="bibr" rid="ref52">52</xref>), and compounds <bold>18–24</bold> are from ref (<xref ref-type="bibr" rid="ref53">53</xref>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0004" id="gr3" position="float"/>
      </fig>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Comparison of hit rate and best hit retrieval in 20 sequences
selected
by IREDFisher and by random selection. (a) Hit rate using a conversion
cutoff of 2% calculated by the equation: Hit rate of ≥2% conversion
= <inline-formula id="d33e578"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m001.gif"/></inline-formula>. (b) Hit rate using a conversion cutoff
of 50% calculated by the equation: Hit rate of ≥50% conversion
= <inline-formula id="d33e581"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m002.gif"/></inline-formula>. Symbol × indicates that no hits with
conversion over 50% were found in the in vitro screening of the corresponding
panels. (c) Likelihood of retrieving the best hit from the whole panel
in the 20 selected sequences using IREDFisher. The error bars for
the random selection were calculated by the standard error of the
mean (SEM) based on 95% confidence levels.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.3">
      <title>Experimental Validation of Predictions Made by IREDFisher</title>
      <p>Next, we challenged the IREDFisher workflow by aiming to select
potential IRED hits for subsequent validation by experimental screening.
We chose the following reductive amination reactions as our targets,
namely, <bold>18</bold> and <bold>25–28</bold> (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a), which represent increasingly
demanding conversions for imine reductases. Reactions corresponding
to products <bold>18</bold> and <bold>25</bold> are common starting
points for screening IREDs, whereas products <bold>26</bold> and <bold>27</bold> are important building blocks in the pharmaceutical industry
and proved to be challenging targets in a previous IRED study.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Synthesis of <bold>28</bold> is particularly
challenging due to the negative charge of the carboxylate group in
the substrate. To date, no IREDs have been reported to accept 4-formylbenzoic
acid as a substrate. Also, we note that 4-formylbenzoic acid <bold>28</bold> is a building block for drugs such as procarbazine (chemotherapy),
imatinib (chemotherapy), mocetinostat, etinostat, tucidinostat (HDAC
inhibitors), revefenacin (COPD treatment), bavisant (ADHD treatment),
and fedovapagon (nocturia treatment) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S1</ext-link>). Inclusion of <bold>28</bold> was used to explore whether the IREDFisher
workflow could identify biocatalysts for novel reductive amination
reactions.</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Validation of IREDFisher predictions in identifying hits for five
chosen reactions. (a) IREDFisher was run in two rounds: in the first
round, the sequences from external sources, public databases, and
established panels were ranked by IREDFisher to prioritize those to
be used for gene synthesis and enzyme expression. In the second round,
33 new enzymes with good expression in <italic>Escherichia
coli</italic> and 193 in-house sequences were ranked by IREDFisher.
The top 20 enzymes for each reaction were then investigated in the
laboratory. The percentages of new enzymes and in-house enzymes are
65 and 35% for <bold>18</bold>, 50 and 50% for <bold>25</bold>, 45
and 55% for <bold>26</bold>, 50 and 50% for <bold>27</bold>, and 55
and 45% for <bold>28</bold>. Compounds are shown in product forms.
Amine nucleophile components are colored in blue. (b) The conversion
of IREDFisher selected sequences toward products <bold>18</bold> and <bold>25</bold>–<bold>28</bold>. Hit rates for each reaction were
calculated using a conversion cutoff of 2%: Hit rate = <inline-formula id="d33e662"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_m003.gif"/></inline-formula>. NS indicates that this sequence is not
in the top 20 selected by IREDFisher and consequently was not tested
in vitro. Sequences labeled pIR are from the in-house panel. Sequences
labeled yIRED are new uncharacterized sequences and highlighted in
bold and italic font.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0006" id="gr5" position="float"/>
      </fig>
      <p>For sequence input, we used 193 well-expressed
enzymes from our
in-house panel along with 33 new sequences found by IREDFisher that
are also expressed well. To find new active enzymes toward selected
targets, we collected uncharacterized IRED homologs from public databases
(NCBI and UniProt) and IREDs from established panels (Robian et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl
et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> and Yao et al.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup>), generating 1239 sequences in total (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a, lower panel). Then, the
first round of the IREDFisher ranking was run for the collected sequences
based on the targeted product to prioritize successful gene synthesis
and protein expression. The top 20 enzyme sequences for targets <bold>18</bold> and <bold>25–30</bold> were selected in silico.
Then, 60 sequences were identified after removing duplicates from
which genes were synthesized and expressed in <italic>E. coli</italic>. This resulted in 33 enzymes (55% of selected enzymes) that expressed
well in <italic>E. coli</italic>, while 27 enzymes (45%
of selected enzymes) failed in cloning and/or expression.</p>
      <p>We
then combined these 33 enzymes with 193 sequences from our in-house
panel and ran a second round of IREDFisher ranking to prioritize these
sequences in activity screening experiments. The top 20 IREDs obtained
by IREDFisher for each targeted reaction were screened in vitro, and
corresponding conversions to products were determined by GC or HPLC
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b). Reaction
optimization was not carried out, as only the relative efficiency
of IREDFisher under standardized conditions was being evaluated. For
target reactions <bold>18</bold> and <bold>25–28</bold>, the
hit rate decreases as the difficulty of the IRED reactions increases,
with 2–11 hits (over 90% conversion) of corresponding substrates
obtained. In a previous study, the hit rate of <bold>26</bold> (26b
in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) and <bold>27</bold> (<bold>23d</bold> in a previous paper<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>) by screening a panel of 384 IREDs was low (2.6% for <bold>26</bold> and 5.5% for <bold>27</bold>), whereas the hit rate in this study
employing IREDFisher increased substantially to 60 and 40%, respectively.
Notably, two hits, with conversion ≥ 90%, were found for the
challenging product <bold>28</bold>, demonstrating that IREDFisher
can find enzymes that catalyze reactions of pharmaceutical importance.
Furthermore, by exploiting the resources from public databases, highly
active IREDs that have not been reported previously were identified
and multiple enzymes (e.g., yIRED10, yIRED23, yIRED25) were found
to have broad substrate scope. The benefit of IREDFisher in prioritizing
screening is clear, in this case reducing the experimental screening
required from ≥ 1000 samples without IREDFisher virtual screening
to only 20 samples.</p>
    </sec>
    <sec id="sec2.4">
      <title>IREDFisher Web Interface and Speed Test</title>
      <p>Encouraged
by the validation results using established screening data and our
own experiments, our intention was to develop a user-friendly workflow
that can be widely used by the biocatalysis community. To avoid any
requirement for the use of personal computational/programming skills,
we have built an IREDFisher web server (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>) (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>). We emphasize
that the current methodology only applies to IREDs. For the input
structure, the imine structure formed by the condensation of aldehyde
or ketone and amine is required. This can be obtained by the free
online structure drawing tool Marvin JS (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">https://marvinjs-demo.chemaxon.com/latest/</uri>) from ChemAxon (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the square on the right). The index of the N
atom in the C=N bond is also required as an input, which can
be generated using the Marvin interface. A FASTA-formatted sequence
file is required if users intend to rank their own sequences (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a, example in the
square on the left). After the job is submitted, output files such
as three-dimensional structures of IREDs, substrate-bound complex
structures, and scoring files are generated and added to the web page.
By checking the sorted rescoring file, the user can obtain an optimized
small IRED screening panel with 20 recommended sequences by IREDFisher
(<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b). In addition,
IREDFisher also allows users to rank the sequences from established
panels and public databases (see the <xref rid="sec4" ref-type="other">Methods</xref> section for details). Therefore, IREDFisher can be employed in ranking:
(i) user-defined sequences; (ii) established IRED panels, e.g., Robian
et al.,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> France et al.,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Wetzl et al.,<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> etc.; and (iii)
IRED sequences collected from the public database in this study. The
speed test showed that IREDFisher can perform the calculation of a
user-defined panel with 85 sequences in 90 min. Moreover, it only
takes ca 30 min to complete the ranking of the established IRED panels
and sequences from public databases by using the structures already
deposited in the IREDFisher web server. Consequently, based on simple
data input, nonspecialists in bioinformatics can have access to workflow
outputs using only a few mouse clicks without human interference,
which makes it applicable for small IRED panel design.</p>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Web interface of IREDFisher.
(a) Job submission interface and input
file examples. Left square: FASTA-formatted sequence file. Right square:
generation of substrate structure and N atom index by Marvin JS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://marvinjs-demo.chemaxon.com/latest/">&lt;underline≥https://marvinjs-demo.chemaxon.com/latest/&lt;/underline≥</ext-link>). (b) Output files. The file for sequence ranking (1a_imine_sort_rescore.csv
in the example) is shown.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_0007" id="gr6" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p>The computational four-step workflow IREDFisher
that aims to streamline
the screening of enzyme panels was produced by integrating sequence
analysis, structure modeling, and molecular docking. Although large
numbers of protein structures have been released recently by AlphaFold,<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> the structures obtained are not always applicable
for the use of molecular docking. For many enzymes, the substrate-binding
site is formed by monomers/dimers, but only monomeric structures were
deposited in the database. For example, most of the new sequences
used in this study were only modeled as monomer in the AlphaFold database.
We have shown that the active site is similar between the dimer models
generated by homology modeling and AlphaFold (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Figure S2</ext-link>), while the former approach saves considerable computation
time (3 min by homology modeling versus 30 min by AlphaFold per structure).
This is also suggested by a previous publication.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> Therefore, the template-based homology modeling is beneficial
for the rapid building of structures in the IREDFisher workflow, allowing
users to rank large numbers of sequences.</p>
    <p>The workflow was applied
by using a model enzyme IRED and subsequently
validated using previously published screening data. IREDFisher demonstrated
the power of retrieving the best hit found simply by screening a small
panel of 20 sequences using the IREDFisher workflow. Experimental
validation in which IREDFisher selects 20 enzymes from a pool of ∼1400
sequences for 5 reactions, and with different levels of product complexity,
further establishes the effectiveness of IREDFisher. IREDFisher ranks
enzymes based on enzyme–substrate-binding interactions and
does not consider features such as the charge distribution on the
protein surface, which might, for example, be important for successful
protein expression in <italic>E. coli</italic>. As such,
poorly expressed proteins could rank better than proteins that are
expressed well in <italic>E. coli</italic>. The workflow
was run initially to identify sequences for gene synthesis and protein
expression analysis. We then performed a second screening experiment
to rank new IRED biocatalysts only with those sequences that expressed
well in <italic>E. coli</italic>. The prediction of
enantioselectivity by IREDFisher is not investigated in this study
because this is challenging. That said, IREDFisher narrows the search
to a small panel of IREDs such that screening those biocatalysts for
enantioselectivity is no longer an onerous task.</p>
    <p>It is noteworthy
that most biocatalytic processes for drug production
need to go through extensive reaction optimization and mutagenesis
approaches such as directed evolution to obtain a biocatalyst that
fulfills the desired process requirements. Directed evolution relies
on the screening of thousands of enzyme variants and usually involves
several rounds of library generation and screening, resulting in large
numbers of variants that require high-throughput screening (HTS) methods
for their evaluation. As such, screening remains the major bottleneck
in biocatalysis applications, and this places major burdens on the
resources and time required to generate a suitable biocatalyst. By
taking advantage of the IREDFisher computational workflow, we have
shown that it is possible to identify suitable biocatalysts for simple
and challenging substrates. If needed, these could be evolved further
to fulfill process needs with reduced screening efforts. IREDFisher
is therefore valuable, either as a standalone computational workflow
to aid the rapid identification of biocatalysts or as a “front-end’
workflow to accelerate directed evolution programs by selecting the
prototype, catalytically competent enzyme scaffolds for a target reaction.
However, we clarify that IREDFisher takes wild-type sequences as input,
which limits its ability to “design” enzymes with non-natural
functions to catalyze extremely challenging reactions.</p>
    <p>IREDFisher
is designed as a “fast prescreen method”
to rank input sequences. As such, it has limitations. Protein dynamics
and energy barrier calculations are not incorporated because this
would be too time consuming for a fast prescreening tool for use by
experimentalists. The IREDFisher scoring function works as a tool
to rank input sequences instead of accurately predicting the conversion/activity
of enzymes. We trained the scoring instead to deliver a maximum hit
rate of the top 20 sequences because 20 screening experiments can
be carried out in one batch with overnight incubation for rapid enzyme
screening. That said, the IREDFisher workflow has the power to find
highly active hits in the 20 recommended sequences. This indicates
that a trade-off between speed and accuracy has been achieved to some
extent. Currently, it is applicable to IREDs as the scoring function
is designed specifically for this enzyme family. We have also tested
IREDFisher on haloalkane dehydrogenases and compared our results with
a previous study.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Only one enzyme identified by
this previous study was ranked in the top 20 sequences from IREDFisher.
Clearly, generic substrate inputs and associated scoring functions
will need to be explored to expand the utility of our workflow to
different enzyme reactions. Specifically, reactive atoms in the substrate
and catalytic residues in the enzyme should be provided by the user
to help select the best binding pose after docking. Also, deep learning
methods are promising approaches to train a model, e.g., by taking
features from predicted binding modes such as distances and angles
between key atoms, atom types, and charge distributions in the active
site. This challenge, together with integration into RetroBiocat,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> will be implemented to enable the process from
the biocatalytic pathway design all the way through to the generation
of small screening panels to allow for direct hit identification.</p>
    <p>In summary, the development and use of IREDFisher have reduced
the size of screening panels to only 20 enzymes, with significant
savings in resource and time required to perform the experimental
screening. For challenging substrates, where conversions with the
wild-type enzyme may be low, the hits obtained could then be used
as a parent sequence for subsequent directed evolution approaches.
The workflow provides a user-friendly free web interface (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>), requiring no experience in computational chemistry or programming,
which users can implement with only a few “mouse clicks”.
The expansion of the web tool to other enzyme classes is envisaged
with more accurate scoring functions, taking advantage of machine
learning and other approaches. This will assist in the identification
of enzymes for transformations of interest from a plethora of continuously
growing sequence data and, therefore, contribute to the increasing
application of biocatalytic methods in the synthesis.</p>
  </sec>
  <sec id="sec4">
    <title>Methods</title>
    <sec id="sec4.1">
      <title>IREDFisher Four-Step Panel Optimization Workflow</title>
      <sec id="sec4.1.1">
        <title>Sequence Preprocessing</title>
        <p>A FASTA-formatted sequence file
given by the user was loaded into the workflow. Each individual sequence
was generated by splitting the whole sequences. For sequence, we searched
homologous proteins in the Protein Data Bank using MODELLER.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> The one with the highest sequence identity was
considered as the template protein of the query sequence. For imine
reductases, only sequences with characterized IREDs (PDB codes: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="3ZGY">3ZGY</ext-link>,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3D">4D3D</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4D3S">4D3S</ext-link>,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQY">4OQY</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="4OQZ">4OQZ</ext-link>,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5A9T">5A9T</ext-link>,<sup><xref ref-type="bibr" rid="ref67">67</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OJL">5OJL</ext-link>,<sup><xref ref-type="bibr" rid="ref69">69</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6EOD">6EOD</ext-link>,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIT">6JIT</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6JIZ">6JIZ</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="6GRL">6GRL</ext-link>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5G6R">5G6R</ext-link>) as the template
proteins were retained for the next step.</p>
      </sec>
      <sec id="sec4.1.2">
        <title>Structure Modeling</title>
        <p>IREDs form homodimers with the active
site located at the interface between the monomers, thus making it
more challenging to build a model in an automated way.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup> The general sequence alignment between the template
protein and query sequence was calculated only for one chain. To overcome
this issue, the single-chain sequence alignment between each query
sequence and the template protein was repeated once more by an in-house
script to generate a double-chain sequence alignment file. To automate
the modeling of the IRED dimeric form, a template protein needs to
be specified. The imine reductase from <italic>Streptosporangium
roseum</italic> (PDB code: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="PDB" xlink:href="5OCM">5OCM</ext-link>(<xref ref-type="bibr" rid="ref68">68</xref>)) is selected
as the dimer template protein given its high resolution and the clear
substrate and cofactor NADPH binding site. Then, models are generated
and optimized using MODELLER<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> based on
the modified double-chain sequence alignment. All models are evaluated
based on the Ramachandran plot, and only those that have over  90% of
the residues in the favorable/core region are defined as qualified
models and subsequently are used for substrate docking.</p>
      </sec>
      <sec id="sec4.1.3">
        <title>Molecular Docking</title>
        <p>To locate the active site easily,
all three-dimensional structures obtained from the last step are aligned
to the template structure 5OCM by the PyMol python library. The cofactor
NADPH is directly placed into the cofactor binding site of each modeled
structure using the reference NADPH from the crystal structure prior
to substrate docking. The center of mass of the bound ligand 9RH in
5OCM is used as the center of the docking box. The docking box size
is calculated by using script eBoxSize.pl,<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> considering the gyration radius of the substrate, which improves
the docking accuracy.<sup><xref ref-type="bibr" rid="ref71">71</xref></sup> Then, all aligned
structures with the bound NADPH are prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> To input the structure of the imine form of
the substrate formed by the condensation of amine and ketone, the
three-dimensional coordinates are generated by Babel<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> and then prepared using AutoDockTools.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> Multiple poses are generated by Autodock vina<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> with exhaustiveness value 10.</p>
        <p>Scoring
and ranking. When the IRED reaction occurs, NADPH transfers a hydride
from atom C4 to the imine substrate.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup> To obtain the most reliable pose, the distance between
the C4 atom in NADPH and N in imine, the substrate is used as a criterion
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Docking
poses with the C4···N distance shorter than 3.5 Å
are removed to avoid clashes. Poses with the C4···N
distance longer than 6.0 Å are also removed because it is beyond
the distance range for hydride transfer. The remaining poses having
the closest C4···N distance are selected as the best
model. To improve the scoring function, we take the catalytic mechanism,
proton transfer, and hydride transfer<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> into consideration. It has been reported that acidic residues, basic
residues, and a conserved histidine residue in the active site play
important roles in the stabilization of the key intermediate in the
IRED-catalyzed reaction.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> Accordingly,
we included three terms in the scoring function: the number of acidic
residues <italic>N</italic><sub>acidic</sub>, the number of basic
residues <italic>N</italic><sub>basic</sub>, and the presence of histidine
residues to represent the effect enzymes have on reactions. The final
scoring function after the optimization of hyperparameters is refined
score = 4.0 × Vina score + 1.0 × <italic>N</italic><sub>acidic</sub> – 9.0 × <italic>N</italic><sub>His</sub> + 9.0 × <italic>N</italic><sub>basic</sub>. In this equation, <italic>N</italic><sub>acidic</sub>/<italic>N</italic><sub>basic</sub> is
the total number of acidic/basic residues in the active site and <italic>N</italic><sub>His</sub> is the presence (<italic>N</italic><sub>His</sub> = 1) or absence of histidine (<italic>N</italic><sub>his</sub> = 0) residue in the active site. The weights for each component
of the scoring function were tuned by running with a range of −10
to 10 using compounds <bold>18</bold>–<bold>24</bold> screened
by Montgomery et al. IRED panel,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> and
the best weight was decided by the highest percentage of hits with
conversion over 50% in the top 20 list. The scoring function was tested
by Roiban et al. panel<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> for substrates <bold>1</bold>–<bold>9</bold> and France et al. panel<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> for substrates <bold>10</bold>–<bold>17</bold>. Only residues within 8 angstroms of the ligand are taken
into account when we count the number of key residues.</p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <title>IREDFisher Structure Databases</title>
      <p>To help users design
an IRED screening panel from scratch by the IREDFisher workflow, we
collected published IRED panels: GSK panel in 2017,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> MIB panel in 2018,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> MIB panel
in 2020,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> MIB metagenomic panel in 2021,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Roche panel in 2016,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> and Peiyuan Yao panel<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> in 2018. After
sequence preprocessing step, a total of 451 published sequences were
collected including the characterized IRED sequences.</p>
      <p>To make
use of the public database, we conducted homology search in UniProt<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and NCBI reference protein<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> databases using the characterized IREDs as seed sequences.
Homologous sequences with sequence identity over 30%, coverage over
80%, and <italic>E</italic>-value under 10 compared to the corresponding
seed sequence were downloaded. 1028 sequences were collected after
removing duplicates, followed by a clustering with threshold 0.7 by
cd-hit.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> After sequence preprocessing,
a total of 591 sequences were collected from the public database.</p>
      <p>All of the above sequences were modeled and prepared for docking
by the IREDFisher workflow. With the well-prepared structure database,
IREDFisher runs much faster.</p>
    </sec>
  </sec>
  <sec id="sec5">
    <title>Experimental Details for In Vitro Screening</title>
    <sec id="sec5.1">
      <title>General (Chemicals and Enzymes)</title>
      <p>All chemicals and solvents
were purchased from commercial sources such as Acros Organics (Geel,
Belgium), Fluorochem (Hadfield, Derbyshire, UK), Alfa Aesar (Karlsruhe,
Germany), and Sigma-Aldrich (Poole, Dorset, UK). Chemicals were used
without additional purification. GC gases were obtained from BOC gases
(Guildford, UK), and HPLC solvents were obtained from Honeywell (Seelze,
Germany).</p>
      <p>GC-MS analysis was performed using an Agilent 7890B
Series GC with a 5977B MS-EI detector in positive mode at a constant
He flow. HPLC analysis was performed using an Agilent 1200 Series
with a UV detector Agilent 1200 Series. LC-MS analysis was performed
using an Agilent 1260 Infinity II with an Agilent 6130 Quadrupole
detector in positive mode using ESI as the ionization source.</p>
      <p>Conversions were determined by achiral HPLC and GC-MS and calculated
with respect to the carbonyl compound based on the convention used
for reductive amination and by LC-MS with the calibration curve. Products
were identified by LC-MS and by comparing retention time with standards.</p>
    </sec>
  </sec>
  <sec id="sec6">
    <title>Enzyme Production and Expression</title>
    <p>All IREDs used in
this study were obtained and expressed using
the same conditions as outlined in <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1038/s41557-020-00606-w">https://doi.org/10.1038/s41557-020-00606-w</uri><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Section S3</ext-link>.</p>
  </sec>
  <sec id="sec7">
    <title>Screening</title>
    <sec id="sec7.1">
      <title>Enzyme Screening for Target Product <bold>18</bold></title>
      <p>Analytical scale reductive amination biotransformations were carried
on 500 μL scale, adjusted to pH 8.0, containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of cyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 20 h. After 24 h, 500 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 500 μL of dichloromethane
(DCM). The organic phase was dried over anhydrous magnesium sulfate
(MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
    </sec>
  </sec>
  <sec id="sec8">
    <title>Enzyme Screening for Target Product <bold>25</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL of lyophilized
powder of the supernatant of lysate IRED, 0.5 mg/mL of GDH (Codexis
CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40 mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of benzaldehyde, and 5% and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. Following 24 h, the reaction
was quenched by the addition of 1 volume of methanol. The mixture
was centrifuged for 5 min at 13300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
  <sec id="sec9">
    <title>Enzyme Screening for Target Product <bold>26</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μL scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 20
mM of <sc>d</sc>-glucose, 5 mM of 2-chlorocyclohexanone, and 10 equivalents
of cyclopropylamine (1 M cyclopropylamine stock pH 8.0 adjusted),
with the reaction volume made up to 500 μL in 100 mM tris buffer.
The reaction mixture was incubated at 37 °C with shaking at 900
rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 250 μL was
recovered from the reaction mixture and quenched with 20 μL
of 10 M sodium hydroxide and extracted with 250 μL of dichloromethane
(DCM) to extract the substrate and possible byproducts. The organic
phase was dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>). The other 250 μL was extracted with 250 μL of dichloromethane
(DCM) to extract the product. The two organic phases were combined,
dried over anhydrous magnesium sulfate (MgSO<sub>4</sub>), and analyzed
by GC-MS.</p>
  </sec>
  <sec id="sec10">
    <title>Enzyme Screening for Target Product <bold>27</bold></title>
    <p>Analytical scale reductive amination biotransformations were carried
out on a 500 μl scale adjusted to pH 8.0 containing 4 mg/mL
of lyophilized powder of the supernatant of lysate IRED, 0.5 mg/mL
of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix), 40
mM of <sc>d</sc>-glucose, 5% of DMSO, 10 mM of cycloheptanone, and
10 equivalents of propargylamine (1 M propargylamine stock pH 8.0
adjusted), with the reaction volume made up to 500 μL in 100
mM tris buffer. The reaction mixture was incubated at 37 °C with
shaking at 900 rpm (Eppendorf ThermoMixer) for 24 h. After 24 h, 500
μL was recovered from the reaction mixture and quenched with
20 μL of 10 M sodium hydroxide and extracted with 500 μL
of dichloromethane (DCM). The organic phase was dried over anhydrous
magnesium sulfate (MgSO<sub>4</sub>) and analyzed by GC-MS.</p>
  </sec>
  <sec id="sec11">
    <title>Enzyme Screening for Target Product <bold>28</bold></title>
    <p>Previous test reactions were carried on at pH 8 as IREDs usually
exhibit higher activities on slightly basic pH. However, reaction
test 3 was done at pH 6 since the acid is partially deprotonated and
the aim was to use pH values closer to formylbenzoic acid pKa to make
it less negatively charged. Analytical scale reductive amination biotransformations
were carried out on a 500 μL scale adjusted to pH 6.0 containing
4 mg/mL of lyophilized powder of the supernatant of lysate IRED, 0.5
mg/mL of GDH (Codexis CDX-901), 0.5 mM of NADP<sup>+</sup> (Prozomix),
20 mM of <sc>d</sc>-glucose, 2.5% of DMSO, 5 mM of 4-formylbenzoic
acid, and 20 equivalents of cyclopropylamine (1 M cyclopropylamine
stock pH 6.0 adjusted), with the reaction volume made up to 500 μL
min of 100 mM 2-(<italic>N</italic>-morpholino) ethanesulfonic acid
(MES) buffer. The reaction mixture was incubated at 37 °C with
shaking at 200 rpm (incubator with orbital shaker) for 24 h and quenched
by the addition of 1 volume of methanol. The mixture was centrifuged
for 5 min at 13 300 rpm, and the supernatant was recovered
to be analyzed by HPLC and LC/MS.</p>
  </sec>
</body>
<back>
  <notes notes-type="data-availability" id="notes-2">
    <title>Data Availability Statement</title>
    <p>All data are
within the article and the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">Supporting Information</ext-link> and are also available from the corresponding author upon reasonable
request. IREDFisher is a free web server: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://enzymeevolver.com/IREDFisher">https://enzymeevolver.com/IREDFisher</uri>. The source code was provided on GitHub (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/yuyuqi-design/iredfisher_src">https://github.com/yuyuqi-design/iredfisher_src</uri>) and can be freely downloaded.</p>
  </notes>
  <notes id="notes-4" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting
Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acscatal.3c02278?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscatal.3c02278</ext-link>.<list id="silist" list-type="simple"><list-item><p>Additional in silico screening details; experimental
details; and materials and methods, including HPLC and LC/MS chromatograms
for the reactions conducted in this study and the sequences of all
new putative imine reductases (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acscatal.3c02278/suppl_file/cs3c02278_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs3c02278_si_001.pdf">
        <caption>
          <p>cs3c02278_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-3">
    <title>Author Contributions</title>
    <p>N.S.S., N.J.T.,
and L.D.M. supervised the project. N.S.S., N.J.T., Y.Y., and L.D.M.
devised the concept. Y.Y., W.F., and R.B. performed the construction
of the workflow, web server, and database. Y.Y. performed the in silico
validation of the workflow. A.R.C., Y.Y., C.S., and R.S.H. performed
the experiment. C.M. performed the organic synthesis. Y.Y., A.R.C.,
N.S.S., N.J.J., and L.D.M. wrote the manuscript and generated the
figures.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d14e1070-autogenerated">
    <p>The authors declare the
following competing financial interest(s): NSS is co-founder, executive
director and share holder of C3 Biotechnologies Ltd which is active
in engineering biology for synthetic fuels production.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>The authors thank Research
IT and the use of the Computational
Shared Facility at The University of Manchester. This study was funded
by the EPSRC, BBSRC, and AstraZeneca plc for funding under the Prosperity
Partnership EP/S005226/1.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Clouthier</surname><given-names>C. M.</given-names></name>; <name><surname>Pelletier</surname><given-names>J. N.</given-names></name><article-title>Expanding the organic toolbox: a guide to integrating
biocatalysis in synthesis</article-title>. <source>Chem. Soc. Rev.</source><year>2012</year>, <volume>41</volume>, <fpage>1585</fpage>–<lpage>1605</lpage>. <pub-id pub-id-type="doi">10.1039/c2cs15286j</pub-id>.<pub-id pub-id-type="pmid">22234546</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Sheldon</surname><given-names>R. A.</given-names></name>; <name><surname>Woodley</surname><given-names>J. M.</given-names></name><article-title>Role of Biocatalysis in Sustainable Chemistry</article-title>. <source>Chem. Rev.</source><year>2018</year>, <volume>118</volume>, <fpage>801</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.7b00203</pub-id>.<pub-id pub-id-type="pmid">28876904</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Panke</surname><given-names>S.</given-names></name>; <name><surname>Held</surname><given-names>M.</given-names></name>; <name><surname>Wubbolts</surname><given-names>M.</given-names></name><article-title>Trends and
innovations in industrial
biocatalysis for the production of fine chemicals</article-title>. <source>Curr. Opin. Biotechnol.</source><year>2004</year>, <volume>15</volume>, <fpage>272</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2004.06.011</pub-id>.<pub-id pub-id-type="pmid">15357999</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Kohls</surname><given-names>H.</given-names></name>; <name><surname>Steffen-Munsberg</surname><given-names>F.</given-names></name>; <name><surname>Hohne</surname><given-names>M.</given-names></name><article-title>Recent achievements in developing
the biocatalytic toolbox for chiral amine synthesis</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2014</year>, <volume>19</volume>, <fpage>180</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2014.02.021</pub-id>.<pub-id pub-id-type="pmid">24721252</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Wu</surname><given-names>S.</given-names></name>; <name><surname>Snajdrova</surname><given-names>R.</given-names></name>; <name><surname>Moore</surname><given-names>J. C.</given-names></name>; <name><surname>Baldenius</surname><given-names>K.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name><article-title>Biocatalysis:
Enzymatic Synthesis for Industrial Applications</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2021</year>, <volume>60</volume>, <fpage>88</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202006648</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><article-title>UniProt: the universal
protein knowledgebase in 2021</article-title>. <source>Nucleic Acids
Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D480</fpage>–<lpage>D489</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1100</pub-id>.<pub-id pub-id-type="pmid">33237286</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Sayers</surname><given-names>E. W.</given-names></name>; <name><surname>Beck</surname><given-names>J.</given-names></name>; <name><surname>Bolton</surname><given-names>E. E.</given-names></name>; <name><surname>Bourexis</surname><given-names>D.</given-names></name>; <name><surname>Brister</surname><given-names>J. R.</given-names></name>; <name><surname>Canese</surname><given-names>K.</given-names></name>; <name><surname>Comeau</surname><given-names>D. C.</given-names></name>; <name><surname>Funk</surname><given-names>K.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Klimke</surname><given-names>W.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Landrum</surname><given-names>M.</given-names></name>; <name><surname>Lathrop</surname><given-names>S.</given-names></name>; <name><surname>Lu</surname><given-names>Z.</given-names></name>; <name><surname>Madden</surname><given-names>T. L.</given-names></name>; <name><surname>O’Leary</surname><given-names>N.</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Rangwala</surname><given-names>S. H.</given-names></name>; <name><surname>Schneider</surname><given-names>V. A.</given-names></name>; <name><surname>Skripchenko</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Ye</surname><given-names>J.</given-names></name>; <name><surname>Trawick</surname><given-names>B. W.</given-names></name>; <name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Sherry</surname><given-names>S. T.</given-names></name><article-title>Database resources
of the National Center for Biotechnology Information</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D10</fpage>–<lpage>D17</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa892</pub-id>.<pub-id pub-id-type="pmid">33095870</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Finnigan</surname><given-names>W.</given-names></name>; <name><surname>Hepworth</surname><given-names>L. J.</given-names></name>; <name><surname>Flitsch</surname><given-names>S. L.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>RetroBioCat as a
computer-aided synthesis planning tool for biocatalytic reactions
and cascades</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>98</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-020-00556-z</pub-id>.<pub-id pub-id-type="pmid">33604511</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Coley</surname><given-names>C. W.</given-names></name>; <name><surname>Rogers</surname><given-names>L.</given-names></name>; <name><surname>Green</surname><given-names>W. H.</given-names></name>; <name><surname>Jensen</surname><given-names>K. F.</given-names></name><article-title>Computer-Assisted
Retrosynthesis Based on Molecular Similarity</article-title>. <source>ACS Cent. Sci.</source><year>2017</year>, <volume>3</volume>, <fpage>1237</fpage>–<lpage>1245</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.7b00355</pub-id>.<pub-id pub-id-type="pmid">29296663</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Szymkuć</surname><given-names>S.</given-names></name>; <name><surname>Gajewska</surname><given-names>E. P.</given-names></name>; <name><surname>Klucznik</surname><given-names>T.</given-names></name>; <name><surname>Molga</surname><given-names>K.</given-names></name>; <name><surname>Dittwald</surname><given-names>P.</given-names></name>; <name><surname>Startek</surname><given-names>M.</given-names></name>; <name><surname>Bajczyk</surname><given-names>M.</given-names></name>; <name><surname>Grzybowski</surname><given-names>B. A.</given-names></name><article-title>Computer-Assisted
Synthetic Planning: The End of the Beginning</article-title>. <source>Angew. Chem., Int. Ed.</source><year>2016</year>, <volume>55</volume>, <fpage>5904</fpage>–<lpage>5937</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201506101</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Cui</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Tian</surname><given-names>W.</given-names></name>; <name><surname>Bu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Cui</surname><given-names>X.</given-names></name>; <name><surname>Zhu</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Wu</surname><given-names>B.</given-names></name><article-title>Development of a versatile
and efficient C–N lyase platform for asymmetric hydroamination
via computational enzyme redesign</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>364</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00604-2</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Bell</surname><given-names>S. G.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>F.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name>; <name><surname>Wong</surname><given-names>L. L.</given-names></name><article-title>Engineering
substrate recognition in catalysis by cytochrome P450cam</article-title>. <source>Biochem. Soc. Trans.</source><year>2003</year>, <volume>31</volume>, <fpage>558</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1042/bst0310558</pub-id>.<pub-id pub-id-type="pmid">12773156</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Dunn</surname><given-names>B. J.</given-names></name>; <name><surname>Khosla</surname><given-names>C.</given-names></name><article-title>Engineering the acyltransferase
substrate specificity
of assembly line polyketide synthases</article-title>. <source>J. R.
Soc., Interface</source><year>2013</year>, <volume>10</volume>, <elocation-id>20130297</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2013.0297</pub-id>.<pub-id pub-id-type="pmid">23720536</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Ali</surname><given-names>M.</given-names></name>; <name><surname>Ishqi</surname><given-names>H. M.</given-names></name>; <name><surname>Husain</surname><given-names>Q.</given-names></name><article-title>Enzyme engineering: Reshaping the
biocatalytic functions</article-title>. <source>Biotechnol. Bioeng.</source><year>2020</year>, <volume>117</volume>, <fpage>1877</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27329</pub-id>.<pub-id pub-id-type="pmid">32159220</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Quijano-Rubio</surname><given-names>A.</given-names></name>; <name><surname>Yeh</surname><given-names>H. W.</given-names></name>; <name><surname>Park</surname><given-names>J.</given-names></name>; <name><surname>Lee</surname><given-names>H.</given-names></name>; <name><surname>Langan</surname><given-names>R. A.</given-names></name>; <name><surname>Boyken</surname><given-names>S. E.</given-names></name>; <name><surname>Lajoie</surname><given-names>M. J.</given-names></name>; <name><surname>Cao</surname><given-names>L.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Miranda</surname><given-names>M. C.</given-names></name>; <name><surname>Wi</surname><given-names>J.</given-names></name>; <name><surname>Hong</surname><given-names>H. J.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Oh</surname><given-names>B-H.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of modular and tunable
protein biosensors</article-title>. <source>Nature</source><year>2021</year>, <volume>591</volume>, <fpage>482</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03258-z</pub-id>.<pub-id pub-id-type="pmid">33503651</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>White</surname><given-names>P.</given-names></name>; <name><surname>Liang</surname><given-names>B.</given-names></name>; <name><surname>Horne</surname><given-names>J. E.</given-names></name>; <name><surname>Bera</surname><given-names>A. K.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Gerben</surname><given-names>S.</given-names></name>; <name><surname>Marx</surname><given-names>S.</given-names></name>; <name><surname>Kang</surname><given-names>A.</given-names></name>; <name><surname>Stiving</surname><given-names>A. Q.</given-names></name>; <name><surname>Harvey</surname><given-names>S. R.</given-names></name>; <name><surname>Marx</surname><given-names>D. C.</given-names></name>; <name><surname>Khan</surname><given-names>G. N.</given-names></name>; <name><surname>Fleming</surname><given-names>K. G.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Brockwell</surname><given-names>D. J.</given-names></name>; <name><surname>Tamm</surname><given-names>L. K.</given-names></name>; <name><surname>Radford</surname><given-names>S. E.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>De novo design of transmembrane
beta barrels</article-title>. <source>Science</source><year>2021</year>, <volume>371</volume>, <elocation-id>eabc8182</elocation-id><pub-id pub-id-type="doi">10.1126/science.abc8182</pub-id>.<pub-id pub-id-type="pmid">33602829</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Klima</surname><given-names>J. C.</given-names></name>; <name><surname>Doyle</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>J. D.</given-names></name>; <name><surname>Rappleye</surname><given-names>M.</given-names></name>; <name><surname>Gagnon</surname><given-names>L. A.</given-names></name>; <name><surname>Lee</surname><given-names>M. Y.</given-names></name>; <name><surname>Barros</surname><given-names>E. P.</given-names></name>; <name><surname>Vorobieva</surname><given-names>A. A.</given-names></name>; <name><surname>Dou</surname><given-names>J.</given-names></name>; <name><surname>Bremner</surname><given-names>S.</given-names></name>; <name><surname>Quon</surname><given-names>J. S.</given-names></name>; <name><surname>Chow</surname><given-names>C. M.</given-names></name>; <name><surname>Carter</surname><given-names>L.</given-names></name>; <name><surname>Mack</surname><given-names>D. L.</given-names></name>; <name><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name><surname>Vaughan</surname><given-names>J. C.</given-names></name>; <name><surname>Berndt</surname><given-names>A.</given-names></name>; <name><surname>Stoddard</surname><given-names>B. L.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Incorporation of sensing modalities
into de novo designed fluorescence-activating proteins</article-title>. <source>Nat. Commun.</source><year>2021</year>, <volume>12</volume>, <fpage>856</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-18911-w</pub-id>.<pub-id pub-id-type="pmid">33558528</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Sahtoe</surname><given-names>D. D.</given-names></name>; <name><surname>Coscia</surname><given-names>A.</given-names></name>; <name><surname>Mustafaoglu</surname><given-names>N.</given-names></name>; <name><surname>Miller</surname><given-names>L. M.</given-names></name>; <name><surname>Olal</surname><given-names>D.</given-names></name>; <name><surname>Vulovic</surname><given-names>I.</given-names></name>; <name><surname>Yu</surname><given-names>T. Y.</given-names></name>; <name><surname>Goreshnik</surname><given-names>I.</given-names></name>; <name><surname>Lin</surname><given-names>Y. R.</given-names></name>; <name><surname>Clark</surname><given-names>L.</given-names></name>; <name><surname>Busch</surname><given-names>F.</given-names></name>; <name><surname>Stewart</surname><given-names>L.</given-names></name>; <name><surname>Wysocki</surname><given-names>V. H.</given-names></name>; <name><surname>Ingber</surname><given-names>D. E.</given-names></name>; <name><surname>Abraham</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name><article-title>Transferrin
receptor targeting by de novo sheet extension</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2021</year>, <volume>118</volume>, <fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2021569118</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Vavra</surname><given-names>O.</given-names></name>; <name><surname>Kokkonen</surname><given-names>P.</given-names></name>; <name><surname>Filipovic</surname><given-names>J.</given-names></name>; <name><surname>Pinto</surname><given-names>G.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name><article-title>Caver Web 1.0: identification of
tunnels and channels
in proteins and analysis of ligand transport</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>W414</fpage>–<lpage>W422</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz378</pub-id>.<pub-id pub-id-type="pmid">31114897</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Sumbalova</surname><given-names>L.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>HotSpot Wizard
3.0: web server for automated design of mutations and smart libraries
based on sequence input information</article-title>. <source>Nucleic
Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>W356</fpage>–<lpage>W362</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky417</pub-id>.<pub-id pub-id-type="pmid">29796670</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Angles</surname><given-names>R.</given-names></name>; <name><surname>Arenas-Salinas</surname><given-names>M.</given-names></name>; <name><surname>Garcia</surname><given-names>R.</given-names></name>; <name><surname>Reyes-Suarez</surname><given-names>J. A.</given-names></name>; <name><surname>Pohl</surname><given-names>E.</given-names></name><article-title>GSP4PDB: a web tool
to visualize, search and explore protein-ligand
structural patterns</article-title>. <source>BMC Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s12859-020-3352-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Viet
Hung</surname><given-names>L.</given-names></name>; <name><surname>Caprari</surname><given-names>S.</given-names></name>; <name><surname>Bizai</surname><given-names>M.</given-names></name>; <name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA: LIgand
Binding site Recognition Application</article-title>. <source>Bioinformatics</source><year>2015</year>, <volume>31</volume>, <fpage>4020</fpage>–<lpage>4022</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv489</pub-id>.<pub-id pub-id-type="pmid">26315904</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Toti</surname><given-names>D.</given-names></name>; <name><surname>Viet Hung</surname><given-names>L.</given-names></name>; <name><surname>Tortosa</surname><given-names>V.</given-names></name>; <name><surname>Brandi</surname><given-names>V.</given-names></name>; <name><surname>Polticelli</surname><given-names>F.</given-names></name><article-title>LIBRA-WA:
a web application for ligand binding site detection and protein function
recognition</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>878</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx715</pub-id>.<pub-id pub-id-type="pmid">29126218</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Lilley</surname><given-names>D. M.</given-names></name>; <name><surname>Clegg</surname><given-names>R. M.</given-names></name>; <name><surname>Diekmann</surname><given-names>S.</given-names></name>; <name><surname>Seeman</surname><given-names>N. C.</given-names></name>; <name><surname>von Kitzing</surname><given-names>E.</given-names></name>; <name><surname>Hagerman</surname><given-names>P.</given-names></name><article-title>Nomenclature Committee of the International
Union of
Biochemistry and Molecular Biology (NC-IUBMB). A nomenclature of junctions
and branchpoints in nucleic acids. Recommendations 1994</article-title>. <source>Eur. J. Biochem.</source><year>1995</year>, <volume>230</volume>, <fpage>1</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20526.x</pub-id>.<pub-id pub-id-type="pmid">7601087</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Dalkiran</surname><given-names>A.</given-names></name>; <name><surname>Rifaioglu</surname><given-names>A. S.</given-names></name>; <name><surname>Martin</surname><given-names>M. J.</given-names></name>; <name><surname>Cetin-Atalay</surname><given-names>R.</given-names></name>; <name><surname>Atalay</surname><given-names>V.</given-names></name>; <name><surname>Dogan</surname><given-names>T.</given-names></name><article-title>ECPred: a
tool for the prediction
of the enzymatic functions of protein sequences based on the EC nomenclature</article-title>. <source>BMC Bioinf.</source><year>2018</year>, <volume>19</volume>, <fpage>334</fpage><pub-id pub-id-type="doi">10.1186/s12859-018-2368-y</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Shen</surname><given-names>H. B.</given-names></name>; <name><surname>Chou</surname><given-names>K. C.</given-names></name><article-title>EzyPred: a top-down
approach for predicting enzyme
functional classes and subclasses</article-title>. <source>Biochem.
Biophys. Res. Commun.</source><year>2007</year>, <volume>364</volume>, <fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.098</pub-id>.<pub-id pub-id-type="pmid">17931599</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Umarov</surname><given-names>R.</given-names></name>; <name><surname>Xie</surname><given-names>B.</given-names></name>; <name><surname>Fan</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Gao</surname><given-names>X.</given-names></name><article-title>DEEPre: sequence-based
enzyme EC number prediction
by deep learning</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>760</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx680</pub-id>.<pub-id pub-id-type="pmid">29069344</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Memon</surname><given-names>S. A.</given-names></name>; <name><surname>Khan</surname><given-names>K. A.</given-names></name>; <name><surname>Naveed</surname><given-names>H.</given-names></name><article-title>HECNet: a hierarchical
approach to
enzyme function classification using a Siamese Triplet Network</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>4583</fpage>–<lpage>4589</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa536</pub-id>.<pub-id pub-id-type="pmid">32449765</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Zhang</surname><given-names>T.</given-names></name>; <name><surname>Tian</surname><given-names>Y.</given-names></name>; <name><surname>Yuan</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>F.</given-names></name>; <name><surname>Ren</surname><given-names>A.</given-names></name>; <name><surname>Hu</surname><given-names>Q. N.</given-names></name><article-title>Bio2Rxn: sequence-based enzymatic reaction predictions by a consensus
strategy</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>3600</fpage>–<lpage>3601</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa135</pub-id>.<pub-id pub-id-type="pmid">32108855</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E. L. L.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Paladin</surname><given-names>L.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L. J.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name><article-title>Pfam: The protein families
database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D412</fpage>–<lpage>D419</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa913</pub-id>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Blum</surname><given-names>M.</given-names></name>; <name><surname>Chang</surname><given-names>H. Y.</given-names></name>; <name><surname>Chuguransky</surname><given-names>S.</given-names></name>; <name><surname>Grego</surname><given-names>T.</given-names></name>; <name><surname>Kandasaamy</surname><given-names>S.</given-names></name>; <name><surname>Mitchell</surname><given-names>A.</given-names></name>; <name><surname>Nuka</surname><given-names>G.</given-names></name>; <name><surname>Paysan-Lafosse</surname><given-names>T.</given-names></name>; <name><surname>Qureshi</surname><given-names>M.</given-names></name>; <name><surname>Raj</surname><given-names>S.</given-names></name>; <name><surname>Richardson</surname><given-names>L.</given-names></name>; <name><surname>Salazar</surname><given-names>G. A.</given-names></name>; <name><surname>Williams</surname><given-names>L.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name>; <name><surname>Bridge</surname><given-names>A.</given-names></name>; <name><surname>Gough</surname><given-names>J.</given-names></name>; <name><surname>Haft</surname><given-names>D. H.</given-names></name>; <name><surname>Letunic</surname><given-names>I.</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Mi</surname><given-names>H.</given-names></name>; <name><surname>Natale</surname><given-names>D.</given-names></name>; <name><surname>Necci</surname><given-names>M.</given-names></name>; <name><surname>Orengo</surname><given-names>C. A.</given-names></name>; <name><surname>Pandurangen</surname><given-names>A. P.</given-names></name>; <name><surname>Rivoire</surname><given-names>C.</given-names></name>; <name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Sillitoe</surname><given-names>I.</given-names></name>; <name><surname>Thanki</surname><given-names>N.</given-names></name>; <name><surname>Thomas</surname><given-names>P. D.</given-names></name>; <name><surname>Tosatto</surname><given-names>S. C. E.</given-names></name>; <name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name><article-title>The InterPro protein families and domains database:
20 years on</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>D344</fpage>–<lpage>D354</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa977</pub-id>.<pub-id pub-id-type="pmid">33156333</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Borko</surname><given-names>S.</given-names></name>; <name><surname>Stourac</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Zendulka</surname><given-names>J.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Martinek</surname><given-names>T.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>EnzymeMiner:
automated mining of soluble enzymes with diverse structures, catalytic
properties and stabilities</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>, <volume>48</volume>, <fpage>W104</fpage>–<lpage>W109</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa372</pub-id>.<pub-id pub-id-type="pmid">32392342</pub-id></mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Wu</surname><given-names>C. H.</given-names></name>; <name><surname>Nikolskaya</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Yeh</surname><given-names>L. S.</given-names></name>; <name><surname>Natale</surname><given-names>D. A.</given-names></name>; <name><surname>Vinayaka</surname><given-names>C. R.</given-names></name>; <name><surname>Hu</surname><given-names>Z. Z.</given-names></name>; <name><surname>Mazumder</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Kourtesis</surname><given-names>P.</given-names></name>; <name><surname>Ledley</surname><given-names>R. S.</given-names></name>; <name><surname>Suzek</surname><given-names>B. E.</given-names></name>; <name><surname>Arminski</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Cardenas</surname><given-names>J. L.</given-names></name>; <name><surname>Chung</surname><given-names>S.</given-names></name>; <name><surname>Castro-Alvear</surname><given-names>J.</given-names></name>; <name><surname>Dinkov</surname><given-names>G.</given-names></name>; <name><surname>Barker</surname><given-names>W. C.</given-names></name><article-title>PIRSF:
family classification
system at the Protein Information Resource</article-title>. <source>Nucleic Acids Res.</source><year>2004</year>, <volume>32</volume>, <fpage>D112</fpage>–<lpage>D114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh097</pub-id>.<pub-id pub-id-type="pmid">14681371</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Qian</surname><given-names>Z.</given-names></name>; <name><surname>Cai</surname><given-names>Y. D.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name><article-title>ECS: an automatic enzyme
classifier based on functional domain composition</article-title>. <source>Comput. Biol. Chem.</source><year>2007</year>, <volume>31</volume>, <fpage>226</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2007.03.008</pub-id>.<pub-id pub-id-type="pmid">17500036</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Alborzi</surname><given-names>S. Z.</given-names></name>; <name><surname>Devignes</surname><given-names>M. D.</given-names></name>; <name><surname>Ritchie</surname><given-names>D. W.</given-names></name><article-title>ECDomainMiner:
discovering hidden
associations between enzyme commission numbers and Pfam domains</article-title>. <source>BMC Bioinf.</source><year>2017</year>, <volume>18</volume>, <fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s12859-017-1519-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Sigrist</surname><given-names>C. J. A.</given-names></name>; <name><surname>Cerutti</surname><given-names>L.</given-names></name>; <name><surname>de Castro</surname><given-names>E.</given-names></name>; <name><surname>Langendijk-Genevaux</surname><given-names>P. S.</given-names></name>; <name><surname>Bulliard</surname><given-names>V.</given-names></name>; <name><surname>Bairoch</surname><given-names>A.</given-names></name>; <name><surname>Hulo</surname><given-names>N.</given-names></name><article-title>PROSITE, a protein
domain database for functional characterization and annotation</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>, <volume>38</volume>, <fpage>D161</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp885</pub-id>.<pub-id pub-id-type="pmid">19858104</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>de
Rond</surname><given-names>T.</given-names></name>; <name><surname>Asay</surname><given-names>J. E.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name><article-title>Co-occurrence of enzyme domains guides
the discovery of an oxazolone synthetase</article-title>. <source>Nat.
Chem. Biol.</source><year>2021</year>, <volume>17</volume>, <fpage>794</fpage>–<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-021-00808-4</pub-id>.<pub-id pub-id-type="pmid">34099916</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Mak</surname><given-names>W. S.</given-names></name>; <name><surname>Tran</surname><given-names>S.</given-names></name>; <name><surname>Marcheschi</surname><given-names>R.</given-names></name>; <name><surname>Bertolani</surname><given-names>S.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Baker</surname><given-names>D.</given-names></name>; <name><surname>Liao</surname><given-names>J. C.</given-names></name>; <name><surname>Siegel</surname><given-names>J. B.</given-names></name><article-title>Integrative
genomic mining for enzyme function to enable engineering of a non-natural
biosynthetic pathway</article-title>. <source>Nat. Commun.</source><year>2015</year>, <volume>6</volume>, <elocation-id>10005</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10005</pub-id>.<pub-id pub-id-type="pmid">26598135</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Vasina</surname><given-names>M.</given-names></name>; <name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Hon</surname><given-names>J.</given-names></name>; <name><surname>Kovar</surname><given-names>D.</given-names></name>; <name><surname>Faldynova</surname><given-names>H.</given-names></name>; <name><surname>Kunka</surname><given-names>A.</given-names></name>; <name><surname>Buryska</surname><given-names>T.</given-names></name>; <name><surname>Badenhorst</surname><given-names>C. P. S.</given-names></name>; <name><surname>Mazurenko</surname><given-names>S.</given-names></name>; <name><surname>Bednar</surname><given-names>D.</given-names></name>; <name><surname>Stavrakis</surname><given-names>S.</given-names></name>; <name><surname>Bornscheuer</surname><given-names>U. T.</given-names></name>; <name><surname>deMello</surname><given-names>A.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name><article-title>Advanced database mining of efficient haloalkane dehalogenases
by sequence and structure bioinformatics and microfluidics</article-title>. <source>Chem. Catal.</source><year>2022</year>, <volume>2</volume>, <fpage>2704</fpage>–<lpage>2725</lpage>. <pub-id pub-id-type="doi">10.1016/j.checat.2022.09.011</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Vanacek</surname><given-names>P.</given-names></name>; <name><surname>Sebestova</surname><given-names>E.</given-names></name>; <name><surname>Babkova</surname><given-names>P.</given-names></name>; <name><surname>Bidmanova</surname><given-names>S.</given-names></name>; <name><surname>Daniel</surname><given-names>L.</given-names></name>; <name><surname>Dvorak</surname><given-names>P.</given-names></name>; <name><surname>Stepankova</surname><given-names>V.</given-names></name>; <name><surname>Chaloupkova</surname><given-names>R.</given-names></name>; <name><surname>Brezovsky</surname><given-names>J.</given-names></name>; <name><surname>Prokop</surname><given-names>Z.</given-names></name>; <name><surname>Damborsky</surname><given-names>J.</given-names></name><article-title>Exploration
of Enzyme Diversity by Integrating Bioinformatics with Expression
Analysis and Biochemical Characterization</article-title>. <source>ACS
Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>2402</fpage>–<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.7b03523</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Lobb</surname><given-names>B.</given-names></name>; <name><surname>Doxey</surname><given-names>A. C.</given-names></name><article-title>Novel function discovery
through sequence and structural
data mining</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2016</year>, <volume>38</volume>, <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2016.05.017</pub-id>.<pub-id pub-id-type="pmid">27289211</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Ghislieri</surname><given-names>D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Approaches
to the Synthesis of Enantiomerically
Pure Chiral Amines</article-title>. <source>Top. Catal.</source><year>2014</year>, <volume>57</volume>, <fpage>284</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s11244-013-0184-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Du</surname><given-names>S.</given-names></name>; <name><surname>Gao</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Chang</surname><given-names>M.</given-names></name><article-title>Secondary amines as coupling partners
in direct catalytic asymmetric
reductive amination</article-title>. <source>Chem. Sci.</source><year>2019</year>, <volume>10</volume>, <fpage>4509</fpage>–<lpage>4514</lpage>. <pub-id pub-id-type="doi">10.1039/C9SC00323A</pub-id>.<pub-id pub-id-type="pmid">31057780</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>A mechanism for reductive
amination catalyzed by fungal reductive aminases</article-title>. <source>ACS Catal.</source><year>2018</year>, <volume>8</volume>, <fpage>11534</fpage>–<lpage>11541</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.8b03491</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Devine</surname><given-names>P. N.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Thompson</surname><given-names>M. P.</given-names></name>; <name><surname>Truppo</surname><given-names>M. D.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Extending the application
of biocatalysis to meet the
challenges of drug development</article-title>. <source>Nat. Rev. Chem.</source><year>2018</year>, <volume>2</volume>, <fpage>409</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/s41570-018-0055-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>A reductive aminase
from Aspergillus
oryzae</article-title>. <source>Nat. Chem.</source><year>2017</year>, <volume>9</volume>, <fpage>961</fpage>–<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2782</pub-id>.<pub-id pub-id-type="pmid">28937665</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Mitsukura</surname><given-names>K.</given-names></name>; <name><surname>Suzuki</surname><given-names>M.</given-names></name>; <name><surname>Tada</surname><given-names>K.</given-names></name>; <name><surname>Yoshida</surname><given-names>T.</given-names></name>; <name><surname>Nagasawa</surname><given-names>T.</given-names></name><article-title>Asymmetric
synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell
catalyst of enantioselective imine reductase</article-title>. <source>Org. Biomol. Chem.</source><year>2010</year>, <volume>8</volume>, <fpage>4533</fpage>–<lpage>4535</lpage>. <pub-id pub-id-type="doi">10.1039/C0OB00353K</pub-id>.<pub-id pub-id-type="pmid">20820664</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Finnigan</surname><given-names>J. D.</given-names></name>; <name><surname>Thorpe</surname><given-names>T. W.</given-names></name>; <name><surname>Palmer</surname><given-names>R. B.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Duncan</surname><given-names>R. A. M.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Graham</surname><given-names>K. M.</given-names></name>; <name><surname>Cook</surname><given-names>D. J.</given-names></name>; <name><surname>Charnock</surname><given-names>S. J.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Screening
and characterization of a diverse panel of metagenomic imine reductases
for biocatalytic reductive amination</article-title>. <source>Nat. Chem.</source><year>2021</year>, <volume>13</volume>, <fpage>140</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-020-00606-w</pub-id>.<pub-id pub-id-type="pmid">33380742</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Luan</surname><given-names>Z.-J.</given-names></name>; <name><surname>Zheng</surname><given-names>G.-W.</given-names></name>; <name><surname>Xu</surname><given-names>J.-H.</given-names></name><article-title>Efficient Synthesis
of Chiral Indolines using an Imine Reductase from Paenibacillus lactis</article-title>. <source>Adv. Synth. Catal.</source><year>2015</year>, <volume>357</volume>, <fpage>1692</fpage>–<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201500160</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name><article-title>One-step asymmetric synthesis of
(R)- and (S)-rasagiline by reductive amination applying imine reductases</article-title>. <source>Green Chem.</source><year>2017</year>, <volume>19</volume>, <fpage>385</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1039/C6GC03023H</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Yao</surname><given-names>P.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>S.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Zhu</surname><given-names>D.</given-names></name><article-title>Imine Reductase-Catalyzed
Enantioselective Reduction of Bulky α,β-Unsaturated Imines
en Route to a Pharmaceutically Important Morphinan Skeleton</article-title>. <source>Adv. Synth. Catal.</source><year>2019</year>, <volume>361</volume>, <fpage>556</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201801326</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Weise</surname><given-names>N. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Identification
of Novel Bacterial Members of the Imine Reductase Enzyme Family that
Perform Reductive Amination</article-title>. <source>ChemCatChem</source><year>2018</year>, <volume>10</volume>, <fpage>510</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701408</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Pushpanath</surname><given-names>A.</given-names></name>; <name><surname>Heath</surname><given-names>R. S.</given-names></name>; <name><surname>Marshall</surname><given-names>J. R.</given-names></name>; <name><surname>Klemstein</surname><given-names>U.</given-names></name>; <name><surname>Galman</surname><given-names>J. L.</given-names></name>; <name><surname>Woodlock</surname><given-names>D.</given-names></name>; <name><surname>Bisagni</surname><given-names>S.</given-names></name>; <name><surname>Taylor</surname><given-names>C. J.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Dominguez</surname><given-names>B.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Characterization of imine reductases in reductive amination
for the exploration of structure-activity relationships</article-title>. <source>Sci. Adv.</source><year>2020</year>, <volume>6</volume>, <elocation-id>eaay9320</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay9320</pub-id>.<pub-id pub-id-type="pmid">32494734</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Berrera</surname><given-names>M.</given-names></name>; <name><surname>Sandon</surname><given-names>N.</given-names></name>; <name><surname>Fishlock</surname><given-names>D.</given-names></name>; <name><surname>Ebeling</surname><given-names>M.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Hanlon</surname><given-names>S.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Expanding
the Imine Reductase Toolbox by Exploring the Bacterial Protein-Sequence
Space</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1749</fpage>–<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500218</pub-id>.<pub-id pub-id-type="pmid">26044455</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Wetzl</surname><given-names>D.</given-names></name>; <name><surname>Gand</surname><given-names>M.</given-names></name>; <name><surname>Ross</surname><given-names>A.</given-names></name>; <name><surname>Müller</surname><given-names>H.</given-names></name>; <name><surname>Matzel</surname><given-names>P.</given-names></name>; <name><surname>Hanlon</surname><given-names>S. P.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name>; <name><surname>Wirz</surname><given-names>B.</given-names></name>; <name><surname>Höhne</surname><given-names>M.</given-names></name>; <name><surname>Iding</surname><given-names>H.</given-names></name><article-title>Asymmetric Reductive
Amination of Ketones Catalyzed by Imine Reductases</article-title>. <source>ChemCatChem</source><year>2016</year>, <volume>8</volume>, <fpage>2023</fpage>–<lpage>2026</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201600384</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Roiban</surname><given-names>G.-D.</given-names></name>; <name><surname>Kern</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Hyslop</surname><given-names>J.</given-names></name>; <name><surname>Tey</surname><given-names>P. L.</given-names></name>; <name><surname>Levine</surname><given-names>M. S.</given-names></name>; <name><surname>Jordan</surname><given-names>L. S.</given-names></name>; <name><surname>Brown</surname><given-names>K. K.</given-names></name>; <name><surname>Hadi</surname><given-names>T.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name><article-title>Efficient
Biocatalytic Reductive
Aminations by Extending the Imine Reductase Toolbox</article-title>. <source>ChemCatChem</source><year>2017</year>, <volume>9</volume>, <fpage>4475</fpage>–<lpage>4479</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201701379</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Schober</surname><given-names>M.</given-names></name>; <name><surname>MacDermaid</surname><given-names>C.</given-names></name>; <name><surname>Ollis</surname><given-names>A. A.</given-names></name>; <name><surname>Chang</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>D.</given-names></name>; <name><surname>Hosford</surname><given-names>J.</given-names></name>; <name><surname>Latham</surname><given-names>J.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>Brown</surname><given-names>M. J. B.</given-names></name>; <name><surname>Fuerst</surname><given-names>D.</given-names></name>; <name><surname>Sanganee</surname><given-names>M. J.</given-names></name>; <name><surname>Roiban</surname><given-names>G.-D.</given-names></name><article-title>Chiral synthesis
of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine
reductase</article-title>. <source>Nat. Catal.</source><year>2019</year>, <volume>2</volume>, <fpage>909</fpage>–<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-019-0341-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Karmilowicz</surname><given-names>M. J.</given-names></name>; <name><surname>Burke</surname><given-names>D.</given-names></name>; <name><surname>Burns</surname><given-names>M. P.</given-names></name>; <name><surname>Clark</surname><given-names>L. A.</given-names></name>; <name><surname>Connor</surname><given-names>C. G.</given-names></name>; <name><surname>Cordi</surname><given-names>E.</given-names></name>; <name><surname>Do</surname><given-names>N. M.</given-names></name>; <name><surname>Doyle</surname><given-names>K. M.</given-names></name>; <name><surname>Hoagland</surname><given-names>S.</given-names></name>; <name><surname>Lewis</surname><given-names>C. A.</given-names></name>; <name><surname>Mangan</surname><given-names>D.</given-names></name>; <name><surname>Martinez</surname><given-names>C. A.</given-names></name>; <name><surname>McInturff</surname><given-names>E. L.</given-names></name>; <name><surname>Meldrum</surname><given-names>K.</given-names></name>; <name><surname>Pearson</surname><given-names>R.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Rane</surname><given-names>A.</given-names></name>; <name><surname>Weaver</surname><given-names>J.</given-names></name><article-title>Biocatalytic reductive
amination
from discovery to commercial manufacturing applied to abrocitinib
JAK1 inhibitor</article-title>. <source>Nat. Catal.</source><year>2021</year>, <volume>4</volume>, <fpage>775</fpage>–<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/s41929-021-00671-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Webb</surname><given-names>B.</given-names></name>; <name><surname>Sali</surname><given-names>A.</given-names></name><article-title>Comparative Protein Structure Modeling
Using MODELLER</article-title>. <source>Curr. Protoc. Bioinf.</source><year>2016</year>, <volume>54</volume>, <fpage>5</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/cpbi.3</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Sánchez</surname><given-names>R.</given-names></name>; <name><surname>Šali</surname><given-names>A.</given-names></name><article-title>Comparative protein structure modeling as an optimization
problem</article-title>. <source>J. Mol. Struct.: THEOCHEM</source><year>1997</year>, <volume>398-399</volume>, <fpage>489</fpage>–<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-1280(96)04971-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Trott</surname><given-names>O.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock Vina: improving
the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source>J. Comput. Chem.</source><year>2010</year>, <volume>31</volume>, <fpage>455</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>.<pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></name>; <name><surname>Adler</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Green</surname><given-names>T.</given-names></name>; <name><surname>Zielinski</surname><given-names>M.</given-names></name>; <name><surname>Zidek</surname><given-names>A.</given-names></name>; <name><surname>Bridgland</surname><given-names>A.</given-names></name>; <name><surname>Cowie</surname><given-names>A.</given-names></name>; <name><surname>Meyer</surname><given-names>C.</given-names></name>; <name><surname>Laydon</surname><given-names>A.</given-names></name>; <name><surname>Velankar</surname><given-names>S.</given-names></name>; <name><surname>Kleywegt</surname><given-names>G. J.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Evans</surname><given-names>R.</given-names></name>; <name><surname>Pritzel</surname><given-names>A.</given-names></name>; <name><surname>Figurnov</surname><given-names>M.</given-names></name>; <name><surname>Ronneberger</surname><given-names>O.</given-names></name>; <name><surname>Bates</surname><given-names>R.</given-names></name>; <name><surname>Kohl</surname><given-names>S. A. A.</given-names></name>; <name><surname>Potapenko</surname><given-names>A.</given-names></name>; <name><surname>Ballard</surname><given-names>A. J.</given-names></name>; <name><surname>Romera-Paredes</surname><given-names>B.</given-names></name>; <name><surname>Nikolov</surname><given-names>S.</given-names></name>; <name><surname>Jain</surname><given-names>R.</given-names></name>; <name><surname>Clancy</surname><given-names>E.</given-names></name>; <name><surname>Reiman</surname><given-names>D.</given-names></name>; <name><surname>Petersen</surname><given-names>S.</given-names></name>; <name><surname>Senior</surname><given-names>A. W.</given-names></name>; <name><surname>Kavukcuoglo</surname><given-names>K.</given-names></name>; <name><surname>Birney</surname><given-names>E.</given-names></name>; <name><surname>Pushmeet</surname><given-names>K.</given-names></name>; <name><surname>Jumper</surname><given-names>J.</given-names></name>; <name><surname>Hassabis</surname><given-names>D.</given-names></name><article-title>Highly accurate
protein structure prediction for the
human proteome</article-title>. <source>Nature</source><year>2021</year>, <volume>596</volume>, <fpage>590</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>.<pub-id pub-id-type="pmid">34293799</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Lee</surname><given-names>C.</given-names></name>; <name><surname>Su</surname><given-names>B. H.</given-names></name>; <name><surname>Tseng</surname><given-names>Y. J.</given-names></name><article-title>Comparative studies of AlphaFold,
RoseTTAFold and Modeller: a case study involving the use of G-protein-coupled
receptors</article-title>. <source>Briefings Bioinf.</source><year>2022</year>, <volume>23</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbac308</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Rodríguez-Mata</surname><given-names>M.</given-names></name>; <name><surname>Frank</surname><given-names>A.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure and activity
of NADPH-dependent reductase Q1EQE0 from Streptomyces kanamyceticus,
which catalyses the R-selective reduction of an imine substrate</article-title>. <source>ChemBioChem</source><year>2013</year>, <volume>14</volume>, <fpage>1372</fpage>–<lpage>1379</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201300321</pub-id>.<pub-id pub-id-type="pmid">23813853</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Wells</surname><given-names>E.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name><article-title>Structure, Activity
and Stereoselectivity of NADPH-Dependent Oxidoreductases Catalysing
the S-Selective Reduction of the Imine Substrate 2-Methylpyrroline</article-title>. <source>ChemBioChem</source><year>2015</year>, <volume>16</volume>, <fpage>1052</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201402625</pub-id>.<pub-id pub-id-type="pmid">25809902</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Huber</surname><given-names>T.</given-names></name>; <name><surname>Schneider</surname><given-names>L.</given-names></name>; <name><surname>Präg</surname><given-names>A.</given-names></name>; <name><surname>Gerhardt</surname><given-names>S.</given-names></name>; <name><surname>Einsle</surname><given-names>O.</given-names></name>; <name><surname>Müller</surname><given-names>M.</given-names></name><article-title>Direct Reductive
Amination of Ketones: Structure and
Activity ofS-Selective Imine Reductases fromStreptomyces</article-title>. <source>ChemCatChem</source><year>2014</year>, <volume>6</volume>, <fpage>2248</fpage>–<lpage>2252</lpage>. <pub-id pub-id-type="doi">10.1002/cctc.201402218</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Leipold</surname><given-names>F.</given-names></name>; <name><surname>Hussain</surname><given-names>S.</given-names></name>; <name><surname>Toca-Gonzalez</surname><given-names>L.</given-names></name>; <name><surname>Marchington</surname><given-names>R.</given-names></name>; <name><surname>Hart</surname><given-names>S.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J. P.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Stereoselectivity and Structural
Characterization of an Imine Reductase (IRED) from Amycolatopsis orientalis</article-title>. <source>ACS Catal.</source><year>2016</year>, <volume>6</volume>, <fpage>3880</fpage>–<lpage>3889</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.6b00782</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Lenz</surname><given-names>M.</given-names></name>; <name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name><article-title>New imine-reducing
enzymes from beta-hydroxyacid dehydrogenases
by single amino acid substitutions</article-title>. <source>Protein
Eng., Des. Sel.</source><year>2018</year>, <volume>31</volume>, <fpage>109</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/protein/gzy006</pub-id>.<pub-id pub-id-type="pmid">29733377</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>Howard</surname><given-names>R. M.</given-names></name>; <name><surname>Steflik</surname><given-names>J.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Adams</surname><given-names>R. W.</given-names></name>; <name><surname>Slabu</surname><given-names>I.</given-names></name>; <name><surname>Crook</surname><given-names>R.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Wallace</surname><given-names>T. W.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Biocatalytic Routes to Enantiomerically
Enriched Dibenz[c,e]azepines</article-title>. <source>Angew. Chem.,
Int. Ed.</source><year>2017</year>, <volume>56</volume>, <fpage>15589</fpage>–<lpage>15593</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201708453</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Mangas-Sanchez</surname><given-names>J.</given-names></name>; <name><surname>France</surname><given-names>S. P.</given-names></name>; <name><surname>Montgomery</surname><given-names>S. L.</given-names></name>; <name><surname>Aleku</surname><given-names>G. A.</given-names></name>; <name><surname>Man</surname><given-names>H.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Ramsden</surname><given-names>J. I.</given-names></name>; <name><surname>Grogan</surname><given-names>G.</given-names></name>; <name><surname>Turner</surname><given-names>N. J.</given-names></name><article-title>Imine reductases
(IREDs)</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2017</year>, <volume>37</volume>, <fpage>19</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2016.11.022</pub-id>.<pub-id pub-id-type="pmid">28038349</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Feinstein</surname><given-names>W. P.</given-names></name>; <name><surname>Brylinski</surname><given-names>M.</given-names></name><article-title>Calculating an optimal box size for
ligand docking
and virtual screening against experimental and predicted binding pockets</article-title>. <source>J. Cheminf.</source><year>2015</year>, <volume>7</volume>, <elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/s13321-015-0067-5</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Morris</surname><given-names>G. M.</given-names></name>; <name><surname>Huey</surname><given-names>R.</given-names></name>; <name><surname>Lindstrom</surname><given-names>W.</given-names></name>; <name><surname>Sanner</surname><given-names>M. F.</given-names></name>; <name><surname>Belew</surname><given-names>R. K.</given-names></name>; <name><surname>Goodsell</surname><given-names>D. S.</given-names></name>; <name><surname>Olson</surname><given-names>A. J.</given-names></name><article-title>AutoDock4
and AutoDockTools4: Automated
docking with selective receptor flexibility</article-title>. <source>J. Comput. Chem.</source><year>2009</year>, <volume>30</volume>, <fpage>2785</fpage>–<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>.<pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>O’Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name><article-title>Open Babel:
An open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Stockinger</surname><given-names>P.</given-names></name>; <name><surname>Roth</surname><given-names>S.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Systematic Evaluation
of Imine-Reducing Enzymes: Common Principles in Imine Reductases,
beta-Hydroxy Acid Dehydrogenases, and Short-Chain Dehydrogenases/
Reductases</article-title>. <source>ChemBioChem</source><year>2020</year>, <volume>21</volume>, <fpage>2689</fpage>–<lpage>2695</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.202000213</pub-id>.<pub-id pub-id-type="pmid">32311225</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Fademrecht</surname><given-names>S.</given-names></name>; <name><surname>Scheller</surname><given-names>P. N.</given-names></name>; <name><surname>Nestl</surname><given-names>B. M.</given-names></name>; <name><surname>Hauer</surname><given-names>B.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name><article-title>Identification
of imine reductase-specific sequence motifs</article-title>. <source>Proteins</source><year>2016</year>, <volume>84</volume>, <fpage>600</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/prot.25008</pub-id>.<pub-id pub-id-type="pmid">26857686</pub-id></mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Pruitt</surname><given-names>K. D.</given-names></name>; <name><surname>Tatusova</surname><given-names>T.</given-names></name>; <name><surname>Maglott</surname><given-names>D. R.</given-names></name><article-title>NCBI reference
sequences (RefSeq):
a curated non-redundant sequence database of genomes, transcripts
and proteins</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>, <volume>35</volume>, <fpage>D61</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl842</pub-id>.<pub-id pub-id-type="pmid">17130148</pub-id></mixed-citation>
    </ref>
    <ref id="ref77">
      <mixed-citation publication-type="journal" id="cit77"><name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Godzik</surname><given-names>A.</given-names></name><article-title>Cd-hit: a fast program for clustering and comparing
large sets of protein or nucleotide sequences</article-title>. <source>Bioinformatics</source><year>2006</year>, <volume>22</volume>, <fpage>1658</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id>.<pub-id pub-id-type="pmid">16731699</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
